<!DOCTYPE html>
<html lang="en">

  <head>
    <meta charset="utf-8">
    </meta>
    <title>Metadata reference</title>
  </head>

  <body>
    <h1>Metadata reference</h1>
    <div id="tocContainer">
      <ul>
        <li><a href="#package">Package ID</a></li>
        <li><a href="#categoryOptionGroupSets">Category Option Group Sets</a></li>
        <li><a href="#categoryOptionGroups">Category Option Groups</a></li>
        <li><a href="#indicatorGroups">Indicator Groups</a></li>
        <li><a href="#indicators">Indicators</a></li>
        <li><a href="#indicatorTypes">Indicator Types</a></li>
        <li><a href="#dashboards">Dashboards</a></li>
        <li><a href="#visualizations">Visualizations</a></li>
        <li><a href="#maps">Maps</a></li>
        <li><a href="#legendSets">Legend Sets</a></li>
        <li><a href="#userGroups">User Groups</a></li>
      </ul>
    </div>
    <h2>Package info</h2>
    <table>
      <tr>
        <th>Property</th>
        <td>Value</td>
      </tr>
      <tr>
        <th>Code</th>
        <td>TB</td>
      </tr>
      <tr>
        <th>Type</th>
        <td>DASHBOARD</td>
      </tr>
      <tr>
        <th>Version</th>
        <td>1.1.2</td>
      </tr>
      <tr>
        <th>DHIS2 version</th>
        <td>2.34.4</td>
      </tr>
      <tr>
        <th>DHIS2 build</th>
        <td>aff07fb</td>
      </tr>
      <tr>
        <th>Last updated</th>
        <td>20210622T210028</td>
      </tr>
      <tr>
        <th>Name</th>
        <td>TB_DASHBOARD_V1.1.2_2.34.4-en</td>
      </tr>
    </table>
    <h2 id="categoryOptionGroupSets">Category Option Group Sets</h2>
    <table>
      <tr>
        <th>Name</th>
        <th>Last updated</th>
        <th>UID</th>
      </tr>
      <tr>
        <td>Sex (Male/Female)</td>
        <td>2021-02-08</td>
        <td>CMrvZp5rmoC</td>
      </tr>
      <tr>
        <td>Age in years (0-4, 5-14, 15-24, 25-34, 35-44, 45-54, 55-64, 65+, unknown)</td>
        <td>2021-02-08</td>
        <td>dxmp3usPQIm</td>
      </tr>
      <tr>
        <td>Age in years (0-5, 5-14, 0-14, 15+, 15-24, 25-34, 35-44, 45-54, 55-64, 65+, unknown)</td>
        <td>2021-02-08</td>
        <td>OZlTcjBnAsn</td>
      </tr>
      <tr>
        <td>Sex (with unknown)</td>
        <td>2021-02-08</td>
        <td>XxEFGdwxOJ0</td>
      </tr>
    </table>
    <h2 id="categoryOptionGroups">Category Option Groups</h2>
    <table>
      <tr>
        <th>Name</th>
        <th>Shortname</th>
        <th>Last updated</th>
        <th>UID</th>
      </tr>
      <tr>
        <td>[CONFIG] Female</td>
        <td>Female</td>
        <td>2021-02-08</td>
        <td>bqoVhX2RfG4</td>
      </tr>
      <tr>
        <td>[CONFIG] 25-34 years</td>
        <td>25-34 y</td>
        <td>2021-02-08</td>
        <td>cRskhJQLr4J</td>
      </tr>
      <tr>
        <td>[CONFIG] 65+ years</td>
        <td>65+ y</td>
        <td>2021-02-08</td>
        <td>DdhMoYLz6Un</td>
      </tr>
      <tr>
        <td>[CONFIG] Male</td>
        <td>Male</td>
        <td>2021-02-08</td>
        <td>EVYKU2fIc6G</td>
      </tr>
      <tr>
        <td>[CONFIG] 15+ years (specific age)</td>
        <td>15+ years (specific)</td>
        <td>2021-02-08</td>
        <td>HkomAEMQt5e</td>
      </tr>
      <tr>
        <td>[CONFIG] 35-44 years</td>
        <td>35-44 y</td>
        <td>2021-02-08</td>
        <td>KkZHYvn7Zor</td>
      </tr>
      <tr>
        <td>[CONFIG] 15-24 years</td>
        <td>15-24 y</td>
        <td>2021-02-08</td>
        <td>L7gAblMOZKs</td>
      </tr>
      <tr>
        <td>[CONFIG] 55-64 years</td>
        <td>55-64 y</td>
        <td>2021-02-08</td>
        <td>QllZ8PveFCQ</td>
      </tr>
      <tr>
        <td>[CONFIG] Unknown Sex</td>
        <td>Unk Sex</td>
        <td>2020-09-17</td>
        <td>SZJNeRyrh22</td>
      </tr>
      <tr>
        <td>[CONFIG] 5-14 years</td>
        <td>5-14 y</td>
        <td>2021-02-08</td>
        <td>V9t81g7Wspa</td>
      </tr>
      <tr>
        <td>[CONFIG] 0-14 years (specific age)</td>
        <td>0-14 years (specific)</td>
        <td>2021-02-08</td>
        <td>vckBfmugFI3</td>
      </tr>
      <tr>
        <td>[CONFIG] 45-54 years</td>
        <td>45-54 y</td>
        <td>2021-02-08</td>
        <td>y5yT8JF4uCA</td>
      </tr>
      <tr>
        <td>[CONFIG] 0-4 years</td>
        <td>0-4 y</td>
        <td>2021-02-08</td>
        <td>yuathFHLjNe</td>
      </tr>
      <tr>
        <td>[CONFIG] Unknown age</td>
        <td>Unknown age</td>
        <td>2021-02-08</td>
        <td>YXE2HxNf3YB</td>
      </tr>
    </table>
    <h3>Category Option Group Sets - Category Option Groups</h3>
    <table>
      <tr>
        <th>Category Option Group Sets</th>
        <th>Category Option Groups</th>
      </tr>
      <tr>
        <td>Sex (Male/Female)</td>
        <td>[CONFIG] Female</td>
      </tr>
      <tr>
        <td>Sex (Male/Female)</td>
        <td>[CONFIG] Male</td>
      </tr>
      <tr>
        <td>Age in years (0-4, 5-14, 15-24, 25-34, 35-44, 45-54, 55-64, 65+, unknown)</td>
        <td>[CONFIG] 0-4 years</td>
      </tr>
      <tr>
        <td>Age in years (0-4, 5-14, 15-24, 25-34, 35-44, 45-54, 55-64, 65+, unknown)</td>
        <td>[CONFIG] 5-14 years</td>
      </tr>
      <tr>
        <td>Age in years (0-4, 5-14, 15-24, 25-34, 35-44, 45-54, 55-64, 65+, unknown)</td>
        <td>[CONFIG] 15-24 years</td>
      </tr>
      <tr>
        <td>Age in years (0-4, 5-14, 15-24, 25-34, 35-44, 45-54, 55-64, 65+, unknown)</td>
        <td>[CONFIG] 25-34 years</td>
      </tr>
      <tr>
        <td>Age in years (0-4, 5-14, 15-24, 25-34, 35-44, 45-54, 55-64, 65+, unknown)</td>
        <td>[CONFIG] 35-44 years</td>
      </tr>
      <tr>
        <td>Age in years (0-4, 5-14, 15-24, 25-34, 35-44, 45-54, 55-64, 65+, unknown)</td>
        <td>[CONFIG] 45-54 years</td>
      </tr>
      <tr>
        <td>Age in years (0-4, 5-14, 15-24, 25-34, 35-44, 45-54, 55-64, 65+, unknown)</td>
        <td>[CONFIG] 55-64 years</td>
      </tr>
      <tr>
        <td>Age in years (0-4, 5-14, 15-24, 25-34, 35-44, 45-54, 55-64, 65+, unknown)</td>
        <td>[CONFIG] 65+ years</td>
      </tr>
      <tr>
        <td>Age in years (0-4, 5-14, 15-24, 25-34, 35-44, 45-54, 55-64, 65+, unknown)</td>
        <td>[CONFIG] Unknown age</td>
      </tr>
      <tr>
        <td>Age in years (0-5, 5-14, 0-14, 15+, 15-24, 25-34, 35-44, 45-54, 55-64, 65+, unknown)</td>
        <td>[CONFIG] 0-4 years</td>
      </tr>
      <tr>
        <td>Age in years (0-5, 5-14, 0-14, 15+, 15-24, 25-34, 35-44, 45-54, 55-64, 65+, unknown)</td>
        <td>[CONFIG] 5-14 years</td>
      </tr>
      <tr>
        <td>Age in years (0-5, 5-14, 0-14, 15+, 15-24, 25-34, 35-44, 45-54, 55-64, 65+, unknown)</td>
        <td>[CONFIG] 0-14 years (specific age)</td>
      </tr>
      <tr>
        <td>Age in years (0-5, 5-14, 0-14, 15+, 15-24, 25-34, 35-44, 45-54, 55-64, 65+, unknown)</td>
        <td>[CONFIG] 15-24 years</td>
      </tr>
      <tr>
        <td>Age in years (0-5, 5-14, 0-14, 15+, 15-24, 25-34, 35-44, 45-54, 55-64, 65+, unknown)</td>
        <td>[CONFIG] 25-34 years</td>
      </tr>
      <tr>
        <td>Age in years (0-5, 5-14, 0-14, 15+, 15-24, 25-34, 35-44, 45-54, 55-64, 65+, unknown)</td>
        <td>[CONFIG] 35-44 years</td>
      </tr>
      <tr>
        <td>Age in years (0-5, 5-14, 0-14, 15+, 15-24, 25-34, 35-44, 45-54, 55-64, 65+, unknown)</td>
        <td>[CONFIG] 45-54 years</td>
      </tr>
      <tr>
        <td>Age in years (0-5, 5-14, 0-14, 15+, 15-24, 25-34, 35-44, 45-54, 55-64, 65+, unknown)</td>
        <td>[CONFIG] 55-64 years</td>
      </tr>
      <tr>
        <td>Age in years (0-5, 5-14, 0-14, 15+, 15-24, 25-34, 35-44, 45-54, 55-64, 65+, unknown)</td>
        <td>[CONFIG] 65+ years</td>
      </tr>
      <tr>
        <td>Age in years (0-5, 5-14, 0-14, 15+, 15-24, 25-34, 35-44, 45-54, 55-64, 65+, unknown)</td>
        <td>[CONFIG] 15+ years (specific age)</td>
      </tr>
      <tr>
        <td>Age in years (0-5, 5-14, 0-14, 15+, 15-24, 25-34, 35-44, 45-54, 55-64, 65+, unknown)</td>
        <td>[CONFIG] Unknown age</td>
      </tr>
      <tr>
        <td>Sex (with unknown)</td>
        <td>[CONFIG] Female</td>
      </tr>
      <tr>
        <td>Sex (with unknown)</td>
        <td>[CONFIG] Male</td>
      </tr>
      <tr>
        <td>Sex (with unknown)</td>
        <td>[CONFIG] Unknown Sex</td>
      </tr>
    </table>
    <h2 id="indicatorGroups">Indicator Groups</h2>
    <table>
      <tr>
        <th>Name</th>
        <th>Shortname</th>
        <th>Last updated</th>
        <th>UID</th>
      </tr>
      <tr>
        <td>Population estimates</td>
        <td></td>
        <td>2021-02-08</td>
        <td>I13HBLJTJMb</td>
      </tr>
      <tr>
        <td>TB case notification</td>
        <td></td>
        <td>2021-02-08</td>
        <td>OMyYjoU07pC</td>
      </tr>
      <tr>
        <td>TB stock</td>
        <td></td>
        <td>2021-05-03</td>
        <td>pMaektY4E9s</td>
      </tr>
      <tr>
        <td>TB RR/MDR</td>
        <td></td>
        <td>2021-02-08</td>
        <td>QCrsjqhAcWA</td>
      </tr>
      <tr>
        <td>TB</td>
        <td></td>
        <td>2021-02-08</td>
        <td>S0n1torLnUz</td>
      </tr>
      <tr>
        <td>TB treatment outcomes</td>
        <td></td>
        <td>2021-02-08</td>
        <td>V4SoC7TzFMi</td>
      </tr>
    </table>
    <h3>Indicator Groups - Indicators</h3>
    <table>
      <tr>
        <th>Indicator Group</th>
        <th>Indicator</th>
      </tr>
      <tr>
        <td>Population estimates</td>
        <td>[CONFIG] GEN - Population total</td>
      </tr>
      <tr>
        <td>TB case notification</td>
        <td>[CONFIG] TB - Cured (all DS-TB cases) (%)</td>
      </tr>
      <tr>
        <td>TB case notification</td>
        <td>[CONFIG] TB - Notified TB cases (new, all forms) aged 0-14 (%)</td>
      </tr>
      <tr>
        <td>TB case notification</td>
        <td>[CONFIG] TB - Notified TB cases (new and relapse, all forms) children aged 0-14 (%)</td>
      </tr>
      <tr>
        <td>TB case notification</td>
        <td>[CONFIG] TB - Notified TB cases (new, all forms) aged 15-24 (%)</td>
      </tr>
      <tr>
        <td>TB case notification</td>
        <td>[CONFIG] TB - TB cases tested for HIV or with known HIV status (%)</td>
      </tr>
      <tr>
        <td>TB case notification</td>
        <td>[CONFIG] TB - Notified TB cases (new, all forms) aged 35-44 (%)</td>
      </tr>
      <tr>
        <td>TB case notification</td>
        <td>[CONFIG] TB - TB cases tested for susceptibility to rifampicin (%)</td>
      </tr>
      <tr>
        <td>TB case notification</td>
        <td>[CONFIG] TB - TB cases tested for HIV with positive test recorded (%)</td>
      </tr>
      <tr>
        <td>TB case notification</td>
        <td>[CONFIG] TB - TB cohort size (all cases, all forms)</td>
      </tr>
      <tr>
        <td>TB case notification</td>
        <td>[CONFIG] TB - Notified TB cases (new, all forms) aged 65+ (%)</td>
      </tr>
      <tr>
        <td>TB case notification</td>
        <td>[CONFIG] TB - Notified TB cases (previously treated, all forms)</td>
      </tr>
      <tr>
        <td>TB case notification</td>
        <td>[CONFIG] TB - TB cases recorded as HIV positive started on ART</td>
      </tr>
      <tr>
        <td>TB case notification</td>
        <td>[CONFIG] TB - Notified TB cases (new and relapse, all forms) aged 15-24 (%)</td>
      </tr>
      <tr>
        <td>TB case notification</td>
        <td>[CONFIG] TB - Laboratory-confirmed RR-TB or MDR-TB among cases with DST results</td>
      </tr>
      <tr>
        <td>TB case notification</td>
        <td>[CONFIG] TB - Laboratory-confirmed RR-TB or MDR-TB cases who started treatment for MDR-TB (%)</td>
      </tr>
      <tr>
        <td>TB case notification</td>
        <td>[CONFIG] TB - Notified TB cases (new and relapse, all forms) aged 0-4 (%)</td>
      </tr>
      <tr>
        <td>TB case notification</td>
        <td>[CONFIG] TB - Notified TB cases (previously treated including relapse, all forms) (%)</td>
      </tr>
      <tr>
        <td>TB case notification</td>
        <td>[CONFIG] TB - Died (all DS-TB cases) (%)</td>
      </tr>
      <tr>
        <td>TB case notification</td>
        <td>[CONFIG] TB - Notified TB cases (new, all forms) aged 5-14 (%)</td>
      </tr>
      <tr>
        <td>TB case notification</td>
        <td>[CONFIG] TB - Ratio of TB cases male:female (new and relapse, all forms)</td>
      </tr>
      <tr>
        <td>TB case notification</td>
        <td>[CONFIG] TB - TB treatment success rate (all DS-TB) (%)</td>
      </tr>
      <tr>
        <td>TB case notification</td>
        <td>[CONFIG] TB - Notified TB cases (new and relapse, pulmonary bacteriologically confirmed)</td>
      </tr>
      <tr>
        <td>TB case notification</td>
        <td>[CONFIG] TB - Notified TB cases (new, all forms) aged 55-64 (%)</td>
      </tr>
      <tr>
        <td>TB case notification</td>
        <td>[CONFIG] TB - TB treatment success rate (previously treated DS-TB) (%)</td>
      </tr>
      <tr>
        <td>TB case notification</td>
        <td>[CONFIG] TB - Laboratory-confirmed MDR-TB cases</td>
      </tr>
      <tr>
        <td>TB case notification</td>
        <td>[CONFIG] TB - TB cases tested for HIV or with known HIV status</td>
      </tr>
      <tr>
        <td>TB case notification</td>
        <td>[CONFIG] TB - Notified TB cases (new and relapse, pulmonary clinically diagnosed)</td>
      </tr>
      <tr>
        <td>TB case notification</td>
        <td>[CONFIG] TB - Notified TB cases (new, all forms) aged 0-4 (%)</td>
      </tr>
      <tr>
        <td>TB case notification</td>
        <td>[CONFIG] TB - Notified TB cases (new, all forms) aged 25-34 (%)</td>
      </tr>
      <tr>
        <td>TB case notification</td>
        <td>[CONFIG] TB - TB cases tested for susceptibility to rifampicin (history unknown)</td>
      </tr>
      <tr>
        <td>TB case notification</td>
        <td>[CONFIG] TB - Notified TB cases (all cases, all forms)</td>
      </tr>
      <tr>
        <td>TB case notification</td>
        <td>[CONFIG] TB - TB notification rate (new and relapse, pulmonary bacteriologically confirmed) per 100 000 population</td>
      </tr>
      <tr>
        <td>TB case notification</td>
        <td>[CONFIG] TB - TB notification rate (new and relapse, all forms) per 100 000 population</td>
      </tr>
      <tr>
        <td>TB case notification</td>
        <td>[CONFIG] TB - TB cases tested for susceptibility to rifampicin</td>
      </tr>
      <tr>
        <td>TB case notification</td>
        <td>[CONFIG] TB - Failed (all DS-TB cases) (%)</td>
      </tr>
      <tr>
        <td>TB case notification</td>
        <td>[CONFIG] TB - Laboratory-confirmed RR-TB or MDR-TB cases who started treatment for MDR-TB</td>
      </tr>
      <tr>
        <td>TB case notification</td>
        <td>[CONFIG] TB - Notified TB cases (previously treated incl. relapse, pulmonary bacteriologically confirmed) (%)</td>
      </tr>
      <tr>
        <td>TB case notification</td>
        <td>[CONFIG] TB - TB notification rate (new and relapse, pulmonary clinically diagnosed) per 100 000 population</td>
      </tr>
      <tr>
        <td>TB case notification</td>
        <td>[CONFIG] TB - TB treatment success rate (new and relapse DS-TB/HIV) (%)</td>
      </tr>
      <tr>
        <td>TB case notification</td>
        <td>[CONFIG] TB - Laboratory-confirmed RR-TB or MDR-TB among cases with DST results (%)</td>
      </tr>
      <tr>
        <td>TB case notification</td>
        <td>[CONFIG] TB - TB cases tested for susceptibility to rifampicin (new)</td>
      </tr>
      <tr>
        <td>TB case notification</td>
        <td>[CONFIG] TB - Notified TB cases (new, pulmonary smear positive) by age group and sex</td>
      </tr>
      <tr>
        <td>TB case notification</td>
        <td>[CONFIG] TB - Lost to follow-up (all DS-TB cases) (%)</td>
      </tr>
      <tr>
        <td>TB case notification</td>
        <td>[CONFIG] TB - TB cases tested for susceptibility to rifampicin (previously treated)</td>
      </tr>
      <tr>
        <td>TB case notification</td>
        <td>[CONFIG] TB - TB cases recorded as HIV positive started on CPT</td>
      </tr>
      <tr>
        <td>TB case notification</td>
        <td>[CONFIG] TB - Notified TB cases (new, pulmonary bacteriologically confirmed) (%)</td>
      </tr>
      <tr>
        <td>TB case notification</td>
        <td>[CONFIG] TB - Notified TB cases (new and relapse, all forms) aged 45-54 (%)</td>
      </tr>
      <tr>
        <td>TB case notification</td>
        <td>[CONFIG] TB - TB treatment success rate (all DS and DR-TB) (%)</td>
      </tr>
      <tr>
        <td>TB case notification</td>
        <td>[CONFIG] TB - Not laboratory-confirmed RR-TB or MDR-TB cases who started treatment for MDR-TB</td>
      </tr>
      <tr>
        <td>TB case notification</td>
        <td>[CONFIG] TB - TB cases tested for HIV or with known HIV status - all cases (%)</td>
      </tr>
      <tr>
        <td>TB case notification</td>
        <td>[CONFIG] TB - Notified TB cases (new, all forms) aged 45-54 (%)</td>
      </tr>
      <tr>
        <td>TB case notification</td>
        <td>[CONFIG] TB - TB cases tested for HIV with positive test recorded</td>
      </tr>
      <tr>
        <td>TB case notification</td>
        <td>[CONFIG] TB - Notified TB cases (new and relapse, all forms) aged 55-64 (%)</td>
      </tr>
      <tr>
        <td>TB case notification</td>
        <td>[CONFIG] TB - Not evaluated (all DS-TB cases) (%)</td>
      </tr>
      <tr>
        <td>TB case notification</td>
        <td>[CONFIG] TB - Notified TB cases (new and relapse, all forms) aged 35-44 (%)</td>
      </tr>
      <tr>
        <td>TB case notification</td>
        <td>[CONFIG] TB - TB treatment success rate (all DR-TB) (%)</td>
      </tr>
      <tr>
        <td>TB case notification</td>
        <td>[CONFIG] TB - Ratio of TB cases aged 0-4:5-14 (new and relapse, all forms)</td>
      </tr>
      <tr>
        <td>TB case notification</td>
        <td>[CONFIG] TB - Notified TB cases (new and relapse, all forms) by age group and sex</td>
      </tr>
      <tr>
        <td>TB case notification</td>
        <td>[CONFIG] TB - Notified TB cases (new and relapse, all forms) aged 65+ (%)</td>
      </tr>
      <tr>
        <td>TB case notification</td>
        <td>[CONFIG] TB - TB cases recorded as HIV positive started on CPT (%)</td>
      </tr>
      <tr>
        <td>TB case notification</td>
        <td>[CONFIG] TB - Notified TB cases (new, extrapulmonary) (%)</td>
      </tr>
      <tr>
        <td>TB case notification</td>
        <td>[CONFIG] TB - TB notification rate (all cases, all forms) per 100 000 population</td>
      </tr>
      <tr>
        <td>TB case notification</td>
        <td>[CONFIG] TB - Completed (all DS-TB cases) (%)</td>
      </tr>
      <tr>
        <td>TB case notification</td>
        <td>[CONFIG] TB - Notified TB cases (new and relapse, all forms)</td>
      </tr>
      <tr>
        <td>TB case notification</td>
        <td>[CONFIG] TB - TB cases recorded as HIV positive started on ART (%)</td>
      </tr>
      <tr>
        <td>TB case notification</td>
        <td>[CONFIG] TB - TB treatment success rate (new and relapse DS-TB) (%)</td>
      </tr>
      <tr>
        <td>TB case notification</td>
        <td>[CONFIG] TB - Notified TB cases (new and relapse, all forms) aged 5-14 (%)</td>
      </tr>
      <tr>
        <td>TB case notification</td>
        <td>[CONFIG] TB - Notified TB cases (new and relapse, all forms) aged 25-34 (%)</td>
      </tr>
      <tr>
        <td>TB stock</td>
        <td>[CONFIG] TB - Proportion of GeneXpert cartridges unusable</td>
      </tr>
      <tr>
        <td>TB stock</td>
        <td>[CONFIG] TB - DR-TB drugs wastage rate (%)</td>
      </tr>
      <tr>
        <td>TB stock</td>
        <td>[CONFIG] TB - DR-TB drugs opening balance</td>
      </tr>
      <tr>
        <td>TB stock</td>
        <td>[CONFIG] TB - DS-TB drugs usable stock</td>
      </tr>
      <tr>
        <td>TB stock</td>
        <td>[CONFIG] TB - DS-TB drugs opening balance</td>
      </tr>
      <tr>
        <td>TB stock</td>
        <td>[CONFIG] TB - DR-TB drugs discarded</td>
      </tr>
      <tr>
        <td>TB stock</td>
        <td>[CONFIG] TB - DR-TB drugs received</td>
      </tr>
      <tr>
        <td>TB stock</td>
        <td>[CONFIG] TB - GeneXpert Cartridges stock out days</td>
      </tr>
      <tr>
        <td>TB stock</td>
        <td>[CONFIG] TB - GeneXpert Cartridges issued</td>
      </tr>
      <tr>
        <td>TB stock</td>
        <td>[CONFIG] TB - DS-TB drugs closing balance</td>
      </tr>
      <tr>
        <td>TB stock</td>
        <td>[CONFIG] TB - DR-TB drugs stock discrepancy (%)</td>
      </tr>
      <tr>
        <td>TB stock</td>
        <td>[CONFIG] TB - DR-TB drugs stock out days</td>
      </tr>
      <tr>
        <td>TB stock</td>
        <td>[CONFIG] TB - DR-TB drugs closing balance</td>
      </tr>
      <tr>
        <td>TB stock</td>
        <td>[CONFIG] TB - Health facilities with DR-TB drugs stock-out days (%)</td>
      </tr>
      <tr>
        <td>TB stock</td>
        <td>[CONFIG] TB - DR-TB drugs stock coverage time</td>
      </tr>
      <tr>
        <td>TB stock</td>
        <td>[CONFIG] TB - GeneXpert Cartridges redistributed</td>
      </tr>
      <tr>
        <td>TB stock</td>
        <td>[CONFIG] TB - Proportion of DS-TB drugs consumed</td>
      </tr>
      <tr>
        <td>TB stock</td>
        <td>[CONFIG] TB - GeneXpert Cartridges received</td>
      </tr>
      <tr>
        <td>TB stock</td>
        <td>[CONFIG] TB - DS-TB drugs received</td>
      </tr>
      <tr>
        <td>TB stock</td>
        <td>[CONFIG] TB - Proportion of GeneXpert cartridges consumed</td>
      </tr>
      <tr>
        <td>TB stock</td>
        <td>[CONFIG] TB - DS-TB drugs issued</td>
      </tr>
      <tr>
        <td>TB stock</td>
        <td>[CONFIG] TB - GeneXpert Cartridges discarded</td>
      </tr>
      <tr>
        <td>TB stock</td>
        <td>[CONFIG] TB - GeneXpert cartridges stock discrepancy (%)</td>
      </tr>
      <tr>
        <td>TB stock</td>
        <td>[CONFIG] TB - DR-TB drugs usable stock</td>
      </tr>
      <tr>
        <td>TB stock</td>
        <td>[CONFIG] TB - GeneXpert cartridges closing balance</td>
      </tr>
      <tr>
        <td>TB stock</td>
        <td>[CONFIG] TB - Proportion of DR-TB drugs unusable</td>
      </tr>
      <tr>
        <td>TB stock</td>
        <td>[CONFIG] TB - DR-TB drugs stock on hand</td>
      </tr>
      <tr>
        <td>TB stock</td>
        <td>[CONFIG] TB - GeneXpert Cartridges stock on hand</td>
      </tr>
      <tr>
        <td>TB stock</td>
        <td>[CONFIG] TB - DS-TB drugs stock on hand</td>
      </tr>
      <tr>
        <td>TB stock</td>
        <td>[CONFIG] TB - GeneXpert usable stock</td>
      </tr>
      <tr>
        <td>TB stock</td>
        <td>[CONFIG] TB - DR-TB drugs issued</td>
      </tr>
      <tr>
        <td>TB stock</td>
        <td>[CONFIG] TB - DS-TB drugs discarded</td>
      </tr>
      <tr>
        <td>TB stock</td>
        <td>[CONFIG] TB - DS-TB drugs stock coverage time</td>
      </tr>
      <tr>
        <td>TB stock</td>
        <td>[CONFIG] TB - DR-TB drugs redistributed</td>
      </tr>
      <tr>
        <td>TB stock</td>
        <td>[CONFIG] TB - DS-TB drugs stock discrepancy (%)</td>
      </tr>
      <tr>
        <td>TB stock</td>
        <td>[CONFIG] TB - GeneXpert Cartridges opening balance</td>
      </tr>
      <tr>
        <td>TB stock</td>
        <td>[CONFIG] TB - Proportion of DS-TB drugs unusable</td>
      </tr>
      <tr>
        <td>TB stock</td>
        <td>[CONFIG] TB - GeneXpert cartridges stock coverage time</td>
      </tr>
      <tr>
        <td>TB stock</td>
        <td>[CONFIG] TB - GeneXpert cartridges wastage rate (%)</td>
      </tr>
      <tr>
        <td>TB stock</td>
        <td>[CONFIG] TB - DS-TB drugs wastage rate (%)</td>
      </tr>
      <tr>
        <td>TB stock</td>
        <td>[CONFIG] TB - Proportion of DR-TB drugs consumed</td>
      </tr>
      <tr>
        <td>TB stock</td>
        <td>[CONFIG] TB - Health facilities with DS-TB drugs stock-out days (%)</td>
      </tr>
      <tr>
        <td>TB stock</td>
        <td>[CONFIG] TB - DS-TB drugs stock out days</td>
      </tr>
      <tr>
        <td>TB stock</td>
        <td>[CONFIG] TB - Health facilities with GeneXpert cartridges stock-out days (%)</td>
      </tr>
      <tr>
        <td>TB stock</td>
        <td>[CONFIG] TB - DS-TB drugs redistributed</td>
      </tr>
      <tr>
        <td>TB RR/MDR</td>
        <td>[CONFIG] TB - TB cases tested for susceptibility to rifampicin (%)</td>
      </tr>
      <tr>
        <td>TB RR/MDR</td>
        <td>[CONFIG] TB - Laboratory-confirmed RR-TB or MDR-TB among cases with DST results</td>
      </tr>
      <tr>
        <td>TB RR/MDR</td>
        <td>[CONFIG] TB - Laboratory-confirmed RR-TB or MDR-TB cases who started treatment for MDR-TB (%)</td>
      </tr>
      <tr>
        <td>TB RR/MDR</td>
        <td>[CONFIG] TB - TB cases tested for susceptibility to rifampicin (new) (%)</td>
      </tr>
      <tr>
        <td>TB RR/MDR</td>
        <td>[CONFIG] TB - Laboratory-confirmed MDR-TB cases</td>
      </tr>
      <tr>
        <td>TB RR/MDR</td>
        <td>[CONFIG] TB - TB cases tested for susceptibility to rifampicin (history unknown)</td>
      </tr>
      <tr>
        <td>TB RR/MDR</td>
        <td>[CONFIG] TB - TB cases tested for susceptibility to rifampicin</td>
      </tr>
      <tr>
        <td>TB RR/MDR</td>
        <td>[CONFIG] TB - Laboratory-confirmed RR-TB or MDR-TB cases who started treatment for MDR-TB</td>
      </tr>
      <tr>
        <td>TB RR/MDR</td>
        <td>[CONFIG] TB - Laboratory-confirmed RR-TB or MDR-TB among cases with DST results (%)</td>
      </tr>
      <tr>
        <td>TB RR/MDR</td>
        <td>[CONFIG] TB - TB cases tested for susceptibility to rifampicin (new)</td>
      </tr>
      <tr>
        <td>TB RR/MDR</td>
        <td>[CONFIG] TB - TB cases tested for susceptibility to rifampicin (previously treated)</td>
      </tr>
      <tr>
        <td>TB RR/MDR</td>
        <td>[CONFIG] TB - Not laboratory-confirmed RR-TB or MDR-TB cases who started treatment for MDR-TB</td>
      </tr>
      <tr>
        <td>TB RR/MDR</td>
        <td>[CONFIG] TB - TB cases tested for susceptibility to rifampicin (previously treated) (%)</td>
      </tr>
      <tr>
        <td>TB</td>
        <td>[CONFIG] TB - Completed (new and relapse pulmonary bacteriologically confirmed DS-TB cases) (%)</td>
      </tr>
      <tr>
        <td>TB</td>
        <td>[CONFIG] TB - Not evaluated (new and relapse pulmonary bacteriologically confirmed DS-TB cases) (%)</td>
      </tr>
      <tr>
        <td>TB</td>
        <td>[CONFIG] TB - TB: Cured - new smear-positive (%)</td>
      </tr>
      <tr>
        <td>TB</td>
        <td>[CONFIG] TB - Cured (all DS-TB cases) (%)</td>
      </tr>
      <tr>
        <td>TB</td>
        <td>[CONFIG] TB - Notified TB cases (new, all forms) aged 0-14 (%)</td>
      </tr>
      <tr>
        <td>TB</td>
        <td>[CONFIG] TB - Notified TB cases (new and relapse, all forms) children aged 0-14 (%)</td>
      </tr>
      <tr>
        <td>TB</td>
        <td>[CONFIG] TB - Lost to follow-up (new smear-positive TB cases) (%)</td>
      </tr>
      <tr>
        <td>TB</td>
        <td>[CONFIG] TB - TB cases recorded as HIV positive started on CPT at outcome</td>
      </tr>
      <tr>
        <td>TB</td>
        <td>[CONFIG] TB - Notified TB cases (new, all forms) aged 15-24 (%)</td>
      </tr>
      <tr>
        <td>TB</td>
        <td>[CONFIG] TB - TB cases tested for HIV or with known HIV status (%)</td>
      </tr>
      <tr>
        <td>TB</td>
        <td>[CONFIG] TB - Lost to follow-up (previously treated DS-TB cases) (%)</td>
      </tr>
      <tr>
        <td>TB</td>
        <td>[CONFIG] TB - Died (all DR-TB cases) (%)</td>
      </tr>
      <tr>
        <td>TB</td>
        <td>[CONFIG] TB - Notified TB cases (new, all forms) aged 35-44 (%)</td>
      </tr>
      <tr>
        <td>TB</td>
        <td>[CONFIG] TB - TB cases tested for susceptibility to rifampicin (%)</td>
      </tr>
      <tr>
        <td>TB</td>
        <td>[CONFIG] TB - TB cases tested for HIV with positive test recorded (%)</td>
      </tr>
      <tr>
        <td>TB</td>
        <td>[CONFIG] TB - TB cohort size (all cases, all forms)</td>
      </tr>
      <tr>
        <td>TB</td>
        <td>[CONFIG] TB - Notified TB cases (new, all forms) aged 65+ (%)</td>
      </tr>
      <tr>
        <td>TB</td>
        <td>[CONFIG] TB - Notified TB cases (previously treated, all forms)</td>
      </tr>
      <tr>
        <td>TB</td>
        <td>[CONFIG] TB - TB cases recorded as HIV positive started on ART</td>
      </tr>
      <tr>
        <td>TB</td>
        <td>[CONFIG] TB - Notified TB cases (new and relapse, all forms) aged 15-24 (%)</td>
      </tr>
      <tr>
        <td>TB</td>
        <td>[CONFIG] TB - Laboratory-confirmed RR-TB or MDR-TB among cases with DST results</td>
      </tr>
      <tr>
        <td>TB</td>
        <td>[CONFIG] TB - Laboratory-confirmed RR-TB or MDR-TB cases who started treatment for MDR-TB (%)</td>
      </tr>
      <tr>
        <td>TB</td>
        <td>[CONFIG] TB - Notified TB cases (new and relapse, all forms) aged 0-4 (%)</td>
      </tr>
      <tr>
        <td>TB</td>
        <td>[CONFIG] TB - Notified TB cases (previously treated including relapse, all forms) (%)</td>
      </tr>
      <tr>
        <td>TB</td>
        <td>[CONFIG] TB - TB cases tested for susceptibility to rifampicin (new) (%)</td>
      </tr>
      <tr>
        <td>TB</td>
        <td>[CONFIG] TB - Died (all DS-TB cases) (%)</td>
      </tr>
      <tr>
        <td>TB</td>
        <td>[CONFIG] TB - Died (new and relapse pulmonary bacteriologically confirmed DS-TB cases) (%)</td>
      </tr>
      <tr>
        <td>TB</td>
        <td>[CONFIG] TB - Notified TB cases (new, all forms) aged 5-14 (%)</td>
      </tr>
      <tr>
        <td>TB</td>
        <td>[CONFIG] TB - Ratio of TB cases male:female (new and relapse, all forms)</td>
      </tr>
      <tr>
        <td>TB</td>
        <td>[CONFIG] TB - TB treatment success rate (all DS-TB) (%)</td>
      </tr>
      <tr>
        <td>TB</td>
        <td>[CONFIG] TB - Notified TB cases (new and relapse, pulmonary bacteriologically confirmed)</td>
      </tr>
      <tr>
        <td>TB</td>
        <td>[CONFIG] TB - Completed (previously treated DS-TB cases) (%)</td>
      </tr>
      <tr>
        <td>TB</td>
        <td>[CONFIG] TB - Notified TB cases (new, all forms) aged 55-64 (%)</td>
      </tr>
      <tr>
        <td>TB</td>
        <td>[CONFIG] TB - TB cases tested for HIV or with known HIV status at outcome</td>
      </tr>
      <tr>
        <td>TB</td>
        <td>[CONFIG] TB - Not evaluated (all DS-TB/HIV cases) (%)</td>
      </tr>
      <tr>
        <td>TB</td>
        <td>[CONFIG] TB - TB treatment success rate (previously treated DS-TB) (%)</td>
      </tr>
      <tr>
        <td>TB</td>
        <td>[CONFIG] TB - Laboratory-confirmed MDR-TB cases</td>
      </tr>
      <tr>
        <td>TB</td>
        <td>[CONFIG] TB - TB cases tested for HIV or with known HIV status</td>
      </tr>
      <tr>
        <td>TB</td>
        <td>[CONFIG] TB - Notified TB cases (new and relapse, pulmonary clinically diagnosed)</td>
      </tr>
      <tr>
        <td>TB</td>
        <td>[CONFIG] TB - Cured (all DR-TB cases) (%)</td>
      </tr>
      <tr>
        <td>TB</td>
        <td>[CONFIG] TB - TB treatment failed (new smear-positive TB cases) (%)</td>
      </tr>
      <tr>
        <td>TB</td>
        <td>[CONFIG] TB - Notified TB cases (new, all forms) aged 0-4 (%)</td>
      </tr>
      <tr>
        <td>TB</td>
        <td>[CONFIG] TB - Notified TB cases (new, all forms) aged 25-34 (%)</td>
      </tr>
      <tr>
        <td>TB</td>
        <td>[CONFIG] TB - TB cases tested for susceptibility to rifampicin (history unknown)</td>
      </tr>
      <tr>
        <td>TB</td>
        <td>[CONFIG] TB - Completed (all DR-TB cases) (%)</td>
      </tr>
      <tr>
        <td>TB</td>
        <td>[CONFIG] TB - Notified TB cases (all cases, all forms)</td>
      </tr>
      <tr>
        <td>TB</td>
        <td>[CONFIG] TB - Failed (all DS-TB/HIV cases) (%)</td>
      </tr>
      <tr>
        <td>TB</td>
        <td>[CONFIG] TB - TB notification rate (new and relapse, pulmonary bacteriologically confirmed) per 100 000 population</td>
      </tr>
      <tr>
        <td>TB</td>
        <td>[CONFIG] TB - TB notification rate (new and relapse, all forms) per 100 000 population</td>
      </tr>
      <tr>
        <td>TB</td>
        <td>[CONFIG] TB - TB cases tested for susceptibility to rifampicin</td>
      </tr>
      <tr>
        <td>TB</td>
        <td>[CONFIG] TB - Not evaluated (previously treated DS-TB cases) (%)</td>
      </tr>
      <tr>
        <td>TB</td>
        <td>[CONFIG] TB - Failed (all DS-TB cases) (%)</td>
      </tr>
      <tr>
        <td>TB</td>
        <td>[CONFIG] TB - Failed (previously treated DS-TB cases) (%)</td>
      </tr>
      <tr>
        <td>TB</td>
        <td>[CONFIG] TB - Laboratory-confirmed RR-TB or MDR-TB cases who started treatment for MDR-TB</td>
      </tr>
      <tr>
        <td>TB</td>
        <td>[CONFIG] TB - Lost to follow-up (new and relapse pulmonary bacteriologically confirmed DS-TB cases) (%)</td>
      </tr>
      <tr>
        <td>TB</td>
        <td>[CONFIG] TB - Notified TB cases (previously treated incl. relapse, pulmonary bacteriologically confirmed) (%)</td>
      </tr>
      <tr>
        <td>TB</td>
        <td>[CONFIG] TB - TB notification rate (new and relapse, pulmonary clinically diagnosed) per 100 000 population</td>
      </tr>
      <tr>
        <td>TB</td>
        <td>[CONFIG] TB - TB treatment success rate (new and relapse DS-TB/HIV) (%)</td>
      </tr>
      <tr>
        <td>TB</td>
        <td>[CONFIG] TB - Cured (previously treated DS-TB cases) (%)</td>
      </tr>
      <tr>
        <td>TB</td>
        <td>[CONFIG] TB - Laboratory-confirmed RR-TB or MDR-TB among cases with DST results (%)</td>
      </tr>
      <tr>
        <td>TB</td>
        <td>[CONFIG] TB - Failed (all DR-TB cases) (%)</td>
      </tr>
      <tr>
        <td>TB</td>
        <td>[CONFIG] TB - TB cases tested for susceptibility to rifampicin (new)</td>
      </tr>
      <tr>
        <td>TB</td>
        <td>[CONFIG] TB - Notified TB cases (new, pulmonary smear positive) by age group and sex</td>
      </tr>
      <tr>
        <td>TB</td>
        <td>[CONFIG] TB - Lost to follow-up (all DS-TB cases) (%)</td>
      </tr>
      <tr>
        <td>TB</td>
        <td>[CONFIG] TB - TB cases tested for susceptibility to rifampicin (previously treated)</td>
      </tr>
      <tr>
        <td>TB</td>
        <td>[CONFIG] TB - TB cases recorded as HIV positive started on CPT</td>
      </tr>
      <tr>
        <td>TB</td>
        <td>[CONFIG] TB - Completed (all DS-TB/HIV cases) (%)</td>
      </tr>
      <tr>
        <td>TB</td>
        <td>[CONFIG] TB - Notified TB cases (new, pulmonary bacteriologically confirmed) (%)</td>
      </tr>
      <tr>
        <td>TB</td>
        <td>[CONFIG] TB - TB cases recorded as HIV positive started on ART at outcome</td>
      </tr>
      <tr>
        <td>TB</td>
        <td>[CONFIG] TB - Died (all DS-TB/HIV cases) (%)</td>
      </tr>
      <tr>
        <td>TB</td>
        <td>[CONFIG] TB - Notified TB cases (new and relapse, all forms) aged 45-54 (%)</td>
      </tr>
      <tr>
        <td>TB</td>
        <td>[CONFIG] TB - TB treatment success rate (all DS and DR-TB) (%)</td>
      </tr>
      <tr>
        <td>TB</td>
        <td>[CONFIG] TB - Not laboratory-confirmed RR-TB or MDR-TB cases who started treatment for MDR-TB</td>
      </tr>
      <tr>
        <td>TB</td>
        <td>[CONFIG] TB - TB cases tested for HIV or with known HIV status - all cases (%)</td>
      </tr>
      <tr>
        <td>TB</td>
        <td>[CONFIG] TB - Lost to follow-up (all DR-TB cases) (%)</td>
      </tr>
      <tr>
        <td>TB</td>
        <td>[CONFIG] TB - Notified TB cases (new, all forms) aged 45-54 (%)</td>
      </tr>
      <tr>
        <td>TB</td>
        <td>[CONFIG] TB - TB cases tested for HIV with positive test recorded</td>
      </tr>
      <tr>
        <td>TB</td>
        <td>[CONFIG] TB - Notified TB cases (new and relapse, all forms) aged 55-64 (%)</td>
      </tr>
      <tr>
        <td>TB</td>
        <td>[CONFIG] TB - Not evaluated (all DS-TB cases) (%)</td>
      </tr>
      <tr>
        <td>TB</td>
        <td>[CONFIG] TB - Died (new smear-positive TB cases) (%)</td>
      </tr>
      <tr>
        <td>TB</td>
        <td>[CONFIG] TB - Not evaluated (new smear-positive TB cases) (%)</td>
      </tr>
      <tr>
        <td>TB</td>
        <td>[CONFIG] TB - Notified TB cases (new and relapse, all forms) aged 35-44 (%)</td>
      </tr>
      <tr>
        <td>TB</td>
        <td>[CONFIG] TB - TB treatment success rate (all DR-TB) (%)</td>
      </tr>
      <tr>
        <td>TB</td>
        <td>[CONFIG] TB - TB cases tested for HIV with positive test recorded at outcome</td>
      </tr>
      <tr>
        <td>TB</td>
        <td>[CONFIG] TB - Ratio of TB cases aged 0-4:5-14 (new and relapse, all forms)</td>
      </tr>
      <tr>
        <td>TB</td>
        <td>[CONFIG] TB - Notified TB cases (new and relapse, all forms) by age group and sex</td>
      </tr>
      <tr>
        <td>TB</td>
        <td>[CONFIG] TB - Cured (all DS-TB/HIV cases) (%)</td>
      </tr>
      <tr>
        <td>TB</td>
        <td>[CONFIG] TB - Notified TB cases (new and relapse, all forms) aged 65+ (%)</td>
      </tr>
      <tr>
        <td>TB</td>
        <td>[CONFIG] TB - Lost to follow-up (all DS-TB/HIV cases) (%)</td>
      </tr>
      <tr>
        <td>TB</td>
        <td>[CONFIG] TB - TB cases recorded as HIV positive started on CPT (%)</td>
      </tr>
      <tr>
        <td>TB</td>
        <td>[CONFIG] TB - Cured (new and relapse pulmonary bacteriologically confirmed DS-TB cases) (%)</td>
      </tr>
      <tr>
        <td>TB</td>
        <td>[CONFIG] TB - TB treatment completed (new smear-positive TB cases) (%)</td>
      </tr>
      <tr>
        <td>TB</td>
        <td>[CONFIG] TB - TB cases tested for susceptibility to rifampicin (previously treated) (%)</td>
      </tr>
      <tr>
        <td>TB</td>
        <td>[CONFIG] TB - Notified TB cases (new, extrapulmonary) (%)</td>
      </tr>
      <tr>
        <td>TB</td>
        <td>[CONFIG] TB - Died (previously treated DS-TB cases) (%)</td>
      </tr>
      <tr>
        <td>TB</td>
        <td>[CONFIG] TB - TB notification rate (all cases, all forms) per 100 000 population</td>
      </tr>
      <tr>
        <td>TB</td>
        <td>[CONFIG] TB - Failed (new and relapse pulmonary bacteriologically confirmed DS-TB cases)</td>
      </tr>
      <tr>
        <td>TB</td>
        <td>[CONFIG] TB - Not evaluated (all DR-TB cases) (%)</td>
      </tr>
      <tr>
        <td>TB</td>
        <td>[CONFIG] TB - Completed (all DS-TB cases) (%)</td>
      </tr>
      <tr>
        <td>TB</td>
        <td>[CONFIG] TB - Notified TB cases (new and relapse, all forms)</td>
      </tr>
      <tr>
        <td>TB</td>
        <td>[CONFIG] TB - TB cases recorded as HIV positive started on ART (%)</td>
      </tr>
      <tr>
        <td>TB</td>
        <td>[CONFIG] TB - TB treatment success rate (new and relapse DS-TB) (%)</td>
      </tr>
      <tr>
        <td>TB</td>
        <td>[CONFIG] TB - Notified TB cases (new and relapse, all forms) aged 5-14 (%)</td>
      </tr>
      <tr>
        <td>TB</td>
        <td>[CONFIG] TB - Notified TB cases (new and relapse, all forms) aged 25-34 (%)</td>
      </tr>
      <tr>
        <td>TB treatment outcomes</td>
        <td>[CONFIG] TB - Completed (new and relapse pulmonary bacteriologically confirmed DS-TB cases) (%)</td>
      </tr>
      <tr>
        <td>TB treatment outcomes</td>
        <td>[CONFIG] TB - Not evaluated (new and relapse pulmonary bacteriologically confirmed DS-TB cases) (%)</td>
      </tr>
      <tr>
        <td>TB treatment outcomes</td>
        <td>[CONFIG] TB - TB: Cured - new smear-positive (%)</td>
      </tr>
      <tr>
        <td>TB treatment outcomes</td>
        <td>[CONFIG] TB - Cured (all DS-TB cases) (%)</td>
      </tr>
      <tr>
        <td>TB treatment outcomes</td>
        <td>[CONFIG] TB - Notified TB cases (new and relapse, all forms) children aged 0-14 (%)</td>
      </tr>
      <tr>
        <td>TB treatment outcomes</td>
        <td>[CONFIG] TB - Lost to follow-up (new smear-positive TB cases) (%)</td>
      </tr>
      <tr>
        <td>TB treatment outcomes</td>
        <td>[CONFIG] TB - TB cases recorded as HIV positive started on CPT at outcome</td>
      </tr>
      <tr>
        <td>TB treatment outcomes</td>
        <td>[CONFIG] TB - TB cases tested for HIV or with known HIV status (%)</td>
      </tr>
      <tr>
        <td>TB treatment outcomes</td>
        <td>[CONFIG] TB - Lost to follow-up (previously treated DS-TB cases) (%)</td>
      </tr>
      <tr>
        <td>TB treatment outcomes</td>
        <td>[CONFIG] TB - Died (all DR-TB cases) (%)</td>
      </tr>
      <tr>
        <td>TB treatment outcomes</td>
        <td>[CONFIG] TB - TB cases tested for susceptibility to rifampicin (%)</td>
      </tr>
      <tr>
        <td>TB treatment outcomes</td>
        <td>[CONFIG] TB - TB cases tested for HIV with positive test recorded (%)</td>
      </tr>
      <tr>
        <td>TB treatment outcomes</td>
        <td>[CONFIG] TB - TB cohort size (all cases, all forms)</td>
      </tr>
      <tr>
        <td>TB treatment outcomes</td>
        <td>[CONFIG] TB - Notified TB cases (previously treated, all forms)</td>
      </tr>
      <tr>
        <td>TB treatment outcomes</td>
        <td>[CONFIG] TB - TB cases recorded as HIV positive started on ART</td>
      </tr>
      <tr>
        <td>TB treatment outcomes</td>
        <td>[CONFIG] TB - Notified TB cases (new and relapse, all forms) aged 15-24 (%)</td>
      </tr>
      <tr>
        <td>TB treatment outcomes</td>
        <td>[CONFIG] TB - Laboratory-confirmed RR-TB or MDR-TB among cases with DST results</td>
      </tr>
      <tr>
        <td>TB treatment outcomes</td>
        <td>[CONFIG] TB - Laboratory-confirmed RR-TB or MDR-TB cases who started treatment for MDR-TB (%)</td>
      </tr>
      <tr>
        <td>TB treatment outcomes</td>
        <td>[CONFIG] TB - Notified TB cases (new and relapse, all forms) aged 0-4 (%)</td>
      </tr>
      <tr>
        <td>TB treatment outcomes</td>
        <td>[CONFIG] TB - Notified TB cases (previously treated including relapse, all forms) (%)</td>
      </tr>
      <tr>
        <td>TB treatment outcomes</td>
        <td>[CONFIG] TB - Died (all DS-TB cases) (%)</td>
      </tr>
      <tr>
        <td>TB treatment outcomes</td>
        <td>[CONFIG] TB - Died (new and relapse pulmonary bacteriologically confirmed DS-TB cases) (%)</td>
      </tr>
      <tr>
        <td>TB treatment outcomes</td>
        <td>[CONFIG] TB - Ratio of TB cases male:female (new and relapse, all forms)</td>
      </tr>
      <tr>
        <td>TB treatment outcomes</td>
        <td>[CONFIG] TB - TB treatment success rate (all DS-TB) (%)</td>
      </tr>
      <tr>
        <td>TB treatment outcomes</td>
        <td>[CONFIG] TB - Notified TB cases (new and relapse, pulmonary bacteriologically confirmed)</td>
      </tr>
      <tr>
        <td>TB treatment outcomes</td>
        <td>[CONFIG] TB - Completed (previously treated DS-TB cases) (%)</td>
      </tr>
      <tr>
        <td>TB treatment outcomes</td>
        <td>[CONFIG] TB - TB cases tested for HIV or with known HIV status at outcome</td>
      </tr>
      <tr>
        <td>TB treatment outcomes</td>
        <td>[CONFIG] TB - Not evaluated (all DS-TB/HIV cases) (%)</td>
      </tr>
      <tr>
        <td>TB treatment outcomes</td>
        <td>[CONFIG] TB - TB treatment success rate (previously treated DS-TB) (%)</td>
      </tr>
      <tr>
        <td>TB treatment outcomes</td>
        <td>[CONFIG] TB - Laboratory-confirmed MDR-TB cases</td>
      </tr>
      <tr>
        <td>TB treatment outcomes</td>
        <td>[CONFIG] TB - TB cases tested for HIV or with known HIV status</td>
      </tr>
      <tr>
        <td>TB treatment outcomes</td>
        <td>[CONFIG] TB - Notified TB cases (new and relapse, pulmonary clinically diagnosed)</td>
      </tr>
      <tr>
        <td>TB treatment outcomes</td>
        <td>[CONFIG] TB - Cured (all DR-TB cases) (%)</td>
      </tr>
      <tr>
        <td>TB treatment outcomes</td>
        <td>[CONFIG] TB - TB treatment failed (new smear-positive TB cases) (%)</td>
      </tr>
      <tr>
        <td>TB treatment outcomes</td>
        <td>[CONFIG] TB - TB cases tested for susceptibility to rifampicin (history unknown)</td>
      </tr>
      <tr>
        <td>TB treatment outcomes</td>
        <td>[CONFIG] TB - Completed (all DR-TB cases) (%)</td>
      </tr>
      <tr>
        <td>TB treatment outcomes</td>
        <td>[CONFIG] TB - Notified TB cases (all cases, all forms)</td>
      </tr>
      <tr>
        <td>TB treatment outcomes</td>
        <td>[CONFIG] TB - Failed (all DS-TB/HIV cases) (%)</td>
      </tr>
      <tr>
        <td>TB treatment outcomes</td>
        <td>[CONFIG] TB - TB notification rate (new and relapse, pulmonary bacteriologically confirmed) per 100 000 population</td>
      </tr>
      <tr>
        <td>TB treatment outcomes</td>
        <td>[CONFIG] TB - TB notification rate (new and relapse, all forms) per 100 000 population</td>
      </tr>
      <tr>
        <td>TB treatment outcomes</td>
        <td>[CONFIG] TB - TB cases tested for susceptibility to rifampicin</td>
      </tr>
      <tr>
        <td>TB treatment outcomes</td>
        <td>[CONFIG] TB - Not evaluated (previously treated DS-TB cases) (%)</td>
      </tr>
      <tr>
        <td>TB treatment outcomes</td>
        <td>[CONFIG] TB - Failed (all DS-TB cases) (%)</td>
      </tr>
      <tr>
        <td>TB treatment outcomes</td>
        <td>[CONFIG] TB - Failed (previously treated DS-TB cases) (%)</td>
      </tr>
      <tr>
        <td>TB treatment outcomes</td>
        <td>[CONFIG] TB - Laboratory-confirmed RR-TB or MDR-TB cases who started treatment for MDR-TB</td>
      </tr>
      <tr>
        <td>TB treatment outcomes</td>
        <td>[CONFIG] TB - Lost to follow-up (new and relapse pulmonary bacteriologically confirmed DS-TB cases) (%)</td>
      </tr>
      <tr>
        <td>TB treatment outcomes</td>
        <td>[CONFIG] TB - TB treatment success rate (new and relapse DS-TB/HIV) (%)</td>
      </tr>
      <tr>
        <td>TB treatment outcomes</td>
        <td>[CONFIG] TB - Cured (previously treated DS-TB cases) (%)</td>
      </tr>
      <tr>
        <td>TB treatment outcomes</td>
        <td>[CONFIG] TB - Laboratory-confirmed RR-TB or MDR-TB among cases with DST results (%)</td>
      </tr>
      <tr>
        <td>TB treatment outcomes</td>
        <td>[CONFIG] TB - Failed (all DR-TB cases) (%)</td>
      </tr>
      <tr>
        <td>TB treatment outcomes</td>
        <td>[CONFIG] TB - TB cases tested for susceptibility to rifampicin (new)</td>
      </tr>
      <tr>
        <td>TB treatment outcomes</td>
        <td>[CONFIG] TB - Lost to follow-up (all DS-TB cases) (%)</td>
      </tr>
      <tr>
        <td>TB treatment outcomes</td>
        <td>[CONFIG] TB - TB cases tested for susceptibility to rifampicin (previously treated)</td>
      </tr>
      <tr>
        <td>TB treatment outcomes</td>
        <td>[CONFIG] TB - TB cases recorded as HIV positive started on CPT</td>
      </tr>
      <tr>
        <td>TB treatment outcomes</td>
        <td>[CONFIG] TB - Completed (all DS-TB/HIV cases) (%)</td>
      </tr>
      <tr>
        <td>TB treatment outcomes</td>
        <td>[CONFIG] TB - TB cases recorded as HIV positive started on ART at outcome</td>
      </tr>
      <tr>
        <td>TB treatment outcomes</td>
        <td>[CONFIG] TB - Died (all DS-TB/HIV cases) (%)</td>
      </tr>
      <tr>
        <td>TB treatment outcomes</td>
        <td>[CONFIG] TB - Notified TB cases (new and relapse, all forms) aged 45-54 (%)</td>
      </tr>
      <tr>
        <td>TB treatment outcomes</td>
        <td>[CONFIG] TB - TB treatment success rate (all DS and DR-TB) (%)</td>
      </tr>
      <tr>
        <td>TB treatment outcomes</td>
        <td>[CONFIG] TB - Not laboratory-confirmed RR-TB or MDR-TB cases who started treatment for MDR-TB</td>
      </tr>
      <tr>
        <td>TB treatment outcomes</td>
        <td>[CONFIG] TB - Lost to follow-up (all DR-TB cases) (%)</td>
      </tr>
      <tr>
        <td>TB treatment outcomes</td>
        <td>[CONFIG] TB - TB cases tested for HIV with positive test recorded</td>
      </tr>
      <tr>
        <td>TB treatment outcomes</td>
        <td>[CONFIG] TB - Notified TB cases (new and relapse, all forms) aged 55-64 (%)</td>
      </tr>
      <tr>
        <td>TB treatment outcomes</td>
        <td>[CONFIG] TB - Not evaluated (all DS-TB cases) (%)</td>
      </tr>
      <tr>
        <td>TB treatment outcomes</td>
        <td>[CONFIG] TB - Died (new smear-positive TB cases) (%)</td>
      </tr>
      <tr>
        <td>TB treatment outcomes</td>
        <td>[CONFIG] TB - Not evaluated (new smear-positive TB cases) (%)</td>
      </tr>
      <tr>
        <td>TB treatment outcomes</td>
        <td>[CONFIG] TB - Notified TB cases (new and relapse, all forms) aged 35-44 (%)</td>
      </tr>
      <tr>
        <td>TB treatment outcomes</td>
        <td>[CONFIG] TB - TB treatment success rate (all DR-TB) (%)</td>
      </tr>
      <tr>
        <td>TB treatment outcomes</td>
        <td>[CONFIG] TB - TB cases tested for HIV with positive test recorded at outcome</td>
      </tr>
      <tr>
        <td>TB treatment outcomes</td>
        <td>[CONFIG] TB - Ratio of TB cases aged 0-4:5-14 (new and relapse, all forms)</td>
      </tr>
      <tr>
        <td>TB treatment outcomes</td>
        <td>[CONFIG] TB - Cured (all DS-TB/HIV cases) (%)</td>
      </tr>
      <tr>
        <td>TB treatment outcomes</td>
        <td>[CONFIG] TB - Notified TB cases (new and relapse, all forms) aged 65+ (%)</td>
      </tr>
      <tr>
        <td>TB treatment outcomes</td>
        <td>[CONFIG] TB - Lost to follow-up (all DS-TB/HIV cases) (%)</td>
      </tr>
      <tr>
        <td>TB treatment outcomes</td>
        <td>[CONFIG] TB - TB cases recorded as HIV positive started on CPT (%)</td>
      </tr>
      <tr>
        <td>TB treatment outcomes</td>
        <td>[CONFIG] TB - Cured (new and relapse pulmonary bacteriologically confirmed DS-TB cases) (%)</td>
      </tr>
      <tr>
        <td>TB treatment outcomes</td>
        <td>[CONFIG] TB - TB treatment completed (new smear-positive TB cases) (%)</td>
      </tr>
      <tr>
        <td>TB treatment outcomes</td>
        <td>[CONFIG] TB - Notified TB cases (new, extrapulmonary) (%)</td>
      </tr>
      <tr>
        <td>TB treatment outcomes</td>
        <td>[CONFIG] TB - Died (previously treated DS-TB cases) (%)</td>
      </tr>
      <tr>
        <td>TB treatment outcomes</td>
        <td>[CONFIG] TB - TB notification rate (all cases, all forms) per 100 000 population</td>
      </tr>
      <tr>
        <td>TB treatment outcomes</td>
        <td>[CONFIG] TB - Failed (new and relapse pulmonary bacteriologically confirmed DS-TB cases)</td>
      </tr>
      <tr>
        <td>TB treatment outcomes</td>
        <td>[CONFIG] TB - Not evaluated (all DR-TB cases) (%)</td>
      </tr>
      <tr>
        <td>TB treatment outcomes</td>
        <td>[CONFIG] TB - Completed (all DS-TB cases) (%)</td>
      </tr>
      <tr>
        <td>TB treatment outcomes</td>
        <td>[CONFIG] TB - Notified TB cases (new and relapse, all forms)</td>
      </tr>
      <tr>
        <td>TB treatment outcomes</td>
        <td>[CONFIG] TB - TB cases recorded as HIV positive started on ART (%)</td>
      </tr>
      <tr>
        <td>TB treatment outcomes</td>
        <td>[CONFIG] TB - TB treatment success rate (new and relapse DS-TB) (%)</td>
      </tr>
      <tr>
        <td>TB treatment outcomes</td>
        <td>[CONFIG] TB - Notified TB cases (new and relapse, all forms) aged 5-14 (%)</td>
      </tr>
      <tr>
        <td>TB treatment outcomes</td>
        <td>[CONFIG] TB - Notified TB cases (new and relapse, all forms) aged 25-34 (%)</td>
      </tr>
    </table>
    <h2 id="indicators">Indicators</h2>
    <table>
      <tr>
        <th>UID</th>
        <th>Name</th>
        <th>Shortname</th>
        <th>Code</th>
        <th>Description</th>
        <th>Numerator</th>
        <th>Denominator</th>
        <th>Type</th>
        <th>Last updated</th>
        <th>Indicator group UID</th>
      </tr>
      <tr>
        <td>AAiHWXynwMP</td>
        <td>[CONFIG] TB - Completed (new and relapse pulmonary bacteriologically confirmed DS-TB cases) (%)</td>
        <td>Completed (pulm bact conf DS-TB) (%)</td>
        <td>TB_C_PCNT_LABCONF_CMPLT</td>
        <td>Number of new and relapse pulmonary bacteriologically confirmed TB patients who completed treatment as a percentage of the total cohort registered</td>
        <td>Completed (completed) - bacteriologically confirmed new and relapse</td>
        <td>New and relapse pulmonary bacteriologically confirmed cases in cohort</td>
        <td>Percentage</td>
        <td>2021-02-08</td>
        <td>S0n1torLnUz, V4SoC7TzFMi</td>
      </tr>
      <tr>
        <td>aArkaKMHNhw</td>
        <td>[CONFIG] TB - Not evaluated (new and relapse pulmonary bacteriologically confirmed DS-TB cases) (%)</td>
        <td>Not evaluated (pulm bact conf DS-TB) (%)</td>
        <td>TB_C_PCNT_LABCONF_NEVAL</td>
        <td>Number of new and relapse pulmonary bacteriologically confirmed TB patients whose treatment outcome is unknown as a percentage of the total cohort registered</td>
        <td>Not evaluated</td>
        <td>New and relapse pulmonary bacteriologically confirmed cases in cohort</td>
        <td>Percentage</td>
        <td>2021-02-08</td>
        <td>S0n1torLnUz, V4SoC7TzFMi</td>
      </tr>
      <tr>
        <td>AgJYWRktH9o</td>
        <td>[CONFIG] TB - Proportion of GeneXpert cartridges unusable</td>
        <td>GeneXpert cartridges unusable (%)</td>
        <td>TB_CARTRIDGES_UNUSABLE</td>
        <td>Proportion of GeneXpert cartridges that, out of the opening balance, could not be used due to either redistribution or discard</td>
        <td>TB - GeneXpert Cartridges discarded + TB - GeneXpert Cartridges redistributed</td>
        <td>TB - GeneXpert Cartridges opening balance</td>
        <td>Percentage</td>
        <td>2021-03-04</td>
        <td>pMaektY4E9s</td>
      </tr>
      <tr>
        <td>ajJXlrOt4NU</td>
        <td>[CONFIG] TB - TB: Cured - new smear-positive (%)</td>
        <td>Cured new smear+ (%)</td>
        <td>TB_C_PCNT_NEW_SP_CUR</td>
        <td>Number of new smear-positive TB patients who were cured as a percentage of the total cohort registered</td>
        <td>Cured</td>
        <td>New pulmonary smear positive cases in cohort</td>
        <td>Percentage</td>
        <td>2021-02-08</td>
        <td>S0n1torLnUz, V4SoC7TzFMi</td>
      </tr>
      <tr>
        <td>AK3YLZQERtT</td>
        <td>[CONFIG] TB - DR-TB drugs wastage rate (%)</td>
        <td>DR-TB drugs wastage rate</td>
        <td>DR-TB_DRUGS_WASTAGE_RATE</td>
        <td>Stock wasted=([Closing balance]-[Stock at hand]) + discarded)</td>
        <td>Stock wasted=([Closing balance]-[Stock at hand]) + discarded)</td>
        <td>Stock used=([Closing balance]-[Stock at hand]) + discarded + dispensed to patient)</td>
        <td>Percentage</td>
        <td>2021-03-21</td>
        <td>pMaektY4E9s</td>
      </tr>
      <tr>
        <td>AmkNXobiXxa</td>
        <td>[CONFIG] TB - Cured (all DS-TB cases) (%)</td>
        <td>Cured (all DS-TB) (%)</td>
        <td>TB_C_PCNT_CUR</td>
        <td>Number of new and previously treated TB patients who were cured as a percentage of the total cohort registered</td>
        <td>total cured</td>
        <td>Total cohort size (cases registered)</td>
        <td>Percentage</td>
        <td>2021-02-08</td>
        <td>OMyYjoU07pC, S0n1torLnUz, V4SoC7TzFMi</td>
      </tr>
      <tr>
        <td>aPfDXoI0tPS</td>
        <td>[CONFIG] TB - Notified TB cases (new, all forms) aged 0-14 (%)</td>
        <td>0-14 (%) </td>
        <td>TB_C_PCNT_NEW_014</td>
        <td></td>
        <td>Number of TB cases aged under 15</td>
        <td>Total number notified by age and sex</td>
        <td>Percentage</td>
        <td>2021-02-08</td>
        <td>OMyYjoU07pC, S0n1torLnUz</td>
      </tr>
      <tr>
        <td>aPT4OksC5z7</td>
        <td>[CONFIG] TB - Notified TB cases (new and relapse, all forms) children aged 0-14 (%)</td>
        <td>0-14 year olds (new and relapse, all forms TB) (%)</td>
        <td>TB_C_PCNT_KIDS</td>
        <td></td>
        <td>Number of TB cases aged 0-15 (new and relapse only)</td>
        <td>Total number notified by age and sex</td>
        <td>Percentage</td>
        <td>2021-02-08</td>
        <td>OMyYjoU07pC, S0n1torLnUz, V4SoC7TzFMi</td>
      </tr>
      <tr>
        <td>AwZgWwQaHvR</td>
        <td>[CONFIG] TB - DR-TB drugs opening balance</td>
        <td>DR-TB drugs opening balance</td>
        <td>TB_DRDRUGS_OPENING_BALANCE</td>
        <td>Number of DR-TB drugs opening balance</td>
        <td>TB - DR-TB drugs opening balance</td>
        <td>1</td>
        <td>Numerator only (number)</td>
        <td>2021-02-18</td>
        <td>pMaektY4E9s</td>
      </tr>
      <tr>
        <td>axHsIHLBpRm</td>
        <td>[CONFIG] TB - Lost to follow-up (new smear-positive TB cases) (%)</td>
        <td>Lost (smear+) (%)</td>
        <td>TB_C_PCNT_NEW_SP_LOST</td>
        <td>Number of new smear-positive TB patients lost to follow-up as a percentage of the total cohort registered</td>
        <td>Lost</td>
        <td>New pulmonary smear positive cases in cohort</td>
        <td>Percentage</td>
        <td>2021-02-08</td>
        <td>S0n1torLnUz, V4SoC7TzFMi</td>
      </tr>
      <tr>
        <td>B0Wm5ZKo9AY</td>
        <td>[CONFIG] TB - TB cases recorded as HIV positive started on CPT at outcome</td>
        <td>TB/HIV on CPT at outcome</td>
        <td>TB_C_HIV_CPT_OUT</td>
        <td>New and relapse HIV-positive TB cases started/continued co-trimoxazole preventive therapy (CPT) recorded at the time of treatment outcome (all TB cases for pre-2013 definitions).</td>
        <td>HIV on CPT at the time of treatment outcome</td>
        <td>1</td>
        <td>Numerator only (number)</td>
        <td>2021-02-08</td>
        <td>S0n1torLnUz, V4SoC7TzFMi</td>
      </tr>
      <tr>
        <td>B1HKzq73wJr</td>
        <td>[CONFIG] TB - Notified TB cases (new, all forms) aged 15-24 (%)</td>
        <td>15-24 (%)</td>
        <td>TB_C_PCNT_NEW_1524</td>
        <td></td>
        <td>Number of TB cases aged 15-24</td>
        <td>Total number notified by age and sex</td>
        <td>Percentage</td>
        <td>2021-02-08</td>
        <td>OMyYjoU07pC, S0n1torLnUz</td>
      </tr>
      <tr>
        <td>bCrpRBKKPhA</td>
        <td>[CONFIG] TB - DS-TB drugs usable stock</td>
        <td>DS-TB drugs usable stock</td>
        <td>TB_DSDRUGS_USABLE_STOCK</td>
        <td></td>
        <td>opening balance+received</td>
        <td>1</td>
        <td>Numerator only (number)</td>
        <td>2021-04-29</td>
        <td>pMaektY4E9s</td>
      </tr>
      <tr>
        <td>bD1Z2FmbHKK</td>
        <td>[CONFIG] TB - DS-TB drugs opening balance</td>
        <td>DS-TB drugs opening balance</td>
        <td>TB_DSDRUGS_OPENING_BALANCE</td>
        <td>Number of DS-TB drugs opening balance</td>
        <td>TB - DS-TB drugs opening balance</td>
        <td>1</td>
        <td>Numerator only (number)</td>
        <td>2021-02-18</td>
        <td>pMaektY4E9s</td>
      </tr>
      <tr>
        <td>bK3hiVktvHR</td>
        <td>[CONFIG] TB - DR-TB drugs discarded</td>
        <td>DR-TB drugs discarded</td>
        <td>TB_DRDRUGS_DISCARDED</td>
        <td>Number of DR-TB drugs discarded during the reporting period (expired, damaged, etc.)</td>
        <td>DR-TB drugs discarded</td>
        <td>1</td>
        <td>Numerator only (number)</td>
        <td>2021-02-08</td>
        <td>pMaektY4E9s</td>
      </tr>
      <tr>
        <td>BmxOvSZmatv</td>
        <td>[CONFIG] TB - DR-TB drugs received</td>
        <td>DR-TB drugs received</td>
        <td>TB_DRDRUGS_RECV</td>
        <td>Number of DR-TB drugs received</td>
        <td>TB - DR-TB drugs received</td>
        <td>1</td>
        <td>Numerator only (number)</td>
        <td>2021-02-18</td>
        <td>pMaektY4E9s</td>
      </tr>
      <tr>
        <td>BzFJFOFMVCu</td>
        <td>[CONFIG] TB - GeneXpert Cartridges stock out days</td>
        <td>GeneXpert Cartridges stock out days</td>
        <td>TB_CARTRIDGE_STOCKOUT_DAYS</td>
        <td>Number of days when the facility was stocked out of GeneXpert Cartridges (at any point during the day) during the reporting period.</td>
        <td>GenExpert Cartridges stock out days</td>
        <td>1</td>
        <td>Numerator only (number)</td>
        <td>2021-03-02</td>
        <td>pMaektY4E9s</td>
      </tr>
      <tr>
        <td>C4cDwij2oqU</td>
        <td>[CONFIG] TB - TB cases tested for HIV or with known HIV status (%)</td>
        <td>TB/HIV tested (%)</td>
        <td>TB_C_PCNT_HIVTEST</td>
        <td>New and relapse TB cases tested or with known HIV status as percentage of notified new and relapse TB cases (all TB cases tested of all TB cases notified for pre-2013)</td>
        <td>TB patients with known HIV status</td>
        <td>New and relapse TB cases notified and all TB cases notified (pre 2013)</td>
        <td>Percentage</td>
        <td>2021-02-08</td>
        <td>OMyYjoU07pC, S0n1torLnUz, V4SoC7TzFMi</td>
      </tr>
      <tr>
        <td>c5yG2hQbSWF</td>
        <td>[CONFIG] TB - Lost to follow-up (previously treated DS-TB cases) (%)</td>
        <td>Lost (previously treated DS-TB) (%)</td>
        <td>TB_C_PCNT_LOST_RET</td>
        <td>Number of previously treated/re-treated TB patients lost to follow-up as a percentage of the total cohort registered</td>
        <td>Total lost to follow-up previously treated TB patients</td>
        <td>Total cohort size of previously treated TB patients</td>
        <td>Percentage</td>
        <td>2021-02-08</td>
        <td>S0n1torLnUz, V4SoC7TzFMi</td>
      </tr>
      <tr>
        <td>c6ju86FLKzU</td>
        <td>[CONFIG] TB - Died (all DR-TB cases) (%)</td>
        <td>Died (all DR-TB) (%)</td>
        <td>TB_C_PCNT_DIED_2ND</td>
        <td>Number of TB patients who died as a percentage of the total cohort registered for 2nd line treatment </td>
        <td>Total died for 2nd line treatment</td>
        <td>Total cohort size of TB patients registered for 2nd line treatment</td>
        <td>Percentage</td>
        <td>2021-02-08</td>
        <td>S0n1torLnUz, V4SoC7TzFMi</td>
      </tr>
      <tr>
        <td>cbAQwCbhhoe</td>
        <td>[CONFIG] TB - GeneXpert Cartridges issued</td>
        <td>GeneXpert cartridges issued</td>
        <td>TB_CARTRIDGE_ISSUED</td>
        <td>Number of GeneXpert cartridges issued</td>
        <td>TB - GenExpert Cartridges issued</td>
        <td>1</td>
        <td>Numerator only (number)</td>
        <td>2021-06-11</td>
        <td>pMaektY4E9s</td>
      </tr>
      <tr>
        <td>cT1tyz6k18X</td>
        <td>[CONFIG] TB - Notified TB cases (new, all forms) aged 35-44 (%)</td>
        <td>35-44 (%)</td>
        <td>TB_C_PCNT_NEW_3544</td>
        <td></td>
        <td>Number of TB cases aged 35-44</td>
        <td>Total number notified by age and sex</td>
        <td>Percentage</td>
        <td>2021-02-08</td>
        <td>OMyYjoU07pC, S0n1torLnUz</td>
      </tr>
      <tr>
        <td>cX7gRvEV6kK</td>
        <td>[CONFIG] TB - TB cases tested for susceptibility to rifampicin (%)</td>
        <td>Tested for RR-TB (%)</td>
        <td>TB_C_PCNT_DST</td>
        <td>All TB cases tested for susceptibility to rifampicin (RR-TB) as a percentage of all TB cases notified</td>
        <td>Total number of cases tested for susceptibility to rifampicin</td>
        <td>Total notified</td>
        <td>Percentage</td>
        <td>2021-02-08</td>
        <td>OMyYjoU07pC, QCrsjqhAcWA, S0n1torLnUz, V4SoC7TzFMi</td>
      </tr>
      <tr>
        <td>DdIWhMWSI8i</td>
        <td>[CONFIG] TB - TB cases tested for HIV with positive test recorded (%)</td>
        <td>TB/HIV positive (%)</td>
        <td>TB_C_PCNT_HIVPOS</td>
        <td>New and relapse TB cases with positive HIV test result recorded as percentage of those tested or with known HIV status</td>
        <td>Known HIV-positive TB cases</td>
        <td>TB cases with known HIV status</td>
        <td>Percentage</td>
        <td>2021-02-08</td>
        <td>OMyYjoU07pC, S0n1torLnUz, V4SoC7TzFMi</td>
      </tr>
      <tr>
        <td>DKdvXuIfxwl</td>
        <td>[CONFIG] TB - DS-TB drugs closing balance</td>
        <td>DS-TB drugs closing balance</td>
        <td>TB_DSDRUGS_CLOSING_BAL</td>
        <td>Number of DS-TB drugs as closing balance [Opening balance + Received - Issued - Redistributed - Discarded] at the end of the reporting period</td>
        <td>DS-TB drugs closing bal</td>
        <td>1</td>
        <td>Numerator only (number)</td>
        <td>2021-02-08</td>
        <td>pMaektY4E9s</td>
      </tr>
      <tr>
        <td>dlUf7CDF3l8</td>
        <td>[CONFIG] TB - DR-TB drugs stock discrepancy (%)</td>
        <td>DR-TB drugs stock discrepancy (%)</td>
        <td>TB_DRDRUGS_DISCREPANCY</td>
        <td>Percentage of the item's stock discrepancy [Stock on hand - Closing balance] / Stock on hand</td>
        <td>DR-TB drugs stock discrepancy</td>
        <td>stock on hand</td>
        <td>Percentage</td>
        <td>2021-05-11</td>
        <td>pMaektY4E9s</td>
      </tr>
      <tr>
        <td>DV5YjkDeN36</td>
        <td>[CONFIG] TB - TB cohort size (all cases, all forms)</td>
        <td>Cohort size (all DS-TB)</td>
        <td>TB_C_COH</td>
        <td>Number of new and previously treated TB patients registered, excluding cases moved to second-line treatment</td>
        <td>Total cohort size (all TB cases)</td>
        <td>1</td>
        <td>Numerator only (number)</td>
        <td>2021-02-08</td>
        <td>OMyYjoU07pC, S0n1torLnUz, V4SoC7TzFMi</td>
      </tr>
      <tr>
        <td>e92Z61nHBJY</td>
        <td>[CONFIG] TB - DR-TB drugs stock out days</td>
        <td>DR-TB drugs stock out days</td>
        <td>TB_DRDRUGS_STOCKOUT_DAYS</td>
        <td>Number of days when the facility was stocked out of DR-TB drugs (at any point during the day) during the reporting period.</td>
        <td>DR-TB drugs stock out days</td>
        <td>1</td>
        <td>Numerator only (number)</td>
        <td>2021-02-08</td>
        <td>pMaektY4E9s</td>
      </tr>
      <tr>
        <td>EHDTSPxpLco</td>
        <td>[CONFIG] TB - DR-TB drugs closing balance</td>
        <td>DR-TB drugs closing balance</td>
        <td>TB_DRDRUGS_CLOSING_BAL</td>
        <td>Number of DR-TB drugs as closing balance [Opening balance + Received - Issued - Redistributed - Discarded] at the end of the reporting period</td>
        <td>DR-TB drugs closing bal</td>
        <td>1</td>
        <td>Numerator only (number)</td>
        <td>2021-02-08</td>
        <td>pMaektY4E9s</td>
      </tr>
      <tr>
        <td>eIG3AwbOY4k</td>
        <td>[CONFIG] TB - Notified TB cases (new, all forms) aged 65+ (%)</td>
        <td>65+ (%)</td>
        <td>TB_C_PCNT_NEW_65</td>
        <td></td>
        <td>Number of TB cases aged 65+</td>
        <td>Total number notified by age and sex</td>
        <td>Percentage</td>
        <td>2021-02-08</td>
        <td>OMyYjoU07pC, S0n1torLnUz</td>
      </tr>
      <tr>
        <td>ePih3BMGzXU</td>
        <td>[CONFIG] TB - Notified TB cases (previously treated, all forms)</td>
        <td>Previously treated (all forms TB)</td>
        <td>TB_C_RET_NREL</td>
        <td>Total number of TB cases re-registered for a new course of treatment (mainly treatment after failure and treatment after loss to follow-up patients) excluding relapse cases</td>
        <td>Total of all previously treated TB cases, but not relapse cases</td>
        <td></td>
        <td>Numerator only (number)</td>
        <td>2021-02-08</td>
        <td>OMyYjoU07pC, S0n1torLnUz, V4SoC7TzFMi</td>
      </tr>
      <tr>
        <td>ERUV57qB52t</td>
        <td>[CONFIG] TB - TB cases recorded as HIV positive started on ART</td>
        <td>TB/HIV on ART</td>
        <td>TB_C_HIV_ART</td>
        <td>New and relapse HIV-positive TB cases started/continued antiretroviral therapy (ART) (all TB cases for pre-2013 definitions)</td>
        <td>HIV on ART</td>
        <td>1</td>
        <td>Numerator only (number)</td>
        <td>2021-02-08</td>
        <td>OMyYjoU07pC, S0n1torLnUz, V4SoC7TzFMi</td>
      </tr>
      <tr>
        <td>eSTkclrbTy5</td>
        <td>[CONFIG] TB - Health facilities with DR-TB drugs stock-out days (%)</td>
        <td>HF with DR-TB drugs stockout days (%)</td>
        <td>HF_WITH_DR-TB_DRUGS_STOCKOUT_DAYS_%</td>
        <td>Proportion of health facilities with DR-TB drugs stockout days</td>
        <td>HF with DR-TB drugs stockout days reported</td>
        <td>HF reporting stockout days</td>
        <td>Percentage</td>
        <td>2021-06-10</td>
        <td>pMaektY4E9s</td>
      </tr>
      <tr>
        <td>ExXsF5qlzdc</td>
        <td>[CONFIG] TB - Notified TB cases (new and relapse, all forms) aged 15-24 (%)</td>
        <td>15-24 (%) </td>
        <td>TB_C_PCNT_1524</td>
        <td></td>
        <td>Number of TB cases aged 15-24 (new and relapse only)</td>
        <td>Total number notified by age and sex (new and relapse only)</td>
        <td>Percentage</td>
        <td>2021-02-08</td>
        <td>OMyYjoU07pC, S0n1torLnUz, V4SoC7TzFMi</td>
      </tr>
      <tr>
        <td>F9eE09Dtqft</td>
        <td>[CONFIG] TB - Laboratory-confirmed RR-TB or MDR-TB among cases with DST results</td>
        <td>Lab-confirmed RR/MDR-TB</td>
        <td>TB_C_CONF_RRMDR</td>
        <td>Number of laboratory-confirmed RR-TB or MDR-TB cases identified among all TB patients (pulmonary or extrapulmonary, new, previously treated, or unknown treatment history) using phenotypic DST or WHO-recommended rapid molecular diagnostics (e.g. Xpert MTB/RIF, line probe assay), before or after starting treatment</td>
        <td>Number of lab-confirmed RR-TB or MDR-TB cases</td>
        <td>1</td>
        <td>Numerator only (number)</td>
        <td>2021-02-08</td>
        <td>OMyYjoU07pC, QCrsjqhAcWA, S0n1torLnUz, V4SoC7TzFMi</td>
      </tr>
      <tr>
        <td>fBAKfSVeUX2</td>
        <td>[CONFIG] TB - Laboratory-confirmed RR-TB or MDR-TB cases who started treatment for MDR-TB (%)</td>
        <td>Lab-confirmed RR/MDR-TB started MDR treatment (%)</td>
        <td>TB_C_PCNT_CONF_RRMDR_TX</td>
        <td>Percentage of laboratory confirmed rifampicin-resistant (RR-/MDR) TB cases notified and started on a second line MDR-TB treatment regimen among all cases with confirmed RR-/MDR-TB</td>
        <td>Lab-confirmed patients started treatment for MDR-TB</td>
        <td>Lab-confirmed RR-TB patients</td>
        <td>Percentage</td>
        <td>2021-02-08</td>
        <td>OMyYjoU07pC, QCrsjqhAcWA, S0n1torLnUz, V4SoC7TzFMi</td>
      </tr>
      <tr>
        <td>fBwmklJ0VNp</td>
        <td>[CONFIG] TB - Notified TB cases (new and relapse, all forms) aged 0-4 (%)</td>
        <td>0-4 (%) </td>
        <td>TB_C_PCNT_04</td>
        <td>Percentage of TB cases aged 0-4 among notified TB cases in given year (new and relapse, all forms)</td>
        <td>Number of TB cases aged 0-4 (new and relapse only)</td>
        <td>Total number notified by age and sex (new and relapse only)</td>
        <td>Percentage</td>
        <td>2021-02-08</td>
        <td>OMyYjoU07pC, S0n1torLnUz, V4SoC7TzFMi</td>
      </tr>
      <tr>
        <td>fdt3FPCzgDc</td>
        <td>[CONFIG] TB - DR-TB drugs stock coverage time</td>
        <td>DR-TB drugs stock coverage time</td>
        <td>TB_DRTB_DRUGS_COVERAGE_TIME</td>
        <td></td>
        <td>usable stock</td>
        <td>consumed stock</td>
        <td>Rate (factor=1)</td>
        <td>2021-05-03</td>
        <td>pMaektY4E9s</td>
      </tr>
      <tr>
        <td>FETY3REnbWa</td>
        <td>[CONFIG] TB - Notified TB cases (previously treated including relapse, all forms) (%)</td>
        <td>Previously treated (all forms TB) (%)</td>
        <td>TB_C_PCNT_RET</td>
        <td>Number of previously treated TB cases (previously treated including relapse, all forms) notified in given period as a percentage of the total notified TB cases.</td>
        <td>Total notified previously treated cases (INCLUDING relapse!)</td>
        <td>Total notified TB cases</td>
        <td>Percentage</td>
        <td>2021-02-08</td>
        <td>OMyYjoU07pC, S0n1torLnUz, V4SoC7TzFMi</td>
      </tr>
      <tr>
        <td>FnadQQyc1dP</td>
        <td>[CONFIG] TB - GeneXpert Cartridges redistributed</td>
        <td>GeneXpert Cartridges redistributed</td>
        <td>TB_CARTRIDGE_REDISTRIBUTED</td>
        <td>Number of GeneXpert Cartridges redistributed</td>
        <td>TB - GenExpert Cartridges redistributed</td>
        <td>1</td>
        <td>Numerator only (number)</td>
        <td>2021-03-02</td>
        <td>pMaektY4E9s</td>
      </tr>
      <tr>
        <td>Fyx8nuRcxja</td>
        <td>[CONFIG] TB - TB cases tested for susceptibility to rifampicin (new) (%)</td>
        <td>Tested for RR-TB (new) (%)</td>
        <td>TB_C_PCNT_DST_NEW</td>
        <td>New TB cases tested for susceptibility to rifampicin (RR-TB) as a percentage of all new TB cases notified</td>
        <td>Number of new TB cases tested for susceptibility to rifampicin</td>
        <td>All new TB cases notified (excluding the cases with unknown treatment history)</td>
        <td>Percentage</td>
        <td>2021-02-08</td>
        <td>QCrsjqhAcWA, S0n1torLnUz</td>
      </tr>
      <tr>
        <td>g6tK0H6KkYe</td>
        <td>[CONFIG] TB - Died (all DS-TB cases) (%)</td>
        <td>Died (all DS-TB) (%)</td>
        <td>TB_C_PCNT_DIED</td>
        <td>Number of new and previously treated TB patients who died as a percentage of the total cohort registered</td>
        <td>Total died</td>
        <td>Total cohort size (cases registered)</td>
        <td>Percentage</td>
        <td>2021-02-08</td>
        <td>OMyYjoU07pC, S0n1torLnUz, V4SoC7TzFMi</td>
      </tr>
      <tr>
        <td>GbqUYVq0NLo</td>
        <td>[CONFIG] TB - Proportion of DS-TB drugs consumed</td>
        <td>DS-TB drugs consumed (%)</td>
        <td>TB_DSTB_DRUGS_CONSUMED</td>
        <td>Proportion of DS-TB drugs that have been used over the opening balance of the same drugs</td>
        <td>TB - DS-TB drugs distributed</td>
        <td>TB - DS-TB drugs opening balance + received = usable stock</td>
        <td>Percentage</td>
        <td>2021-04-29</td>
        <td>pMaektY4E9s</td>
      </tr>
      <tr>
        <td>gcMtkbbotUv</td>
        <td>[CONFIG] TB - GeneXpert Cartridges received</td>
        <td>GeneXpert Cartridges received</td>
        <td>TB_CARTRIDGE_RECV</td>
        <td>Number of GeneXpert Cartridges received</td>
        <td>TB - GenExpert Cartridges received</td>
        <td>1</td>
        <td>Numerator only (number)</td>
        <td>2021-03-02</td>
        <td>pMaektY4E9s</td>
      </tr>
      <tr>
        <td>gHZcDFFvq5x</td>
        <td>[CONFIG] TB - Died (new and relapse pulmonary bacteriologically confirmed DS-TB cases) (%)</td>
        <td>Died (pulm bact conf DS-TB) (%)</td>
        <td>TB_C_PCNT_LABCONF_DIED</td>
        <td>Number of new and relapse pulmonary bacteriologically confirmed TB patients who died as a percentage of the total cohort registered</td>
        <td>Died</td>
        <td>New and relapse pulmonary bacteriologically confirmed cases in cohort</td>
        <td>Percentage</td>
        <td>2021-02-08</td>
        <td>S0n1torLnUz, V4SoC7TzFMi</td>
      </tr>
      <tr>
        <td>GjDECoLvM1z</td>
        <td>[CONFIG] TB - Notified TB cases (new, all forms) aged 5-14 (%)</td>
        <td>5-14 (%)</td>
        <td>TB_C_PCNT_NEW_514</td>
        <td></td>
        <td>Number of TB cases aged 5-14</td>
        <td>Total number notified by age and sex</td>
        <td>Percentage</td>
        <td>2021-02-08</td>
        <td>OMyYjoU07pC, S0n1torLnUz</td>
      </tr>
      <tr>
        <td>gm3SU0QX9tO</td>
        <td>[CONFIG] TB - Ratio of TB cases male:female (new and relapse, all forms)</td>
        <td>Ratio male:female (new and relapse, all forms TB)</td>
        <td>TB_C_RATIO_M_F</td>
        <td>Number of male TB cases (new and relapse, all forms) notified in given period compared to the female TB cases (new and relapse, all forms) notified in the same period. </td>
        <td>Total number of males</td>
        <td>Total number of females</td>
        <td>Rate (factor=1)</td>
        <td>2021-02-08</td>
        <td>OMyYjoU07pC, S0n1torLnUz, V4SoC7TzFMi</td>
      </tr>
      <tr>
        <td>gN08xtpAR9V</td>
        <td>[CONFIG] TB - TB treatment success rate (all DS-TB) (%)</td>
        <td>Tx success (all DS-TB) (%)</td>
        <td>TB_C_ALLDS_TSR</td>
        <td>Number of all DS-TB cases who were successfully treated (cured or who completed their treatment) as a percentage of the total cohort of all DS-TB cases registered, excluding cases moved to second-line treatment</td>
        <td>Number of all DS-TB cases who were successfully treated (cured or who completed their treatment)</td>
        <td>Total number of new and relapse TB cases registered, excluding cases moved to second-line treatment</td>
        <td>Percentage</td>
        <td>2021-02-08</td>
        <td>OMyYjoU07pC, S0n1torLnUz, V4SoC7TzFMi</td>
      </tr>
      <tr>
        <td>gPJEsVY8R39</td>
        <td>[CONFIG] TB - Notified TB cases (new and relapse, pulmonary bacteriologically confirmed)</td>
        <td>New and relapse (pulm bac conf TB)</td>
        <td>TB_C_NEWINC_LABCONF</td>
        <td>Number of TB cases notified in a given year (new and relapse and history unknown; pulmonary bacteriologically confirmed)</td>
        <td>Pulm bact confirmed new and relapse and history unknown</td>
        <td>1</td>
        <td>Numerator only (number)</td>
        <td>2021-02-08</td>
        <td>OMyYjoU07pC, S0n1torLnUz, V4SoC7TzFMi</td>
      </tr>
      <tr>
        <td>h7bxqdKWYCa</td>
        <td>[CONFIG] GEN - Population total</td>
        <td>Population</td>
        <td>GEN_E_POP_TOT</td>
        <td>Estimated total population</td>
        <td>total population</td>
        <td>1</td>
        <td>Numerator only (number)</td>
        <td>2021-02-08</td>
        <td>I13HBLJTJMb</td>
      </tr>
      <tr>
        <td>HBB4o9xQScX</td>
        <td>[CONFIG] TB - Completed (previously treated DS-TB cases) (%)</td>
        <td>Completed (previously treated DS-TB) (%)</td>
        <td>TB_C_PCNT_CMPLT_RET</td>
        <td>Number of previously treated/re-treated TB patients who completed treatment as a percentage of the total cohort registered</td>
        <td>Total previously treated TB patients with completed treatment</td>
        <td>Total cohort size of previously treated TB patients</td>
        <td>Percentage</td>
        <td>2021-02-08</td>
        <td>S0n1torLnUz, V4SoC7TzFMi</td>
      </tr>
      <tr>
        <td>HBkfpoEMWna</td>
        <td>[CONFIG] TB - Notified TB cases (new, all forms) aged 55-64 (%)</td>
        <td>55-64 (%)</td>
        <td>TB_C_PCNT_NEW_5564</td>
        <td></td>
        <td>Number of TB cases aged 55-64</td>
        <td>Total number notified by age and sex</td>
        <td>Percentage</td>
        <td>2021-02-08</td>
        <td>OMyYjoU07pC, S0n1torLnUz</td>
      </tr>
      <tr>
        <td>hO7plbvXQPQ</td>
        <td>[CONFIG] TB - TB cases tested for HIV or with known HIV status at outcome</td>
        <td>TB/HIV tested at outcome</td>
        <td>TB_C_HIV_TEST_OUT</td>
        <td>New and relapse TB cases tested or with known HIV status at the time of treatment outcome (all TB cases for pre-2013 definitions) </td>
        <td>TB patients tested (new and relapse or all for pre-2013 definitions) recorded at the time of treatment outcome</td>
        <td>1</td>
        <td>Numerator only (number)</td>
        <td>2021-02-08</td>
        <td>S0n1torLnUz, V4SoC7TzFMi</td>
      </tr>
      <tr>
        <td>HSLNfDLCbUc</td>
        <td>[CONFIG] TB - Not evaluated (all DS-TB/HIV cases) (%)</td>
        <td>Not evaluated (all DS-TB/HIV) (%)</td>
        <td>TB_C_PCNT_NEVAL_HIV</td>
        <td>Number of new and previously treated TB/HIV patients whose treatment outcome is unknown as a percentage of the total cohort registered</td>
        <td>Total not evaluated HIV TB</td>
        <td>Total cohort size (cases registered) HIV TB</td>
        <td>Percentage</td>
        <td>2021-02-08</td>
        <td>S0n1torLnUz, V4SoC7TzFMi</td>
      </tr>
      <tr>
        <td>hSpmpUl6eJk</td>
        <td>[CONFIG] TB - DS-TB drugs received</td>
        <td>DS-TB drugs received</td>
        <td>TB_DSDRUGS_RECV</td>
        <td>Number of DS-TB drugs received</td>
        <td>TB - DS-TB drugs received</td>
        <td>1</td>
        <td>Numerator only (number)</td>
        <td>2021-02-18</td>
        <td>pMaektY4E9s</td>
      </tr>
      <tr>
        <td>IIbDJrLi4z5</td>
        <td>[CONFIG] TB - TB treatment success rate (previously treated DS-TB) (%)</td>
        <td>Tx success (previously treated DS-TB) (%)</td>
        <td>TB_C_RET_TSR</td>
        <td>Number of previously treated (excluding relapse) TB cases who were successfully treated (cured or who completed their treatment) as a percentage of the total cohort of previously treated (excluding relapse) TB cases registered, excluding cases moved to second-line treatment</td>
        <td>Number of previously treated (excluding relapse) TB cases who were successfully treated (cured or who completed their treatment)</td>
        <td>Total number of previously treated (excluding relapse) TB cases registered, excluding cases moved to second-line treatment</td>
        <td>Percentage</td>
        <td>2021-02-08</td>
        <td>OMyYjoU07pC, S0n1torLnUz, V4SoC7TzFMi</td>
      </tr>
      <tr>
        <td>j6wYomVhfNs</td>
        <td>[CONFIG] TB - Laboratory-confirmed MDR-TB cases</td>
        <td>Lab-confirmed MDR-TB</td>
        <td>TB_C_CONF_MDR</td>
        <td>Number of laboratory-confirmed MDR-TB cases identified among all TB patients (pulmonary or extrapulmonary, new, previously treated, or unknown treatment history) using phenotypic DST or WHO-recommended rapid molecular diagnostics (e.g. Xpert MTB/RIF, line probe assay), before or after starting treatment</td>
        <td>Lab-confirmed MDR-TB</td>
        <td>1</td>
        <td>Numerator only (number)</td>
        <td>2021-02-08</td>
        <td>OMyYjoU07pC, QCrsjqhAcWA, S0n1torLnUz, V4SoC7TzFMi</td>
      </tr>
      <tr>
        <td>J7ChdEuwMPW</td>
        <td>[CONFIG] TB - TB cases tested for HIV or with known HIV status</td>
        <td>TB/HIV tested</td>
        <td>TB_C_HIV_TEST</td>
        <td>New and relapse TB cases tested or with known HIV status (all TB cases for pre-2013 definitions)</td>
        <td>TB patients tested (new and relapse or all for pre-2013 definitions) </td>
        <td>1</td>
        <td>Numerator only (number)</td>
        <td>2021-02-08</td>
        <td>OMyYjoU07pC, S0n1torLnUz, V4SoC7TzFMi</td>
      </tr>
      <tr>
        <td>JaXPqKA823j</td>
        <td>[CONFIG] TB - Proportion of GeneXpert cartridges consumed</td>
        <td>GeneXpert cartridges consumed (%)</td>
        <td>TB_CARTRIDGES_CONSUMED</td>
        <td>Proportion of GeneXpert cartridges that have been used for diagnostics over the opening balace of GeneXpert cartridges</td>
        <td>TB - GenExpert Cartridges distributed</td>
        <td>TB - GenExpert Cartridges opening balance + received = usable stock</td>
        <td>Percentage</td>
        <td>2021-04-29</td>
        <td>pMaektY4E9s</td>
      </tr>
      <tr>
        <td>JCs9GgdcC7d</td>
        <td>[CONFIG] TB - Notified TB cases (new and relapse, pulmonary clinically diagnosed)</td>
        <td>New and relapse (pulm clin diag TB)</td>
        <td>TB_C_NEWINC_CLINDX</td>
        <td>Number of TB cases notified in a given year (new and relapse and history unknown; pulmonary clinically diagnosed)</td>
        <td>Pulmonary clinically diagnosed new and relapse and history unknown</td>
        <td>1</td>
        <td>Numerator only (number)</td>
        <td>2021-02-08</td>
        <td>OMyYjoU07pC, S0n1torLnUz, V4SoC7TzFMi</td>
      </tr>
      <tr>
        <td>jDitMFtRib4</td>
        <td>[CONFIG] TB - DS-TB drugs issued</td>
        <td>DS-TB drugs issued</td>
        <td>TB_DSDRUGS_ISSUED</td>
        <td>Number of DS-TB drugs issued</td>
        <td>TB - DS-TB drugs issued</td>
        <td>1</td>
        <td>Numerator only (number)</td>
        <td>2021-06-11</td>
        <td>pMaektY4E9s</td>
      </tr>
      <tr>
        <td>JfrM1j1pYhc</td>
        <td>[CONFIG] TB - Cured (all DR-TB cases) (%)</td>
        <td>Cured (all DR-TB) (%)</td>
        <td>TB_C_PCNT_CUR_2ND</td>
        <td>Number TB patients who were cured at the second line treatment as a percentage of the total cohort registered for the second line treatment</td>
        <td>Total cured TB patients of the second line treatment</td>
        <td>Total cohort size of TB patients from 2nd line treatment</td>
        <td>Percentage</td>
        <td>2021-02-08</td>
        <td>S0n1torLnUz, V4SoC7TzFMi</td>
      </tr>
      <tr>
        <td>jlzNtLhlpue</td>
        <td>[CONFIG] TB - TB treatment failed (new smear-positive TB cases) (%)</td>
        <td>Failed (smear+) (%)</td>
        <td>TB_C_PCNT_NEW_SP_FAIL</td>
        <td>Number of new smear-positive TB patients whose treatment failed as a percentage of the total cohort registered</td>
        <td>Failed</td>
        <td>New pulmonary smear positive cases in cohort</td>
        <td>Percentage</td>
        <td>2021-02-08</td>
        <td>S0n1torLnUz, V4SoC7TzFMi</td>
      </tr>
      <tr>
        <td>jU1JpPt2T62</td>
        <td>[CONFIG] TB - Notified TB cases (new, all forms) aged 0-4 (%)</td>
        <td>0-4 (%)</td>
        <td>TB_C_PCNT_NEW_04</td>
        <td></td>
        <td>Number of TB cases aged under 5</td>
        <td>Total number notified by age and sex</td>
        <td>Percentage</td>
        <td>2021-02-08</td>
        <td>OMyYjoU07pC, S0n1torLnUz</td>
      </tr>
      <tr>
        <td>K8jFJ0e67kU</td>
        <td>[CONFIG] TB - GeneXpert Cartridges discarded</td>
        <td>GeneXpert Cartridges discarded</td>
        <td>TB_CARTRIDGE_DISCARDED</td>
        <td>Number of GeneXpert Cartridges discarded during the reporting period (expired, damaged, etc.)</td>
        <td>GenExpert Cartridges discarded</td>
        <td>1</td>
        <td>Numerator only (number)</td>
        <td>2021-03-02</td>
        <td>pMaektY4E9s</td>
      </tr>
      <tr>
        <td>KlETO0IOKtI</td>
        <td>[CONFIG] TB - Notified TB cases (new, all forms) aged 25-34 (%)</td>
        <td>25-34 (%)</td>
        <td>TB_C_PCNT_NEW_2534</td>
        <td></td>
        <td>Number of TB cases aged 25-34</td>
        <td>Total number notified by age and sex</td>
        <td>Percentage</td>
        <td>2021-02-08</td>
        <td>OMyYjoU07pC, S0n1torLnUz</td>
      </tr>
      <tr>
        <td>KQf9KBm7VW5</td>
        <td>[CONFIG] TB - GeneXpert cartridges stock discrepancy (%)</td>
        <td>GeneXpert cartridges stock discrepancy (%)</td>
        <td>TB_CARTRIDGE_DISCREPANCY</td>
        <td>Percentage of the item's stock discrepancy [Stock on hand - Closing balance] / Stock on hand</td>
        <td>GenExpert cartridges stock discrepancy</td>
        <td>stock on hand</td>
        <td>Percentage</td>
        <td>2021-05-11</td>
        <td>pMaektY4E9s</td>
      </tr>
      <tr>
        <td>kWuyYvtjl6s</td>
        <td>[CONFIG] TB - TB cases tested for susceptibility to rifampicin (history unknown)</td>
        <td>Tested for RR-TB (history unknown)</td>
        <td>TB_C_OTH_RTEST</td>
        <td>History unknown TB cases tested for susceptibility to rifampicin</td>
        <td>R testing for history unknown TB cases</td>
        <td>1</td>
        <td>Numerator only (number)</td>
        <td>2021-02-08</td>
        <td>OMyYjoU07pC, QCrsjqhAcWA, S0n1torLnUz, V4SoC7TzFMi</td>
      </tr>
      <tr>
        <td>L6TXyCTI2mW</td>
        <td>[CONFIG] TB - Completed (all DR-TB cases) (%)</td>
        <td>Completed (all DR-TB) (%)</td>
        <td>TB_C_PCNT_CMPLT_2ND</td>
        <td>Number of TB patients who completed the 2nd line treatment as a percentage of the total cohort registered for 2nd line treatment</td>
        <td>TB patients with completed 2n line treatment</td>
        <td>Total cohort size of TB patients on 2nd line treatment</td>
        <td>Percentage</td>
        <td>2021-02-08</td>
        <td>S0n1torLnUz, V4SoC7TzFMi</td>
      </tr>
      <tr>
        <td>LmHsc7UGtQf</td>
        <td>[CONFIG] TB - DR-TB drugs usable stock</td>
        <td>DR-TB drugs usable stock</td>
        <td>TB_DRDRUGS_USABLE_STOCK</td>
        <td></td>
        <td>opening balance+received</td>
        <td>1</td>
        <td>Numerator only (number)</td>
        <td>2021-04-29</td>
        <td>pMaektY4E9s</td>
      </tr>
      <tr>
        <td>lRAKLRVIMgp</td>
        <td>[CONFIG] TB - Notified TB cases (all cases, all forms)</td>
        <td>All cases (all forms TB)</td>
        <td>TB_C_NOTIFIED</td>
        <td>Number of TB cases notified in a given year (all cases, all forms)</td>
        <td>All notified cases</td>
        <td></td>
        <td>Numerator only (number)</td>
        <td>2021-02-08</td>
        <td>OMyYjoU07pC, S0n1torLnUz, V4SoC7TzFMi</td>
      </tr>
      <tr>
        <td>m0VAZ280hFd</td>
        <td>[CONFIG] TB - Failed (all DS-TB/HIV cases) (%)</td>
        <td>Failed (all DS-TB/HIV) (%)</td>
        <td>TB_C_PCNT_FAIL_HIV</td>
        <td>Number of new and previously treated TB/HIV patients whose treatment failed as a percentage of the total cohort registered</td>
        <td>Total failed treatment HIV TB</td>
        <td>Total cohort size HIV TB</td>
        <td>Percentage</td>
        <td>2021-02-08</td>
        <td>S0n1torLnUz, V4SoC7TzFMi</td>
      </tr>
      <tr>
        <td>m1qHAB0I74y</td>
        <td>[CONFIG] TB - TB notification rate (new and relapse, pulmonary bacteriologically confirmed) per 100 000 population</td>
        <td>Rate - new and relapse (pulm bac conf TB)</td>
        <td>TB_C_NEWINC_LABCONF_100K</td>
        <td>Number of TB cases notified in a given year (new and relapse, pulmonary bacteriologically confirmed), per 100, 000 population</td>
        <td>Pulm bact confirmed new and relapse and history unknown</td>
        <td>population</td>
        <td>Per 100 000</td>
        <td>2021-02-08</td>
        <td>OMyYjoU07pC, S0n1torLnUz, V4SoC7TzFMi</td>
      </tr>
      <tr>
        <td>mDpLYl0sbQd</td>
        <td>[CONFIG] TB - GeneXpert cartridges closing balance</td>
        <td>GeneXpert cartridges closing balance</td>
        <td>TB_CARTRIDGE_CLOSING_BAL</td>
        <td>Number of GeneXpert Cartridges as closing balance [Opening balance + Received - Issued - Redistributed - Discarded] at the end of the reporting period</td>
        <td>GenExpert cartridges closing bal</td>
        <td>1</td>
        <td>Numerator only (number)</td>
        <td>2021-03-02</td>
        <td>pMaektY4E9s</td>
      </tr>
      <tr>
        <td>MlqHbdCyibN</td>
        <td>[CONFIG] TB - TB notification rate (new and relapse, all forms) per 100 000 population</td>
        <td>Rate - new and relapse (all forms TB)</td>
        <td>TB_C_NEWINC_100K</td>
        <td>Number of TB cases notified in a given year (new and relapse, all forms), per 100, 000 population</td>
        <td>New, relapse and cases with unknown treatment</td>
        <td>population </td>
        <td>Per 100 000</td>
        <td>2021-02-08</td>
        <td>OMyYjoU07pC, S0n1torLnUz, V4SoC7TzFMi</td>
      </tr>
      <tr>
        <td>mPz2CV8PamC</td>
        <td>[CONFIG] TB - TB cases tested for susceptibility to rifampicin</td>
        <td>Tested for RR-TB</td>
        <td>TB_C_DST</td>
        <td>Total number of TB cases tested for susceptibility to rifampicin - RR-TB</td>
        <td>Total number of cases tested for susceptibility to rifampicin</td>
        <td>1</td>
        <td>Numerator only (number)</td>
        <td>2021-02-08</td>
        <td>OMyYjoU07pC, QCrsjqhAcWA, S0n1torLnUz, V4SoC7TzFMi</td>
      </tr>
      <tr>
        <td>N7OZj7DONas</td>
        <td>[CONFIG] TB - Not evaluated (previously treated DS-TB cases) (%)</td>
        <td>Not evaluated (previously treated DS-TB) (%)</td>
        <td>TB_C_PCNT_NEVAL_RET</td>
        <td>Number of previously treated/re-treated TB patients whose treatment outcome is unknown as a percentage of the total cohort registered</td>
        <td>Total previously treated TB patients not evaluated</td>
        <td>Total cohort size of previously treated TB patients</td>
        <td>Percentage</td>
        <td>2021-02-08</td>
        <td>S0n1torLnUz, V4SoC7TzFMi</td>
      </tr>
      <tr>
        <td>NbbSAGzGYrH</td>
        <td>[CONFIG] TB - Failed (all DS-TB cases) (%)</td>
        <td>Failed (all DS-TB) (%)</td>
        <td>TB_C_PCNT_FAIL</td>
        <td>Number of new and previously treated TB patients whose treatment failed as a percentage of the total cohort registered</td>
        <td>Total failed treatment</td>
        <td>Total cohort size</td>
        <td>Percentage</td>
        <td>2021-02-08</td>
        <td>OMyYjoU07pC, S0n1torLnUz, V4SoC7TzFMi</td>
      </tr>
      <tr>
        <td>nbSUx9d1e1M</td>
        <td>[CONFIG] TB - Proportion of DR-TB drugs unusable</td>
        <td>DR-TB drugs unusable (%)</td>
        <td>TB_DSSTB_DRUGS_UNUSABLE</td>
        <td>Proportion of DR-TB drugs that, out of the opening balance, could not be used due to either redistribution or discard</td>
        <td>TB - DR-TB drugs discarded + TB - DR-TB drugs redistributed</td>
        <td>TB - DR-TB drugs opening balance</td>
        <td>Percentage</td>
        <td>2021-03-04</td>
        <td>pMaektY4E9s</td>
      </tr>
      <tr>
        <td>nhoEcbYl2hU</td>
        <td>[CONFIG] TB - Failed (previously treated DS-TB cases) (%)</td>
        <td>Failed (previously treated DS-TB) (%)</td>
        <td>TB_C_PCNT_FAIL_RET</td>
        <td>Number of previously treated/re-treated TB patients whose treatment failed as a percentage of the total cohort registered</td>
        <td>Total failed treatment previously treated TB patients</td>
        <td>Total cohort size of previously treated TB patients</td>
        <td>Percentage</td>
        <td>2021-02-08</td>
        <td>S0n1torLnUz, V4SoC7TzFMi</td>
      </tr>
      <tr>
        <td>NlKiCH8eRVc</td>
        <td>[CONFIG] TB - Laboratory-confirmed RR-TB or MDR-TB cases who started treatment for MDR-TB</td>
        <td>Lab-confirmed RR/MDR-TB started MDR treatment</td>
        <td>TB_C_CONF_RRMDR_TX</td>
        <td>Number of patients (laboratory-confirmed RR-TB or MDR-TB) who started treatment for MDR-TB. Include pulmonary and extrapulmonary TB and also patients diagnosed before the reporting period but started on treatment during the reporting period.</td>
        <td>TB cases started on MDR treatment </td>
        <td>1</td>
        <td>Numerator only (number)</td>
        <td>2021-02-08</td>
        <td>OMyYjoU07pC, QCrsjqhAcWA, S0n1torLnUz, V4SoC7TzFMi</td>
      </tr>
      <tr>
        <td>NNwvy3Ym6vj</td>
        <td>[CONFIG] TB - Lost to follow-up (new and relapse pulmonary bacteriologically confirmed DS-TB cases) (%)</td>
        <td>Lost (pulm bact conf DS-TB) (%)</td>
        <td>TB_C_PCNT_LABCONF_LOST</td>
        <td>Number of new and relapse pulmonary bacteriologically confirmed TB patients who were lost to follow-up as a percentage of the total cohort registered</td>
        <td>Lost to follow-up</td>
        <td>New and relapse pulmonary bacteriologically confirmed cases in cohort</td>
        <td>Percentage</td>
        <td>2021-02-08</td>
        <td>S0n1torLnUz, V4SoC7TzFMi</td>
      </tr>
      <tr>
        <td>NqBeQEiXK14</td>
        <td>[CONFIG] TB - Notified TB cases (previously treated incl. relapse, pulmonary bacteriologically confirmed) (%)</td>
        <td>Previously treated incl rel (pulm bac conf TB) (%)</td>
        <td>TB_PCNT_BAC_RET</td>
        <td>Number of previously treated TB cases which were confirmed bacteriologoically in given period as a percentage of the total previously treated pulmonary bacteriologically confirmed TB cases. INCLUDING relapses!</td>
        <td>Previously treated TB cases bac conf including relapse</td>
        <td>Previously treated pulmonary TB cases (bact conf and clin diag, smer +, smear -)</td>
        <td>Percentage</td>
        <td>2021-02-08</td>
        <td>OMyYjoU07pC, S0n1torLnUz</td>
      </tr>
      <tr>
        <td>o7QoPpjWR9h</td>
        <td>[CONFIG] TB - TB notification rate (new and relapse, pulmonary clinically diagnosed) per 100 000 population</td>
        <td>Rate - new and relapse (pulm clin diag TB)</td>
        <td>TB_C_NEWINC_CLINDX_100K</td>
        <td>Number of TB cases notified in a given year (new and relapse, pulmonary clinically diagnosed), per 100, 000 population</td>
        <td>Pulm clin diagnosed new and relapse and history unknown</td>
        <td>population</td>
        <td>Per 100 000</td>
        <td>2021-02-08</td>
        <td>OMyYjoU07pC, S0n1torLnUz</td>
      </tr>
      <tr>
        <td>odbgarQuUvh</td>
        <td>[CONFIG] TB - DR-TB drugs stock on hand</td>
        <td>DR-TB drugs stock on hand</td>
        <td>TB_DRDRUGS_STOCK_ON_HAND</td>
        <td>Number of DR-TB drugs stock on hand</td>
        <td>TB - DR-TB drugs stock on hand</td>
        <td>1</td>
        <td>Numerator only (number)</td>
        <td>2021-03-21</td>
        <td>pMaektY4E9s</td>
      </tr>
      <tr>
        <td>onTdlaF4eFF</td>
        <td>[CONFIG] TB - TB treatment success rate (new and relapse DS-TB/HIV) (%)</td>
        <td>Tx success (new and relapse DS-TB/HIV) (%)</td>
        <td>TB_C_TBHIV_TSR</td>
        <td>Number of new and relapse HIV-positive TB cases who were successfully treated (cured or who completed their treatment) as a percentage of the total cohort of HIV-positive new and relapse TB cases registered, excluding cases moved to second-line treatment</td>
        <td>Number of new and relapse HIV-positive TB cases who were successfully treated (cured or who completed their treatment)</td>
        <td>Total number of new and relapse HIV-positive TB cases registered, excluding cases moved to second-line treatment</td>
        <td>Percentage</td>
        <td>2021-02-08</td>
        <td>OMyYjoU07pC, S0n1torLnUz, V4SoC7TzFMi</td>
      </tr>
      <tr>
        <td>OuSWXCijKks</td>
        <td>[CONFIG] TB - Cured (previously treated DS-TB cases) (%)</td>
        <td>Cured (previously treated DS-TB) (%)</td>
        <td>TB_C_PCNT_CUR_RET</td>
        <td>Number of previously treated/re-treated TB patients who were cured as a percentage of the total cohort registered</td>
        <td>Total cured previously treated TB patients</td>
        <td>Total cohort size of previously treated TB patients</td>
        <td>Percentage</td>
        <td>2021-02-08</td>
        <td>S0n1torLnUz, V4SoC7TzFMi</td>
      </tr>
      <tr>
        <td>OvZVFIRgrtG</td>
        <td>[CONFIG] TB - GeneXpert Cartridges stock on hand</td>
        <td>GeneXpert Cartridges stock on hand</td>
        <td>TB_CARTRIDGE_STOCK_ON_HAND</td>
        <td>Number of GeneXpert Cartridges stock on hand</td>
        <td>TB - GenExpert Cartridges stock on hand</td>
        <td>1</td>
        <td>Numerator only (number)</td>
        <td>2021-03-21</td>
        <td>pMaektY4E9s</td>
      </tr>
      <tr>
        <td>ozucBtxJm2l</td>
        <td>[CONFIG] TB - DS-TB drugs stock on hand</td>
        <td>DS-TB drugs stock on hand</td>
        <td>TB_DSDRUGS_STOCK_ON_HAND</td>
        <td>Number of DS-TB drugs stock on hand</td>
        <td>TB - DS-TB drugs stock on hand</td>
        <td>1</td>
        <td>Numerator only (number)</td>
        <td>2021-03-21</td>
        <td>pMaektY4E9s</td>
      </tr>
      <tr>
        <td>p18w24U0caC</td>
        <td>[CONFIG] TB - Laboratory-confirmed RR-TB or MDR-TB among cases with DST results (%)</td>
        <td>Lab-confirmed RR/MDR-TB (%)</td>
        <td>TB_C_PCNT_RRMDR</td>
        <td>Laboratory-confirmed RR-TB or MDR-TB cases as a percentage of TB cases with drug susceptibility test results recorded for at least rifampicin, during a specified time period, usually one year.</td>
        <td>Number with laboratory-confirmed RR-TB or MDR-TB</td>
        <td>Number tested for susceptibility to rifampicifn</td>
        <td>Percentage</td>
        <td>2021-02-08</td>
        <td>OMyYjoU07pC, QCrsjqhAcWA, S0n1torLnUz, V4SoC7TzFMi</td>
      </tr>
      <tr>
        <td>P6wlyWUyJHp</td>
        <td>[CONFIG] TB - Failed (all DR-TB cases) (%)</td>
        <td>Failed (all DR-TB) (%)</td>
        <td>TB_C_PCNT_FAIL_2ND</td>
        <td>Number of TB patients whose treatment failed as a percentage of the total cohort registered for 2nd line treatment</td>
        <td>TB patients who failed 2nd line treatment </td>
        <td>Total cohort size</td>
        <td>Percentage</td>
        <td>2021-02-08</td>
        <td>S0n1torLnUz, V4SoC7TzFMi</td>
      </tr>
      <tr>
        <td>pe3UIgLzj8p</td>
        <td>[CONFIG] TB - TB cases tested for susceptibility to rifampicin (new)</td>
        <td>Tested for RR-TB (new)</td>
        <td>TB_C_NEW_RTEST</td>
        <td>New TB cases tested for susceptibility to rifampicin</td>
        <td>R testing for new TB cases</td>
        <td>1</td>
        <td>Numerator only (number)</td>
        <td>2021-02-08</td>
        <td>OMyYjoU07pC, QCrsjqhAcWA, S0n1torLnUz, V4SoC7TzFMi</td>
      </tr>
      <tr>
        <td>PgU1N0PfAwN</td>
        <td>[CONFIG] TB - Notified TB cases (new, pulmonary smear positive) by age group and sex</td>
        <td>New (pulm smear + TB) by age and sex</td>
        <td>TB_C_NEWSP_AGESEX</td>
        <td>Number of TB cases notified in a given year (new; pulmonary smear positive) disaggregated by age groups and sex</td>
        <td>New pulmonary smear-positive TB cases by age and sex</td>
        <td>1</td>
        <td>Numerator only (number)</td>
        <td>2021-02-08</td>
        <td>OMyYjoU07pC, S0n1torLnUz</td>
      </tr>
      <tr>
        <td>PJ5fX7RGHZt</td>
        <td>[CONFIG] TB - Lost to follow-up (all DS-TB cases) (%)</td>
        <td>Lost (all DS-TB) (%)</td>
        <td>TB_C_PCNT_LOST</td>
        <td>Number of new and previously treated TB patients lost to follow-up as a percentage of the total cohort registered</td>
        <td>Total lost to follow-up</td>
        <td>Total cohort size (cases registered)</td>
        <td>Percentage</td>
        <td>2021-02-08</td>
        <td>OMyYjoU07pC, S0n1torLnUz, V4SoC7TzFMi</td>
      </tr>
      <tr>
        <td>PjSomS4AXiD</td>
        <td>[CONFIG] TB - TB cases tested for susceptibility to rifampicin (previously treated)</td>
        <td>Tested for RR-TB (previously treated)</td>
        <td>TB_C_RET_RTEST</td>
        <td>Previously treated TB cases tested for susceptibility to rifampicin</td>
        <td>R testing for previously treated TB cases</td>
        <td>1</td>
        <td>Numerator only (number)</td>
        <td>2021-02-08</td>
        <td>OMyYjoU07pC, QCrsjqhAcWA, S0n1torLnUz, V4SoC7TzFMi</td>
      </tr>
      <tr>
        <td>pRHeUC3sjcO</td>
        <td>[CONFIG] TB - GeneXpert usable stock</td>
        <td>GeneXpert usable stock</td>
        <td>TB_GENEXPERT_USABLE_STOCK</td>
        <td></td>
        <td>opening balance+received</td>
        <td>1</td>
        <td>Numerator only (number)</td>
        <td>2021-04-29</td>
        <td>pMaektY4E9s</td>
      </tr>
      <tr>
        <td>pS9zsya8eUi</td>
        <td>[CONFIG] TB - DR-TB drugs issued</td>
        <td>DR-TB drugs issued</td>
        <td>TB_DRDRUGS_ISSUED</td>
        <td>Number of DR-TB drugs issued</td>
        <td>TB - DR-TB drugs issued</td>
        <td>1</td>
        <td>Numerator only (number)</td>
        <td>2021-06-11</td>
        <td>pMaektY4E9s</td>
      </tr>
      <tr>
        <td>qzl44PwyQCY</td>
        <td>[CONFIG] TB - TB cases recorded as HIV positive started on CPT</td>
        <td>TB/HIV on CPT</td>
        <td>TB_C_HIV_CPT</td>
        <td>New and relapse HIV-positive TB patients started/continued co-trimoxazole preventive therapy (CPT) (all TB cases for pre-2013 definitions)</td>
        <td>HIV on CPT</td>
        <td>1</td>
        <td>Numerator only (number)</td>
        <td>2021-02-08</td>
        <td>OMyYjoU07pC, S0n1torLnUz, V4SoC7TzFMi</td>
      </tr>
      <tr>
        <td>RfRy5y9ANl2</td>
        <td>[CONFIG] TB - DS-TB drugs discarded</td>
        <td>DS-TB drugs discarded</td>
        <td>TB_DSDRUGS_DISCARDED</td>
        <td>Number of DS-TB drugs discarded during the reporting period (expired, damaged, etc.)</td>
        <td>DS-TB drugs discarded</td>
        <td>1</td>
        <td>Numerator only (number)</td>
        <td>2021-02-08</td>
        <td>pMaektY4E9s</td>
      </tr>
      <tr>
        <td>RgcWLiawMTQ</td>
        <td>[CONFIG] TB - Completed (all DS-TB/HIV cases) (%)</td>
        <td>Completed (all DS-TB/HIV) (%)</td>
        <td>TB_C_PCNT_CMPLT_HIV</td>
        <td>Number of new and previously treated TB/HIV patients who completed treatment as a percentage of the total cohort registered</td>
        <td>Total completed treatment HIV TB</td>
        <td>Total cohort size (cases registered) HIV TB</td>
        <td>Percentage</td>
        <td>2021-02-08</td>
        <td>S0n1torLnUz, V4SoC7TzFMi</td>
      </tr>
      <tr>
        <td>Ri9wLtxwnJu</td>
        <td>[CONFIG] TB - DS-TB drugs stock coverage time</td>
        <td>DS-TB drugs stock coverage time</td>
        <td>TB_DSTB_DRUGS_COVERAGE_TIME</td>
        <td></td>
        <td>usable stock</td>
        <td>consumed stock</td>
        <td>Rate (factor=1)</td>
        <td>2021-05-03</td>
        <td>pMaektY4E9s</td>
      </tr>
      <tr>
        <td>RIMCpjlrVPz</td>
        <td>[CONFIG] TB - Notified TB cases (new, pulmonary bacteriologically confirmed) (%)</td>
        <td>New (pulm bac conf TB) (%)</td>
        <td>TB_C_PCNT_BAC_NEW</td>
        <td>Number of new TB cases which were confirmed bacteriologoically in given period as a percentage of the total new pulmonary bacteriologically confirmed TB cases.</td>
        <td>New pulm bacteriologically confirmed cases (for old forms smear +)</td>
        <td>New pulmonary TB cases (bact conf and clin diag, smer +, smear -)</td>
        <td>Percentage</td>
        <td>2021-02-08</td>
        <td>OMyYjoU07pC, S0n1torLnUz</td>
      </tr>
      <tr>
        <td>RJlAMDG3FZn</td>
        <td>[CONFIG] TB - TB cases recorded as HIV positive started on ART at outcome</td>
        <td>TB/HIV on ART at outcome</td>
        <td>TB_C_HIV_ART_OUT</td>
        <td>New and relapse HIV-positive TB cases started/continued antiretroviral therapy at the time of treatment outcome (ART) (all for pre-2013 definitions recorded)</td>
        <td>HIV on ART at the time of treatment outcome</td>
        <td>1</td>
        <td>Numerator only (number)</td>
        <td>2021-02-08</td>
        <td>S0n1torLnUz, V4SoC7TzFMi</td>
      </tr>
      <tr>
        <td>RlFZHghqtq7</td>
        <td>[CONFIG] TB - Died (all DS-TB/HIV cases) (%)</td>
        <td>Died (all DS-TB/HIV) (%)</td>
        <td>TB_C_PCNT_DIED_HIV</td>
        <td>Number of new and previously treated TB/HIV patients who died as a percentage of the total cohort registered</td>
        <td>Total died HIV TB</td>
        <td>Total cohort size (cases registered) of HIV TB </td>
        <td>Percentage</td>
        <td>2021-02-08</td>
        <td>S0n1torLnUz, V4SoC7TzFMi</td>
      </tr>
      <tr>
        <td>rv14EhkmZof</td>
        <td>[CONFIG] TB - Notified TB cases (new and relapse, all forms) aged 45-54 (%)</td>
        <td>45-54 (%) </td>
        <td>TB_C_PCNT_4554</td>
        <td></td>
        <td>Number of TB cases aged 45-54 (new and relapse only)</td>
        <td>Total number notified by age and sex (new and relapse only)</td>
        <td>Percentage</td>
        <td>2021-02-08</td>
        <td>OMyYjoU07pC, S0n1torLnUz, V4SoC7TzFMi</td>
      </tr>
      <tr>
        <td>sk4N1FMqDwQ</td>
        <td>[CONFIG] TB - DR-TB drugs redistributed</td>
        <td>DR-TB drugs redistributed</td>
        <td>TB_DRDRUGS_REDISTRIBUTED</td>
        <td>Number of DR-TB drugs redistributed</td>
        <td>TB - DR-TB drugs redistributed</td>
        <td>1</td>
        <td>Numerator only (number)</td>
        <td>2021-02-18</td>
        <td>pMaektY4E9s</td>
      </tr>
      <tr>
        <td>skv1s6LGh0N</td>
        <td>[CONFIG] TB - DS-TB drugs stock discrepancy (%)</td>
        <td>DS-TB drugs stock discrepancy (%)</td>
        <td>TB_DSDRUGS_DISCREPANCY</td>
        <td>Percentage of the item's stock discrepancy [Stock on hand - Closing balance] / Stock on hand</td>
        <td>DS-TB drugs stock discrepancy</td>
        <td>stock on hand</td>
        <td>Percentage</td>
        <td>2021-05-11</td>
        <td>pMaektY4E9s</td>
      </tr>
      <tr>
        <td>SPJLukKxHaj</td>
        <td>[CONFIG] TB - TB treatment success rate (all DS and DR-TB) (%)</td>
        <td>Tx success (all DS+DR-TB) (%)</td>
        <td>TB_C_ALLDSDR_TSR</td>
        <td>Number of all DS+DR TB cases who were successfully treated (cured or who completed their treatment) as a percentage of the total cohort of all DS+DR TB cases registered.</td>
        <td>Number of all DS+DR TB cases who were successfully treated (cured or who completed their treatment)</td>
        <td>Total number DS+DR-TB cases registered, excluding cases moved to second-line treatment</td>
        <td>Percentage</td>
        <td>2021-02-08</td>
        <td>OMyYjoU07pC, S0n1torLnUz, V4SoC7TzFMi</td>
      </tr>
      <tr>
        <td>sqVJYe4DGLs</td>
        <td>[CONFIG] TB - Not laboratory-confirmed RR-TB or MDR-TB cases who started treatment for MDR-TB</td>
        <td>Unconfirmed RR/MDR-TB started MDR-TB treatment</td>
        <td>TB_C_UNCONF_RRMDR_TX</td>
        <td>Number of patients (not laboratory-confirmed RR-TB or MDR-TB) who started treatment for MDR-TB. Include pulmonary and extrapulmonary TB and also patients diagnosed before the reporting period but started on treatment during the reporting period.</td>
        <td>non conf started on MDR treatment </td>
        <td>1</td>
        <td>Numerator only (number)</td>
        <td>2021-02-08</td>
        <td>OMyYjoU07pC, QCrsjqhAcWA, S0n1torLnUz, V4SoC7TzFMi</td>
      </tr>
      <tr>
        <td>SrgAuZUkqHh</td>
        <td>[CONFIG] TB - TB cases tested for HIV or with known HIV status - all cases (%)</td>
        <td>TB/HIV tested - all cases (%)</td>
        <td>TB_C_PCNT_HIVTEST_ALL</td>
        <td>All TB cases tested or with known HIV status as percentage of all notified TB cases</td>
        <td>TB patients with known HIV status</td>
        <td>Total notified TB (pre-2013 definitions) or total TB (standard definitions)</td>
        <td>Percentage</td>
        <td>2021-02-08</td>
        <td>OMyYjoU07pC, S0n1torLnUz</td>
      </tr>
      <tr>
        <td>Tm4N8CLJM9I</td>
        <td>[CONFIG] TB - Lost to follow-up (all DR-TB cases) (%)</td>
        <td>Lost (all DR-TB) (%)</td>
        <td>TB_C_PCNT_LOST_2ND</td>
        <td>Number of TB patients lost to follow-up as a percentage of the total cohort registered for 2nd line treatment</td>
        <td>Total lost to follow-up previously treated TB patients for 2nd line treatment</td>
        <td>Total cohort size of TB patients on 2nd line treatment</td>
        <td>Percentage</td>
        <td>2021-02-08</td>
        <td>S0n1torLnUz, V4SoC7TzFMi</td>
      </tr>
      <tr>
        <td>trwSfpxsWcb</td>
        <td>[CONFIG] TB - Notified TB cases (new, all forms) aged 45-54 (%)</td>
        <td>45-54 (%)</td>
        <td>TB_C_PCNT_NEW_4554</td>
        <td></td>
        <td>Number of TB cases aged 45-54</td>
        <td>Total number notified by age and sex</td>
        <td>Percentage</td>
        <td>2021-02-08</td>
        <td>OMyYjoU07pC, S0n1torLnUz</td>
      </tr>
      <tr>
        <td>tSmuPZGxDdu</td>
        <td>[CONFIG] TB - TB cases tested for HIV with positive test recorded</td>
        <td>TB/HIV positive</td>
        <td>TB_C_HIV_POS</td>
        <td>New and relapse TB cases with positive HIV test result recorded (all TB cases for pre-2013 definitions) </td>
        <td>TB patients with positive HIV test</td>
        <td>1</td>
        <td>Numerator only (number)</td>
        <td>2021-02-08</td>
        <td>OMyYjoU07pC, S0n1torLnUz, V4SoC7TzFMi</td>
      </tr>
      <tr>
        <td>TV1Qm6X0ILb</td>
        <td>[CONFIG] TB - Notified TB cases (new and relapse, all forms) aged 55-64 (%)</td>
        <td>55-64 (%) </td>
        <td>TB_C_PCNT_5564</td>
        <td></td>
        <td>Number of TB cases aged 55-64 (new and relapse only)</td>
        <td>Total number notified by age and sex (new and relapse only)</td>
        <td>Percentage</td>
        <td>2021-02-08</td>
        <td>OMyYjoU07pC, S0n1torLnUz, V4SoC7TzFMi</td>
      </tr>
      <tr>
        <td>tvB7kjQuQda</td>
        <td>[CONFIG] TB - Not evaluated (all DS-TB cases) (%)</td>
        <td>Not evaluated (all DS-TB) (%)</td>
        <td>TB_C_PCNT_NEVAL</td>
        <td>Number of new and previously treated TB patients whose treatment outcome is unknown as a percentage of the total cohort registered</td>
        <td>Total not evaluated</td>
        <td>Total cohort size (cases registered)</td>
        <td>Percentage</td>
        <td>2021-02-08</td>
        <td>OMyYjoU07pC, S0n1torLnUz, V4SoC7TzFMi</td>
      </tr>
      <tr>
        <td>TVbAl90q4tl</td>
        <td>[CONFIG] TB - Died (new smear-positive TB cases) (%)</td>
        <td>Died (smear+) (%)</td>
        <td>TB_C_PCNT_NEW_SP_DIED</td>
        <td>Number of new smear-positive TB patients who died as a percentage of the total cohort registered</td>
        <td>Died</td>
        <td>New pulmonary smear positive cases in cohort</td>
        <td>Percentage</td>
        <td>2021-02-08</td>
        <td>S0n1torLnUz, V4SoC7TzFMi</td>
      </tr>
      <tr>
        <td>U1c4P0YOBC5</td>
        <td>[CONFIG] TB - GeneXpert Cartridges opening balance</td>
        <td>GeneXpert Cartridges opening balance</td>
        <td>TB_CARTRIDGE_OPENING_BALANCE</td>
        <td>Number of GeneXpert Cartridges opening balance</td>
        <td>TB - GenExpert Cartridges opening balance</td>
        <td>1</td>
        <td>Numerator only (number)</td>
        <td>2021-03-02</td>
        <td>pMaektY4E9s</td>
      </tr>
      <tr>
        <td>uIaLNEz7eFy</td>
        <td>[CONFIG] TB - Not evaluated (new smear-positive TB cases) (%)</td>
        <td>Not evaluated (smear+) (%)</td>
        <td>TB_C_PCNT_NEW_SP_NEVAL</td>
        <td>Number of new smear-positive TB patients whose treatment outcome is unknown as a percentage of the total cohort registered</td>
        <td>Not evaluated</td>
        <td>New pulmonary smear positive cases in cohort</td>
        <td>Percentage</td>
        <td>2021-02-08</td>
        <td>S0n1torLnUz, V4SoC7TzFMi</td>
      </tr>
      <tr>
        <td>UiSEm1IJmhb</td>
        <td>[CONFIG] TB - Proportion of DS-TB drugs unusable</td>
        <td>DS-TB drugs unusable (%)</td>
        <td>TB_DRSTB_DRUGS_UNUSABLE</td>
        <td>Proportion of DS-TB drugs that, out of the opening balance, could not be used due to either redistribution or discard</td>
        <td>TB - DS-TB drugs discarded + TB - DS-TB drugs redistributed</td>
        <td>TB - DS-TB drugs opening balance</td>
        <td>Percentage</td>
        <td>2021-03-04</td>
        <td>pMaektY4E9s</td>
      </tr>
      <tr>
        <td>v7cZx5SUBXP</td>
        <td>[CONFIG] TB - Notified TB cases (new and relapse, all forms) aged 35-44 (%)</td>
        <td>35-44 (%) </td>
        <td>TB_C_PCNT_3544</td>
        <td></td>
        <td>Number of TB cases aged 35-44 (new and relapse only)</td>
        <td>Total number notified by age and sex (new and relapse only)</td>
        <td>Percentage</td>
        <td>2021-02-08</td>
        <td>OMyYjoU07pC, S0n1torLnUz, V4SoC7TzFMi</td>
      </tr>
      <tr>
        <td>v9ygyBUS4Rh</td>
        <td>[CONFIG] TB - TB treatment success rate (all DR-TB) (%)</td>
        <td>Tx success (all DR-TB) (%)</td>
        <td>TB_C_RRMDR_TSR</td>
        <td>Number of rifampicin-resistant (RR) or multidrug-resistant (MDR) TB cases who were successfully treated (cured or who completed their treatment) as a percentage of the total cohort of rifampicin-resistant or multidrug-resistant TB cases started on second-line treatment</td>
        <td>Number of rifampicin-resistant or multidrug-resistant TB cases who were successfully treated (cured or who completed their treatment)</td>
        <td>Total number of rifampicin-resistant or multidrug-resistant TB cases started on second-line treatment</td>
        <td>Percentage</td>
        <td>2021-02-08</td>
        <td>OMyYjoU07pC, S0n1torLnUz, V4SoC7TzFMi</td>
      </tr>
      <tr>
        <td>Vb6NHYRWTyi</td>
        <td>[CONFIG] TB - GeneXpert cartridges stock coverage time</td>
        <td>GeneXpert cartridges stock coverage time</td>
        <td>TB_XPERT_COVERAGE_TIME</td>
        <td></td>
        <td>usable stock</td>
        <td>consumed stock</td>
        <td>Rate (factor=1)</td>
        <td>2021-04-30</td>
        <td>pMaektY4E9s</td>
      </tr>
      <tr>
        <td>vc2AIHZvwbQ</td>
        <td>[CONFIG] TB - TB cases tested for HIV with positive test recorded at outcome</td>
        <td>TB/HIV positive at outcome</td>
        <td>TB_C_HIV_POS_OUT</td>
        <td>New and relapse TB cases with positive HIV test at the time of treatment outcome (all TB casesfor pre-2013 definitions)</td>
        <td>TB patients with positive HIV test recorded at the time of treatment outcome</td>
        <td>1</td>
        <td>Numerator only (number)</td>
        <td>2021-02-08</td>
        <td>S0n1torLnUz, V4SoC7TzFMi</td>
      </tr>
      <tr>
        <td>VcwgKNqXO9n</td>
        <td>[CONFIG] TB - Ratio of TB cases aged 0-4:5-14 (new and relapse, all forms)</td>
        <td>Ratio 0-4:5-14 (new and relapse, all forms TB)</td>
        <td>TB_C_RATIO_04_514</td>
        <td>Number of TB cases (new and relapse, all forms) aged 0-4 notified in given period compared to the TB cases (new and relapse, all forms) aged 5-14 notified in the same period. </td>
        <td>Number of TB cases aged 0-4 (new and relapse, all forms)</td>
        <td>Number of TB cases aged 5-14 (new and relapse, all forms)</td>
        <td>Rate (factor=1)</td>
        <td>2021-02-08</td>
        <td>OMyYjoU07pC, S0n1torLnUz, V4SoC7TzFMi</td>
      </tr>
      <tr>
        <td>VDfuDVALf0f</td>
        <td>[CONFIG] TB - GeneXpert cartridges wastage rate (%)</td>
        <td>GeneXpert cartridges wastage rate</td>
        <td>GENEXPERT_CARTRIDGES_WASTAGE_RATE</td>
        <td>Stock wasted=([Closing balance]-[Stock at hand]) + discarded)</td>
        <td>Stock wasted=([Closing balance]-[Stock at hand]) + discarded)</td>
        <td>Stock used=([Closing balance]-[Stock at hand]) + discarded + dispensed to patient)</td>
        <td>Percentage</td>
        <td>2021-03-21</td>
        <td>pMaektY4E9s</td>
      </tr>
      <tr>
        <td>VLtzufVWnHc</td>
        <td>[CONFIG] TB - Notified TB cases (new and relapse, all forms) by age group and sex</td>
        <td>New and relapse (all forms TB) by age and sex</td>
        <td>TB_NEWREL_AGESEX</td>
        <td>Number of TB cases notified in a given year (new and relapse and history unknown; all forms) disaggregated by age groups and sex</td>
        <td>New and relapse TB cases</td>
        <td>1</td>
        <td>Numerator only (number)</td>
        <td>2021-02-08</td>
        <td>OMyYjoU07pC, S0n1torLnUz</td>
      </tr>
      <tr>
        <td>VTNrh2DfO91</td>
        <td>[CONFIG] TB - Cured (all DS-TB/HIV cases) (%)</td>
        <td>Cured (all DS-TB/HIV) (%)</td>
        <td>TB_C_PCNT_CUR_HIV</td>
        <td>Number of TB/HIV patients who were cured as a percentage of the total cohort registered</td>
        <td>total cured - HIV TB cases</td>
        <td>Total cohort size (cases registered) of HIV TB </td>
        <td>Percentage</td>
        <td>2021-02-08</td>
        <td>S0n1torLnUz, V4SoC7TzFMi</td>
      </tr>
      <tr>
        <td>vwRyMhcuZDh</td>
        <td>[CONFIG] TB - Notified TB cases (new and relapse, all forms) aged 65+ (%)</td>
        <td>65+ (%)</td>
        <td>TB_C_PCNT_65+</td>
        <td></td>
        <td>Number of TB cases aged 65+ (new and relapse only)</td>
        <td>Total number notified by age and sex (new and relapse only)</td>
        <td>Percentage</td>
        <td>2021-02-08</td>
        <td>OMyYjoU07pC, S0n1torLnUz, V4SoC7TzFMi</td>
      </tr>
      <tr>
        <td>w3CiHTdwV4j</td>
        <td>[CONFIG] TB - Lost to follow-up (all DS-TB/HIV cases) (%)</td>
        <td>Lost (all DS-TB/HIV) (%)</td>
        <td>TB_C_PCNT_LOST_HIV</td>
        <td>Number of new and previously treated TB/HIV patients lost to follow-up as a percentage of the total cohort registered</td>
        <td>Total lost to follow-up HIV TB </td>
        <td>Total cohort size (cases registered) HIV TB</td>
        <td>Percentage</td>
        <td>2021-02-08</td>
        <td>S0n1torLnUz, V4SoC7TzFMi</td>
      </tr>
      <tr>
        <td>W4IZTF82Bwx</td>
        <td>[CONFIG] TB - DS-TB drugs wastage rate (%)</td>
        <td>DS-TB drugs wastage rate</td>
        <td>DS-TB_DRUGS_WASTAGE_RATE</td>
        <td>Stock wasted=([Closing balance]-[Stock at hand]) + discarded)</td>
        <td>Stock wasted=([Closing balance]-[Stock at hand]) + discarded)</td>
        <td>Stock used=([Closing balance]-[Stock at hand]) + discarded + dispensed to patient)</td>
        <td>Percentage</td>
        <td>2021-03-21</td>
        <td>pMaektY4E9s</td>
      </tr>
      <tr>
        <td>w7apwGjX5oC</td>
        <td>[CONFIG] TB - TB cases recorded as HIV positive started on CPT (%)</td>
        <td>TB/HIV on CPT (%)</td>
        <td>TB_C_PCNT_HIVCPT</td>
        <td>New and relapse HIV-positive TB cases started/continued co-trimoxazol preventive therapy as percentage of those HIV positive (all TB cases for pre-2013 definitions)</td>
        <td>TB/HIV on CPT</td>
        <td>Known HIV-positive TB cases</td>
        <td>Percentage</td>
        <td>2021-02-08</td>
        <td>OMyYjoU07pC, S0n1torLnUz, V4SoC7TzFMi</td>
      </tr>
      <tr>
        <td>WBuAm3uZWWs</td>
        <td>[CONFIG] TB - Proportion of DR-TB drugs consumed</td>
        <td>DR-TB drugs consumed (%)</td>
        <td>TB_DRTB_DRUGS_CONSUMED</td>
        <td>Proportion of DR-TB drugs that have been used over the opening balance of the same drugs</td>
        <td>TB - DR-TB drugs distributed</td>
        <td>TB - DR-TB drugs opening balance + distributed = usable stock</td>
        <td>Percentage</td>
        <td>2021-04-29</td>
        <td>pMaektY4E9s</td>
      </tr>
      <tr>
        <td>WCE27g52nBt</td>
        <td>[CONFIG] TB - Cured (new and relapse pulmonary bacteriologically confirmed DS-TB cases) (%)</td>
        <td>Cured (pulm bact conf DS-TB) (%)</td>
        <td>TB_C_PCNT_LABCONF_CUR</td>
        <td>Number of new and relapse pulmonary bacteriologically confirmed TB patients who were cured as a percentage of the total cohort registered</td>
        <td>Cured</td>
        <td>New and relapse pulmonary bacteriologically confirmed cases in cohort</td>
        <td>Percentage</td>
        <td>2021-02-08</td>
        <td>S0n1torLnUz, V4SoC7TzFMi</td>
      </tr>
      <tr>
        <td>WgDUfvpjXFq</td>
        <td>[CONFIG] TB - TB treatment completed (new smear-positive TB cases) (%)</td>
        <td>Completed (smear+) (%)</td>
        <td>TB_C_PCNT_NEW_SP_CMPLT</td>
        <td>Number of new smear-positive TB patients who completed treatment as a percentage of the total cohort registered</td>
        <td>Completed</td>
        <td>New pulmonary smear positive cases in cohort</td>
        <td>Percentage</td>
        <td>2021-02-08</td>
        <td>S0n1torLnUz, V4SoC7TzFMi</td>
      </tr>
      <tr>
        <td>whkj4kr4ghD</td>
        <td>[CONFIG] TB - TB cases tested for susceptibility to rifampicin (previously treated) (%)</td>
        <td>Tested for RR-TB (previously treated)(%)</td>
        <td>TB_C_PCNT_DST_RET</td>
        <td>Previously treated TB cases (including relapses) tested for susceptibility to rifampicin (RR-TB) as a percentage of all previously treated (including relapses) TB cases notified</td>
        <td>Number of previously treated (incl. relapses) cases tested for susceptibility to rifampicin</td>
        <td>All previously treated (including relapses) TB cases notified</td>
        <td>Percentage</td>
        <td>2021-02-08</td>
        <td>QCrsjqhAcWA, S0n1torLnUz</td>
      </tr>
      <tr>
        <td>WID08ddfy5T</td>
        <td>[CONFIG] TB - Health facilities with DS-TB drugs stock-out days (%)</td>
        <td>HF with DS-TB drugs stockout days (%)</td>
        <td>HF_WITH_DS-TB_DRUGS_STOCKOUT_DAYS_%</td>
        <td>Proportion of health facilities with DS-TB drugs stockout days</td>
        <td>HF with DS-TB drugs stockout days reported</td>
        <td>HF reporting stockout days</td>
        <td>Percentage</td>
        <td>2021-06-10</td>
        <td>pMaektY4E9s</td>
      </tr>
      <tr>
        <td>WRDnlKY9y1d</td>
        <td>[CONFIG] TB - Notified TB cases (new, extrapulmonary) (%)</td>
        <td>New extrapulmonary TB (%)</td>
        <td>TB_C_PCNT_EP</td>
        <td>Number of extrapulmonary TB cases (new, bacteriologically confirmed and clinically diagnosed) notified in given period as a percentage of the total notified TB cases.</td>
        <td>New extrapulmonary cases</td>
        <td>Total new cases</td>
        <td>Percentage</td>
        <td>2021-02-08</td>
        <td>OMyYjoU07pC, S0n1torLnUz, V4SoC7TzFMi</td>
      </tr>
      <tr>
        <td>wTmoLwBYFa8</td>
        <td>[CONFIG] TB - Died (previously treated DS-TB cases) (%)</td>
        <td>Died (previously treated DS-TB) (%)</td>
        <td>TB_C_PCNT_DIED_RET</td>
        <td>Number of previously treated/re-treated TB patients who died as a percentage of the total cohort registered</td>
        <td>Total died</td>
        <td>Total cohort size of previously treated TB patients</td>
        <td>Percentage</td>
        <td>2021-02-08</td>
        <td>S0n1torLnUz, V4SoC7TzFMi</td>
      </tr>
      <tr>
        <td>WWephINt8ga</td>
        <td>[CONFIG] TB - TB notification rate (all cases, all forms) per 100 000 population</td>
        <td>Rate - all cases (all forms TB)</td>
        <td>TB_C_NOTIFIED_100K</td>
        <td>Number of TB cases notified (all cases, all forms) in a given year, per 100, 000 population</td>
        <td>All notified cases</td>
        <td>population</td>
        <td>Per 100 000</td>
        <td>2021-02-08</td>
        <td>OMyYjoU07pC, S0n1torLnUz, V4SoC7TzFMi</td>
      </tr>
      <tr>
        <td>XjyUl0Jmjbj</td>
        <td>[CONFIG] TB - Failed (new and relapse pulmonary bacteriologically confirmed DS-TB cases)</td>
        <td>Failed (pulm bact conf DS-TB) (%)</td>
        <td>TB_C_PCNT_LABCONF_FAIL</td>
        <td>Number of new and relapse pulmonary bacteriologically confirmed TB patients whose treatment failed as a percentage of the total cohort registered</td>
        <td>Failed</td>
        <td>New and relapse pulmonary bacteriologically confirmed cases in cohort</td>
        <td>Percentage</td>
        <td>2021-02-08</td>
        <td>S0n1torLnUz, V4SoC7TzFMi</td>
      </tr>
      <tr>
        <td>xlmDFjsyuiS</td>
        <td>[CONFIG] TB - Not evaluated (all DR-TB cases) (%)</td>
        <td>Not evaluated (all DR-TB) (%)</td>
        <td>TB_C_PCNT_NEVAL_2ND</td>
        <td>Number of TB patients whose treatment outcome is unknown as a percentage of the total cohort registered on the 2nd line treatment </td>
        <td>Total TB patients not evaluated from 2nd line treatment</td>
        <td>Total cohort size of TB patients of 2nd line treatment</td>
        <td>Percentage</td>
        <td>2021-02-08</td>
        <td>S0n1torLnUz, V4SoC7TzFMi</td>
      </tr>
      <tr>
        <td>yGDEeabaiza</td>
        <td>[CONFIG] TB - Completed (all DS-TB cases) (%)</td>
        <td>Completed (all DS-TB) (%)</td>
        <td>TB_C_PCNT_CMPLT</td>
        <td>Number of new and previously treated TB patients who completed treatment as a percentage of the total cohort registered</td>
        <td>Total completed treatment</td>
        <td>Total cohort size (cases registered)</td>
        <td>Percentage</td>
        <td>2021-02-08</td>
        <td>OMyYjoU07pC, S0n1torLnUz, V4SoC7TzFMi</td>
      </tr>
      <tr>
        <td>YWTs6xdTRFF</td>
        <td>[CONFIG] TB - Notified TB cases (new and relapse, all forms)</td>
        <td>New and relapse (all forms TB)</td>
        <td>TB_C_NEWINC</td>
        <td>New episodes of TB, all forms, includes new cases, relapses and cases with unknown treatment history</td>
        <td>New, relapse and cases with unknown treatment history</td>
        <td>1</td>
        <td>Numerator only (number)</td>
        <td>2021-02-08</td>
        <td>OMyYjoU07pC, S0n1torLnUz, V4SoC7TzFMi</td>
      </tr>
      <tr>
        <td>ZAkEhIOXlhS</td>
        <td>[CONFIG] TB - TB cases recorded as HIV positive started on ART (%)</td>
        <td>TB/HIV on ART (%)</td>
        <td>TB_C_PCNT_HIVART</td>
        <td>New and relapse HIV-positive TB cases started/continued antiretroviral therapy (ART) as percentage of those HIV positive (all TB cases for pre-2013 definitions)</td>
        <td>TB/HIV on ART</td>
        <td>Known HIV-positive TB cases</td>
        <td>Percentage</td>
        <td>2021-02-08</td>
        <td>OMyYjoU07pC, S0n1torLnUz, V4SoC7TzFMi</td>
      </tr>
      <tr>
        <td>zbgm5GueWu9</td>
        <td>[CONFIG] TB - DS-TB drugs stock out days</td>
        <td>DS-TB drugs stock out days</td>
        <td>TB_DSDRUGS_STOCKOUT_DAYS</td>
        <td>Number of days when the facility was stocked out of DS-TB drugs (at any point during the day) during the reporting period.</td>
        <td>DS-TB drugs stock out days</td>
        <td>1</td>
        <td>Numerator only (number)</td>
        <td>2021-02-08</td>
        <td>pMaektY4E9s</td>
      </tr>
      <tr>
        <td>ZEGEI9XgtZU</td>
        <td>[CONFIG] TB - TB treatment success rate (new and relapse DS-TB) (%)</td>
        <td>Tx success (new and relapse DS-TB) (%)</td>
        <td>TB_C_NEWREL_TSR</td>
        <td>Number of new and relapse TB cases who were successfully treated (cured or who completed their treatment) as a percentage of the total cohort of new and relapse TB cases registered, excluding cases moved to second-line treatment</td>
        <td>Number of new and relapse TB cases who were successfully treated (cured or who completed their treatment)</td>
        <td>Total number of new and relapse TB cases registered, excluding cases moved to second-line treatment</td>
        <td>Percentage</td>
        <td>2021-02-08</td>
        <td>OMyYjoU07pC, S0n1torLnUz, V4SoC7TzFMi</td>
      </tr>
      <tr>
        <td>ZFd8LiJ1y3C</td>
        <td>[CONFIG] TB - Health facilities with GeneXpert cartridges stock-out days (%)</td>
        <td>HF with GeneXpert cartridges SO days (%)</td>
        <td>HF_WITH_GENEXPERT_CARTRIDGES_STOCKOUT_DAYS_%</td>
        <td>Proportion of health facilities with GeneXpert cartridges stockout days</td>
        <td>HF with GeneXpert cartridges stockout days</td>
        <td>HF reporting stockout days</td>
        <td>Percentage</td>
        <td>2021-06-10</td>
        <td>pMaektY4E9s</td>
      </tr>
      <tr>
        <td>zw1DhQYN9mb</td>
        <td>[CONFIG] TB - Notified TB cases (new and relapse, all forms) aged 5-14 (%)</td>
        <td>5-14 (%) </td>
        <td>TB_C_PCNT_514</td>
        <td></td>
        <td>Number of TB cases aged 5-14 (new and relapse only)</td>
        <td>Total number notified TB cases by age and sex (new and relapse only)</td>
        <td>Percentage</td>
        <td>2021-02-08</td>
        <td>OMyYjoU07pC, S0n1torLnUz, V4SoC7TzFMi</td>
      </tr>
      <tr>
        <td>zyyolGvDOLQ</td>
        <td>[CONFIG] TB - Notified TB cases (new and relapse, all forms) aged 25-34 (%)</td>
        <td>25-34 (%) </td>
        <td>TB_C_PCNT_2534</td>
        <td></td>
        <td>Number of TB cases aged 25-34 (new and relapse only)</td>
        <td>Total number notified by age and sex (new and relapse only)</td>
        <td>Percentage</td>
        <td>2021-02-08</td>
        <td>OMyYjoU07pC, S0n1torLnUz, V4SoC7TzFMi</td>
      </tr>
      <tr>
        <td>ZZiJYBFEJ3v</td>
        <td>[CONFIG] TB - DS-TB drugs redistributed</td>
        <td>DS-TB drugs redistributed</td>
        <td>TB_DSDRUGS_REDISTRIBUTED</td>
        <td>Number of DS-TB drugs redistributed</td>
        <td>TB - DS-TB drugs redistributed</td>
        <td>1</td>
        <td>Numerator only (number)</td>
        <td>2021-02-18</td>
        <td>pMaektY4E9s</td>
      </tr>
    </table>
    <h2 id="indicatorTypes">Indicator types</h2>
    <table>
      <tr>
        <th>Name</th>
        <th>Factor</th>
        <th>Last updated</th>
        <th>UID</th>
      </tr>
      <tr>
        <td>Per 100 000</td>
        <td>100000</td>
        <td>2021-02-08</td>
        <td>BY11PjGMCg2</td>
      </tr>
      <tr>
        <td>Percentage</td>
        <td>100</td>
        <td>2021-02-08</td>
        <td>hmSnCXmLYwt</td>
      </tr>
      <tr>
        <td>Rate (factor=1)</td>
        <td>1</td>
        <td>2021-02-08</td>
        <td>k4RGC3sMTzO</td>
      </tr>
      <tr>
        <td>Numerator only (number)</td>
        <td>1</td>
        <td>2021-02-08</td>
        <td>kHy61PbChXr</td>
      </tr>
    </table>
    <h2 id="dashboards">Dashboards</h2>
    <h3>TB1. Notifications (numbers) (annual)</h3>
    <table>
      <tr>
        <td>Name</td>
        <td>Last updated</td>
        <td>UID</td>
      </tr>
      <tr>
        <td>TB1. Notifications (numbers) (annual)</td>
        <td>2021-02-08</td>
        <td>BwYHhBSvLNL</td>
      </tr>
    </table>
    <h4>Dashboard items</h4>
    <table>
      <tr>
        <th>Content UID</th>
        <th>Content/item type</th>
        <th>Content name</th>
        <th>Dashboard Item UID</th>
        <th>Last updated</th>
        <th>Dashboard UID</th>
      </tr>
      <tr>
        <td>LguXYuBEmNQ</td>
        <td>LINE</td>
        <td>TBc_1.1_TB notifications (annual)</td>
        <td>nz9eRv4twT1</td>
        <td>2019-06-28</td>
        <td>BwYHhBSvLNL</td>
      </tr>
      <tr>
        <td>VBUUGBP8RFn</td>
        <td>COLUMN</td>
        <td>TBc_1.2_New and relapse cases by age group and sex (annual)</td>
        <td>qA3xecK9d3N</td>
        <td>2019-06-28</td>
        <td>BwYHhBSvLNL</td>
      </tr>
      <tr>
        <td>aMrO2iGluMw</td>
        <td>LINE</td>
        <td>TBc_1.3_New and relapse cases by age group (%) (annual)</td>
        <td>Id0MtXmYnGx</td>
        <td>2019-06-28</td>
        <td>BwYHhBSvLNL</td>
      </tr>
      <tr>
        <td>kVt5sqalZ0t</td>
        <td>PIVOT_TABLE</td>
        <td>TBt_1.1_TB notifications (annual)</td>
        <td>Obwiyggbku7</td>
        <td>2019-06-28</td>
        <td>BwYHhBSvLNL</td>
      </tr>
      <tr>
        <td></td>
        <td>MAP</td>
        <td></td>
        <td>YXE5JC3UA7M</td>
        <td>2019-06-28</td>
        <td>BwYHhBSvLNL</td>
      </tr>
    </table>
    <h3>TB6. TB/HIV</h3>
    <table>
      <tr>
        <td>Name</td>
        <td>Last updated</td>
        <td>UID</td>
      </tr>
      <tr>
        <td>TB6. TB/HIV</td>
        <td>2021-02-08</td>
        <td>CKcF4jgN0hK</td>
      </tr>
    </table>
    <h4>Dashboard items</h4>
    <table>
      <tr>
        <th>Content UID</th>
        <th>Content/item type</th>
        <th>Content name</th>
        <th>Dashboard Item UID</th>
        <th>Last updated</th>
        <th>Dashboard UID</th>
      </tr>
      <tr>
        <td>SlEHkRsqvAC</td>
        <td>LINE</td>
        <td>TBc_6.1_TB/HIV</td>
        <td>shr7LMtM8On</td>
        <td>2019-06-28</td>
        <td>CKcF4jgN0hK</td>
      </tr>
      <tr>
        <td>OhyeSu7q7iz</td>
        <td>COLUMN</td>
        <td>TBc_6.2_TB/HIV cascade of care</td>
        <td>p2EP63TQ7Lq</td>
        <td>2019-06-28</td>
        <td>CKcF4jgN0hK</td>
      </tr>
      <tr>
        <td>LrUYQgoxjjU</td>
        <td>LINE</td>
        <td>TBc_6.3_TB/HIV (%)</td>
        <td>DbwBROfurIz</td>
        <td>2019-06-28</td>
        <td>CKcF4jgN0hK</td>
      </tr>
      <tr>
        <td>YhP2FYWUnHK</td>
        <td>LINE</td>
        <td>TBc_6.4_Treatment for TB/HIV (%)</td>
        <td>mzHx1LaqrMU</td>
        <td>2019-06-28</td>
        <td>CKcF4jgN0hK</td>
      </tr>
      <tr>
        <td></td>
        <td>MAP</td>
        <td></td>
        <td>d1zWxOwUYd4</td>
        <td>2019-06-28</td>
        <td>CKcF4jgN0hK</td>
      </tr>
      <tr>
        <td></td>
        <td>MAP</td>
        <td></td>
        <td>eef3jlqOLg1</td>
        <td>2019-06-28</td>
        <td>CKcF4jgN0hK</td>
      </tr>
      <tr>
        <td></td>
        <td>MAP</td>
        <td></td>
        <td>D6D3bTBJ61k</td>
        <td>2019-06-28</td>
        <td>CKcF4jgN0hK</td>
      </tr>
      <tr>
        <td></td>
        <td>MAP</td>
        <td></td>
        <td>yD0PNNPCIug</td>
        <td>2019-06-28</td>
        <td>CKcF4jgN0hK</td>
      </tr>
      <tr>
        <td>MovAqKdNJ8g</td>
        <td>PIVOT_TABLE</td>
        <td>TBt_6.1_TB/HIV</td>
        <td>xbJbi0G9gVj</td>
        <td>2019-06-28</td>
        <td>CKcF4jgN0hK</td>
      </tr>
      <tr>
        <td>n6ZXdAl1sfD</td>
        <td>PIVOT_TABLE</td>
        <td>TBt_6.2_TB/HIV recorded at the time of case notification and treatment outcome</td>
        <td>k2RE10PJ1UR</td>
        <td>2019-06-28</td>
        <td>CKcF4jgN0hK</td>
      </tr>
    </table>
    <h3>TB4. Outcomes (annual)</h3>
    <table>
      <tr>
        <td>Name</td>
        <td>Last updated</td>
        <td>UID</td>
      </tr>
      <tr>
        <td>TB4. Outcomes (annual)</td>
        <td>2021-02-08</td>
        <td>dp6xqlPGxbA</td>
      </tr>
    </table>
    <h4>Dashboard items</h4>
    <table>
      <tr>
        <th>Content UID</th>
        <th>Content/item type</th>
        <th>Content name</th>
        <th>Dashboard Item UID</th>
        <th>Last updated</th>
        <th>Dashboard UID</th>
      </tr>
      <tr>
        <td>MtQa13mO6rU</td>
        <td>LINE</td>
        <td>TBc_4.1_TB treatment success rate for DS-TB (%) (annual)</td>
        <td>jZ8cWjx2Zly</td>
        <td>2019-06-28</td>
        <td>dp6xqlPGxbA</td>
      </tr>
      <tr>
        <td>lHQXAQohz06</td>
        <td>LINE</td>
        <td>TBc_4.2_TB notifications vs treatment outcome cohort for DS-TB (annual)</td>
        <td>z81FhoG0C5W</td>
        <td>2019-06-28</td>
        <td>dp6xqlPGxbA</td>
      </tr>
      <tr>
        <td>F5XKTZVRiTS</td>
        <td>STACKED_COLUMN</td>
        <td>TBc_4.3_Treatment outcomes for DS-TB (%) (annual)</td>
        <td>fk7Y6sY2iOG</td>
        <td>2019-06-28</td>
        <td>dp6xqlPGxbA</td>
      </tr>
      <tr>
        <td>irZRk20Tenx</td>
        <td>LINE</td>
        <td>TBc_4.4_TB treatment success rate for DS and DR-TB (%) (annual)</td>
        <td>GI8KHAj0uJo</td>
        <td>2019-06-28</td>
        <td>dp6xqlPGxbA</td>
      </tr>
      <tr>
        <td></td>
        <td>MAP</td>
        <td></td>
        <td>GoxKhw01VL4</td>
        <td>2019-06-28</td>
        <td>dp6xqlPGxbA</td>
      </tr>
      <tr>
        <td></td>
        <td>MAP</td>
        <td></td>
        <td>QEUxuaZkHtJ</td>
        <td>2019-06-28</td>
        <td>dp6xqlPGxbA</td>
      </tr>
      <tr>
        <td></td>
        <td>MAP</td>
        <td></td>
        <td>m4ZXrCYaJSQ</td>
        <td>2019-06-28</td>
        <td>dp6xqlPGxbA</td>
      </tr>
      <tr>
        <td></td>
        <td>MAP</td>
        <td></td>
        <td>MMVRvraY3Sv</td>
        <td>2019-06-28</td>
        <td>dp6xqlPGxbA</td>
      </tr>
      <tr>
        <td>WqjHS2fujHP</td>
        <td>PIVOT_TABLE</td>
        <td>TBt_4.1_TB treatment success for new and relapse DS-TB (%) (annual)</td>
        <td>QyqAwI0jtUQ</td>
        <td>2019-06-28</td>
        <td>dp6xqlPGxbA</td>
      </tr>
    </table>
    <h3>TB Stock</h3>
    <table>
      <tr>
        <td>Name</td>
        <td>Last updated</td>
        <td>UID</td>
      </tr>
      <tr>
        <td>TB Stock</td>
        <td>2021-06-22</td>
        <td>Ea95jPFEnHD</td>
      </tr>
    </table>
    <h4>Dashboard items</h4>
    <table>
      <tr>
        <th>Content UID</th>
        <th>Content/item type</th>
        <th>Content name</th>
        <th>Dashboard Item UID</th>
        <th>Last updated</th>
        <th>Dashboard UID</th>
      </tr>
      <tr>
        <td></td>
        <td>MAP</td>
        <td></td>
        <td>CM2PcEqCR9o</td>
        <td>2021-06-22</td>
        <td>Ea95jPFEnHD</td>
      </tr>
      <tr>
        <td></td>
        <td>MAP</td>
        <td></td>
        <td>KqDxs3fV59E</td>
        <td>2021-06-22</td>
        <td>Ea95jPFEnHD</td>
      </tr>
      <tr>
        <td></td>
        <td>MAP</td>
        <td></td>
        <td>mBvN5C7NCJ4</td>
        <td>2021-06-22</td>
        <td>Ea95jPFEnHD</td>
      </tr>
      <tr>
        <td>nSDMgCmJIuY</td>
        <td>PIVOT_TABLE</td>
        <td>TB - GenExpert Cartridges stock status</td>
        <td>V8tZEe2ARAM</td>
        <td>2021-06-22</td>
        <td>Ea95jPFEnHD</td>
      </tr>
      <tr>
        <td>zYQMT6pnu9V</td>
        <td>PIVOT_TABLE</td>
        <td>TB - GenExpert Cartridges stock discrepancy</td>
        <td>JIKtXlBXXtz</td>
        <td>2021-06-22</td>
        <td>Ea95jPFEnHD</td>
      </tr>
      <tr>
        <td></td>
        <td>MAP</td>
        <td></td>
        <td>anxaaxDVh9I</td>
        <td>2021-06-22</td>
        <td>Ea95jPFEnHD</td>
      </tr>
      <tr>
        <td>VjMcZMgOVmC</td>
        <td>AREA</td>
        <td>TB - Proportion of facilities with stockout days for GeneXpert cartridges</td>
        <td>UciKAQatbZe</td>
        <td>2021-06-22</td>
        <td>Ea95jPFEnHD</td>
      </tr>
      <tr>
        <td></td>
        <td>TEXT</td>
        <td></td>
        <td>dLEMpO2i1Z3</td>
        <td>2021-06-22</td>
        <td>Ea95jPFEnHD</td>
      </tr>
      <tr>
        <td>qjxIL321YEn</td>
        <td>PIVOT_TABLE</td>
        <td>TB - DS-TB drugs stock</td>
        <td>XTRFKHZ2yoi</td>
        <td>2021-06-22</td>
        <td>Ea95jPFEnHD</td>
      </tr>
      <tr>
        <td>VrMKZcU5a3W</td>
        <td>PIVOT_TABLE</td>
        <td>TB - DS-TB drugs stock discrepancy</td>
        <td>UBj7OZXkZMQ</td>
        <td>2021-06-22</td>
        <td>Ea95jPFEnHD</td>
      </tr>
      <tr>
        <td></td>
        <td>MAP</td>
        <td></td>
        <td>VFnInTDCop9</td>
        <td>2021-06-22</td>
        <td>Ea95jPFEnHD</td>
      </tr>
      <tr>
        <td>rPbD7zgFdZT</td>
        <td>AREA</td>
        <td>TB - Proportion of facilities with stockout days for DS-TB drugs</td>
        <td>LX4EVFrVwqo</td>
        <td>2021-06-22</td>
        <td>Ea95jPFEnHD</td>
      </tr>
      <tr>
        <td></td>
        <td>TEXT</td>
        <td></td>
        <td>b0vGBKCZLCq</td>
        <td>2021-06-22</td>
        <td>Ea95jPFEnHD</td>
      </tr>
      <tr>
        <td>EMJHKidKuoc</td>
        <td>PIVOT_TABLE</td>
        <td>TB - DR-TB drugs stock discrepancy</td>
        <td>U8U4RonVgtD</td>
        <td>2021-06-22</td>
        <td>Ea95jPFEnHD</td>
      </tr>
      <tr>
        <td>dsQZNkGSTAc</td>
        <td>PIVOT_TABLE</td>
        <td>TB - DR-TB drugs stock status, last 6 months</td>
        <td>PcPEpYyy0Aj</td>
        <td>2021-06-22</td>
        <td>Ea95jPFEnHD</td>
      </tr>
      <tr>
        <td></td>
        <td>TEXT</td>
        <td></td>
        <td>VlMY2ASTMq8</td>
        <td>2021-06-22</td>
        <td>Ea95jPFEnHD</td>
      </tr>
      <tr>
        <td></td>
        <td>MAP</td>
        <td></td>
        <td>nvXUfRqe14f</td>
        <td>2021-06-22</td>
        <td>Ea95jPFEnHD</td>
      </tr>
      <tr>
        <td>ZAeLdaLBgjB</td>
        <td>AREA</td>
        <td>TB - Proportion of facilities with stockout days for DR-TB drugs</td>
        <td>qcKDsbgk22f</td>
        <td>2021-06-22</td>
        <td>Ea95jPFEnHD</td>
      </tr>
    </table>
    <h3>TB3. Notifications (% and ratios)</h3>
    <table>
      <tr>
        <td>Name</td>
        <td>Last updated</td>
        <td>UID</td>
      </tr>
      <tr>
        <td>TB3. Notifications (% and ratios)</td>
        <td>2021-02-08</td>
        <td>if78tRW7B91</td>
      </tr>
    </table>
    <h4>Dashboard items</h4>
    <table>
      <tr>
        <th>Content UID</th>
        <th>Content/item type</th>
        <th>Content name</th>
        <th>Dashboard Item UID</th>
        <th>Last updated</th>
        <th>Dashboard UID</th>
      </tr>
      <tr>
        <td>NoiUFmU3mwj</td>
        <td>PIVOT_TABLE</td>
        <td>TBt_3.1_TB notifications (% and ratios) (red=outside of expected range)</td>
        <td>dI0BuQ22mrU</td>
        <td>2019-06-28</td>
        <td>if78tRW7B91</td>
      </tr>
      <tr>
        <td>mwZFo4vmMOW</td>
        <td>LINE</td>
        <td>TBc_3.1_Extrapulmonary among new TB cases (%)</td>
        <td>I8JfSmcBEAW</td>
        <td>2019-06-28</td>
        <td>if78tRW7B91</td>
      </tr>
      <tr>
        <td></td>
        <td>MAP</td>
        <td></td>
        <td>ZFF0EYzSHTu</td>
        <td>2019-06-28</td>
        <td>if78tRW7B91</td>
      </tr>
      <tr>
        <td></td>
        <td>MAP</td>
        <td></td>
        <td>UbDvCPn6lA4</td>
        <td>2019-06-28</td>
        <td>if78tRW7B91</td>
      </tr>
      <tr>
        <td>QyQzm2GQCzQ</td>
        <td>LINE</td>
        <td>TBc_3.2_Previously treated among all TB cases (%)</td>
        <td>f46K4CdFW4j</td>
        <td>2019-06-28</td>
        <td>if78tRW7B91</td>
      </tr>
      <tr>
        <td>NAjbRucsu2k</td>
        <td>LINE</td>
        <td>TBc_3.3_Ratio of male:female in new and relapse TB cases</td>
        <td>BOWxnLBWwwC</td>
        <td>2019-06-28</td>
        <td>if78tRW7B91</td>
      </tr>
      <tr>
        <td></td>
        <td>MAP</td>
        <td></td>
        <td>tby2zeoJvAn</td>
        <td>2019-06-28</td>
        <td>if78tRW7B91</td>
      </tr>
      <tr>
        <td></td>
        <td>MAP</td>
        <td></td>
        <td>FkxqwYT02FH</td>
        <td>2019-06-28</td>
        <td>if78tRW7B91</td>
      </tr>
      <tr>
        <td>H4ZogkYjAKR</td>
        <td>LINE</td>
        <td>TBc_3.4_0-14 year olds among new and relapse TB cases (%)</td>
        <td>fPuLv2sFO7Y</td>
        <td>2019-06-28</td>
        <td>if78tRW7B91</td>
      </tr>
      <tr>
        <td>ZheCuN6QKui</td>
        <td>LINE</td>
        <td>TBc_3.5_Ratio of TB cases aged 0-4:5-14 year olds in new and relapse</td>
        <td>eF7XzWNAg07</td>
        <td>2019-06-28</td>
        <td>if78tRW7B91</td>
      </tr>
      <tr>
        <td></td>
        <td>MAP</td>
        <td></td>
        <td>EkVn7xbGCZ1</td>
        <td>2019-06-28</td>
        <td>if78tRW7B91</td>
      </tr>
      <tr>
        <td></td>
        <td>MAP</td>
        <td></td>
        <td>FvXSHrTso6M</td>
        <td>2019-06-28</td>
        <td>if78tRW7B91</td>
      </tr>
      <tr>
        <td>GL1rmJsVIax</td>
        <td>LINE</td>
        <td>TBc_3.6_Bacteriologically confirmed among all pulmonary TB cases (%)</td>
        <td>zbLRuAXW3h3</td>
        <td>2019-06-28</td>
        <td>if78tRW7B91</td>
      </tr>
      <tr>
        <td></td>
        <td>MAP</td>
        <td></td>
        <td>QAM7Kevs5o5</td>
        <td>2019-06-28</td>
        <td>if78tRW7B91</td>
      </tr>
    </table>
    <h3>TB6. TB/HIV (annual)</h3>
    <table>
      <tr>
        <td>Name</td>
        <td>Last updated</td>
        <td>UID</td>
      </tr>
      <tr>
        <td>TB6. TB/HIV (annual)</td>
        <td>2021-02-08</td>
        <td>L2UmLVcb6Dm</td>
      </tr>
    </table>
    <h4>Dashboard items</h4>
    <table>
      <tr>
        <th>Content UID</th>
        <th>Content/item type</th>
        <th>Content name</th>
        <th>Dashboard Item UID</th>
        <th>Last updated</th>
        <th>Dashboard UID</th>
      </tr>
      <tr>
        <td>ATqz1kTBfxW</td>
        <td>LINE</td>
        <td>TBc_6.1_TB/HIV (annual)</td>
        <td>OeMcgjmNLMg</td>
        <td>2019-06-28</td>
        <td>L2UmLVcb6Dm</td>
      </tr>
      <tr>
        <td></td>
        <td>MAP</td>
        <td></td>
        <td>D92gRVlZ8cU</td>
        <td>2019-06-28</td>
        <td>L2UmLVcb6Dm</td>
      </tr>
      <tr>
        <td>X8UHouVdDjc</td>
        <td>COLUMN</td>
        <td>TBc_6.2_TB/HIV cascade of care (annual)</td>
        <td>ZjaM3EaXzMQ</td>
        <td>2019-06-28</td>
        <td>L2UmLVcb6Dm</td>
      </tr>
      <tr>
        <td>NWjd84JZ9RD</td>
        <td>LINE</td>
        <td>TBc_6.3_TB/HIV (%) (annual)</td>
        <td>cyoKklhDNSY</td>
        <td>2019-06-28</td>
        <td>L2UmLVcb6Dm</td>
      </tr>
      <tr>
        <td></td>
        <td>MAP</td>
        <td></td>
        <td>FTbVCFB10Vn</td>
        <td>2019-06-28</td>
        <td>L2UmLVcb6Dm</td>
      </tr>
      <tr>
        <td></td>
        <td>MAP</td>
        <td></td>
        <td>nP0q23XggJq</td>
        <td>2019-06-28</td>
        <td>L2UmLVcb6Dm</td>
      </tr>
      <tr>
        <td></td>
        <td>MAP</td>
        <td></td>
        <td>ogUmIuGstD3</td>
        <td>2019-06-28</td>
        <td>L2UmLVcb6Dm</td>
      </tr>
      <tr>
        <td>fnMFUxmPG8Y</td>
        <td>LINE</td>
        <td>TBc_6.4_Treatment for TB/HIV (%) (annual)</td>
        <td>KSV8x7mQjDn</td>
        <td>2019-06-28</td>
        <td>L2UmLVcb6Dm</td>
      </tr>
      <tr>
        <td>T3gUqqzJLsH</td>
        <td>PIVOT_TABLE</td>
        <td>TBt_6.1_TB/HIV (annual)</td>
        <td>XoCshygFgWg</td>
        <td>2019-06-28</td>
        <td>L2UmLVcb6Dm</td>
      </tr>
      <tr>
        <td>hQ1ksBSIpQr</td>
        <td>PIVOT_TABLE</td>
        <td>TBt_6.2_TB/HIV recorded at the time of case notification and treatment outcome (annual)</td>
        <td>pm7Nn4sPr7L</td>
        <td>2019-06-28</td>
        <td>L2UmLVcb6Dm</td>
      </tr>
    </table>
    <h3>TB3. Notifications (% and ratios) (annual)</h3>
    <table>
      <tr>
        <td>Name</td>
        <td>Last updated</td>
        <td>UID</td>
      </tr>
      <tr>
        <td>TB3. Notifications (% and ratios) (annual)</td>
        <td>2021-02-08</td>
        <td>MaJqTSteIqg</td>
      </tr>
    </table>
    <h4>Dashboard items</h4>
    <table>
      <tr>
        <th>Content UID</th>
        <th>Content/item type</th>
        <th>Content name</th>
        <th>Dashboard Item UID</th>
        <th>Last updated</th>
        <th>Dashboard UID</th>
      </tr>
      <tr>
        <td>o0FulK7B5Tm</td>
        <td>PIVOT_TABLE</td>
        <td>TBt_3.1_TB notifications (% and ratios) (red=outside of expected range) (annual)</td>
        <td>LJBavF0oh1a</td>
        <td>2019-06-28</td>
        <td>MaJqTSteIqg</td>
      </tr>
      <tr>
        <td>cnmGWqRdu7f</td>
        <td>LINE</td>
        <td>TBc_3.1_Extrapulmonary among new TB cases (%) (annual)</td>
        <td>OuYa4mQbFIh</td>
        <td>2019-06-28</td>
        <td>MaJqTSteIqg</td>
      </tr>
      <tr>
        <td></td>
        <td>MAP</td>
        <td></td>
        <td>qSKpXi8CYbH</td>
        <td>2019-06-28</td>
        <td>MaJqTSteIqg</td>
      </tr>
      <tr>
        <td></td>
        <td>MAP</td>
        <td></td>
        <td>cJhZEudYmCB</td>
        <td>2019-06-28</td>
        <td>MaJqTSteIqg</td>
      </tr>
      <tr>
        <td>y1PsykoX8yk</td>
        <td>LINE</td>
        <td>TBc_3.2_Previously treated among all TB cases (%) (annual)</td>
        <td>qHIIthzUTFP</td>
        <td>2019-06-28</td>
        <td>MaJqTSteIqg</td>
      </tr>
      <tr>
        <td>n88jd53fqYz</td>
        <td>LINE</td>
        <td>TBc_3.3_Ratio of male:female in new and relapse TB cases (annual)</td>
        <td>Js28yhoExGv</td>
        <td>2019-06-28</td>
        <td>MaJqTSteIqg</td>
      </tr>
      <tr>
        <td></td>
        <td>MAP</td>
        <td></td>
        <td>EJUIt79AFdp</td>
        <td>2019-06-28</td>
        <td>MaJqTSteIqg</td>
      </tr>
      <tr>
        <td></td>
        <td>MAP</td>
        <td></td>
        <td>UwIuXB0ru0y</td>
        <td>2019-06-28</td>
        <td>MaJqTSteIqg</td>
      </tr>
      <tr>
        <td>m4E9SYCJGk8</td>
        <td>LINE</td>
        <td>TBc_3.4_0-14 year olds among new and relapse TB cases (%) (annual)</td>
        <td>E0P6FWkCHIj</td>
        <td>2019-06-28</td>
        <td>MaJqTSteIqg</td>
      </tr>
      <tr>
        <td>sdrEn6gVLwu</td>
        <td>LINE</td>
        <td>TBc_3.5_Ratio of TB cases aged 0-4:5-14 year olds in new and relapse (annual)</td>
        <td>pVqPr1L2DIe</td>
        <td>2019-06-28</td>
        <td>MaJqTSteIqg</td>
      </tr>
      <tr>
        <td></td>
        <td>MAP</td>
        <td></td>
        <td>WQY9oYmPqPy</td>
        <td>2019-06-28</td>
        <td>MaJqTSteIqg</td>
      </tr>
      <tr>
        <td></td>
        <td>MAP</td>
        <td></td>
        <td>rJq63vCI4xP</td>
        <td>2019-06-28</td>
        <td>MaJqTSteIqg</td>
      </tr>
      <tr>
        <td>n5RtZTSpSMB</td>
        <td>LINE</td>
        <td>TBc_3.6_Bacteriologically confirmed among all pulmonary TB cases (%) (annual)</td>
        <td>Uc7hVulDfzT</td>
        <td>2019-06-28</td>
        <td>MaJqTSteIqg</td>
      </tr>
      <tr>
        <td></td>
        <td>MAP</td>
        <td></td>
        <td>Q2IMp2skRDR</td>
        <td>2019-06-28</td>
        <td>MaJqTSteIqg</td>
      </tr>
    </table>
    <h3>TB4. Outcomes</h3>
    <table>
      <tr>
        <td>Name</td>
        <td>Last updated</td>
        <td>UID</td>
      </tr>
      <tr>
        <td>TB4. Outcomes</td>
        <td>2021-02-08</td>
        <td>pZXvrpebwFT</td>
      </tr>
    </table>
    <h4>Dashboard items</h4>
    <table>
      <tr>
        <th>Content UID</th>
        <th>Content/item type</th>
        <th>Content name</th>
        <th>Dashboard Item UID</th>
        <th>Last updated</th>
        <th>Dashboard UID</th>
      </tr>
      <tr>
        <td>xNUAsk6iKWN</td>
        <td>LINE</td>
        <td>TBc_4.1_TB treatment success rate for DS-TB (%)</td>
        <td>IJuEfo4RKjs</td>
        <td>2019-06-28</td>
        <td>pZXvrpebwFT</td>
      </tr>
      <tr>
        <td></td>
        <td>MAP</td>
        <td></td>
        <td>N6g3WrsvWgi</td>
        <td>2019-06-28</td>
        <td>pZXvrpebwFT</td>
      </tr>
      <tr>
        <td>z4sqramOZ2O</td>
        <td>LINE</td>
        <td>TBc_4.2_TB notifications vs treatment outcome cohort for DS-TB</td>
        <td>AvEoJBCGSEc</td>
        <td>2019-06-28</td>
        <td>pZXvrpebwFT</td>
      </tr>
      <tr>
        <td>QviEQL6VIGG</td>
        <td>STACKED_COLUMN</td>
        <td>TBc_4.3_Treatment outcomes for DS-TB (%)</td>
        <td>aQ7X6BPuvCG</td>
        <td>2019-06-28</td>
        <td>pZXvrpebwFT</td>
      </tr>
      <tr>
        <td></td>
        <td>MAP</td>
        <td></td>
        <td>LlMoGm1BcKv</td>
        <td>2019-06-28</td>
        <td>pZXvrpebwFT</td>
      </tr>
      <tr>
        <td></td>
        <td>MAP</td>
        <td></td>
        <td>HhAX7geBGGQ</td>
        <td>2019-06-28</td>
        <td>pZXvrpebwFT</td>
      </tr>
      <tr>
        <td></td>
        <td>MAP</td>
        <td></td>
        <td>kjEE275wD6L</td>
        <td>2019-06-28</td>
        <td>pZXvrpebwFT</td>
      </tr>
      <tr>
        <td>QpBF8PgtqCo</td>
        <td>PIVOT_TABLE</td>
        <td>TBt_4.1_TB treatment success for new and relapse DS-TB (%)</td>
        <td>zhklAZMSeCv</td>
        <td>2019-06-28</td>
        <td>pZXvrpebwFT</td>
      </tr>
    </table>
    <h3>TB2. Notifications (rates) (annual)</h3>
    <table>
      <tr>
        <td>Name</td>
        <td>Last updated</td>
        <td>UID</td>
      </tr>
      <tr>
        <td>TB2. Notifications (rates) (annual)</td>
        <td>2021-02-08</td>
        <td>VtRtBqorLfR</td>
      </tr>
    </table>
    <h4>Dashboard items</h4>
    <table>
      <tr>
        <th>Content UID</th>
        <th>Content/item type</th>
        <th>Content name</th>
        <th>Dashboard Item UID</th>
        <th>Last updated</th>
        <th>Dashboard UID</th>
      </tr>
      <tr>
        <td>flmCSE02H0L</td>
        <td>LINE</td>
        <td>TBc_2.1_TB notification rate (per 100 000 population) (annual)</td>
        <td>IhRXuXlSqcX</td>
        <td>2019-06-28</td>
        <td>VtRtBqorLfR</td>
      </tr>
      <tr>
        <td></td>
        <td>MAP</td>
        <td></td>
        <td>pnm1O5xvHcu</td>
        <td>2019-06-28</td>
        <td>VtRtBqorLfR</td>
      </tr>
      <tr>
        <td>RebWOM2dwTr</td>
        <td>LINE</td>
        <td>TBc_2.2_Population</td>
        <td>SMesP19mefY</td>
        <td>2019-06-28</td>
        <td>VtRtBqorLfR</td>
      </tr>
      <tr>
        <td></td>
        <td>MAP</td>
        <td></td>
        <td>abS1intHRTr</td>
        <td>2019-06-28</td>
        <td>VtRtBqorLfR</td>
      </tr>
      <tr>
        <td>yme39V6fjq2</td>
        <td>PIVOT_TABLE</td>
        <td>TBt_2.1_TB notification rate (per 100 000 population) (annual)</td>
        <td>KT41iiQUfPh</td>
        <td>2019-06-28</td>
        <td>VtRtBqorLfR</td>
      </tr>
    </table>
    <h3>TB1. Notifications (numbers)</h3>
    <table>
      <tr>
        <td>Name</td>
        <td>Last updated</td>
        <td>UID</td>
      </tr>
      <tr>
        <td>TB1. Notifications (numbers)</td>
        <td>2021-02-08</td>
        <td>w48LnY9Gamc</td>
      </tr>
    </table>
    <h4>Dashboard items</h4>
    <table>
      <tr>
        <th>Content UID</th>
        <th>Content/item type</th>
        <th>Content name</th>
        <th>Dashboard Item UID</th>
        <th>Last updated</th>
        <th>Dashboard UID</th>
      </tr>
      <tr>
        <td>dqXV24zjpab</td>
        <td>LINE</td>
        <td>TBc_1.1_TB notifications</td>
        <td>yZG9zAC6JHB</td>
        <td>2019-06-28</td>
        <td>w48LnY9Gamc</td>
      </tr>
      <tr>
        <td>TfeoSE7Ha8F</td>
        <td>COLUMN</td>
        <td>TBc_1.2_New and relapse cases by age group and sex</td>
        <td>wEXmZGyxdS9</td>
        <td>2019-06-28</td>
        <td>w48LnY9Gamc</td>
      </tr>
      <tr>
        <td>xZzgm1PhIUN</td>
        <td>LINE</td>
        <td>TBc_1.3_New and relapse cases by age group (%)</td>
        <td>nHn8Wyfvrng</td>
        <td>2019-06-28</td>
        <td>w48LnY9Gamc</td>
      </tr>
      <tr>
        <td></td>
        <td>MAP</td>
        <td></td>
        <td>iKxZ7HyjjC1</td>
        <td>2019-06-28</td>
        <td>w48LnY9Gamc</td>
      </tr>
      <tr>
        <td>ByQmGVlO9GY</td>
        <td>PIVOT_TABLE</td>
        <td>TBt_1.1_TB notifications</td>
        <td>Ht3oOsFNYsg</td>
        <td>2019-06-28</td>
        <td>w48LnY9Gamc</td>
      </tr>
    </table>
    <h3>TB5. DR-TB (annual)</h3>
    <table>
      <tr>
        <td>Name</td>
        <td>Last updated</td>
        <td>UID</td>
      </tr>
      <tr>
        <td>TB5. DR-TB (annual)</td>
        <td>2021-02-08</td>
        <td>xJXvUOEhnE9</td>
      </tr>
    </table>
    <h4>Dashboard items</h4>
    <table>
      <tr>
        <th>Content UID</th>
        <th>Content/item type</th>
        <th>Content name</th>
        <th>Dashboard Item UID</th>
        <th>Last updated</th>
        <th>Dashboard UID</th>
      </tr>
      <tr>
        <td>Fw0CsA5Dpvf</td>
        <td>STACKED_COLUMN</td>
        <td>TBc_5.5_Treatment outcomes for DR-TB (%) (annual)</td>
        <td>bUWDwyerBIa</td>
        <td>2019-09-24</td>
        <td>xJXvUOEhnE9</td>
      </tr>
      <tr>
        <td>ag7ePsZlVv3</td>
        <td>COLUMN</td>
        <td>TBc_5.1_Cascade of care for RR/MDR-TB (annual)</td>
        <td>CBAqS2I0Nyf</td>
        <td>2019-09-24</td>
        <td>xJXvUOEhnE9</td>
      </tr>
      <tr>
        <td>giHwCjbaeHp</td>
        <td>LINE</td>
        <td>TBc_5.2_Drug susceptibility testing (DST) coverage for TB cases (%) (annual)</td>
        <td>Id2NdYsksAS</td>
        <td>2019-09-24</td>
        <td>xJXvUOEhnE9</td>
      </tr>
      <tr>
        <td>aW6QKbEDCY7</td>
        <td>LINE</td>
        <td>TBc_5.3_TB cases with laboratory confirmed RR/MDR-TB (%) (annual)</td>
        <td>HEWA7fJ7eIh</td>
        <td>2019-09-24</td>
        <td>xJXvUOEhnE9</td>
      </tr>
      <tr>
        <td>rd4XoF2W92u</td>
        <td>LINE</td>
        <td>TBc_5.4_Laboratory-confirmed RR/MDR-TB cases started MDR treatment (%) (annual)</td>
        <td>gyDj0nK4eOF</td>
        <td>2019-09-24</td>
        <td>xJXvUOEhnE9</td>
      </tr>
      <tr>
        <td>hox3ExUTOAJ</td>
        <td>PIVOT_TABLE</td>
        <td>TBt_5.1_Drug resistance TB (annual)</td>
        <td>NlLftHwaxDS</td>
        <td>2019-09-24</td>
        <td>xJXvUOEhnE9</td>
      </tr>
    </table>
    <h2 id="visualizations">Visualizations</h2>
    <table>
      <tr>
        <th>Name</th>
        <th>Description</th>
        <th>Last updated</th>
        <th>UID</th>
      </tr>
      <tr>
        <td>TBc_4.3b_Treatment outcomes for previously treated DS-TB (%)</td>
        <td></td>
        <td>2021-02-08</td>
        <td>A3sd6M0Ar3A</td>
      </tr>
      <tr>
        <td>TBc_5.1_Cascade of care for RR/MDR-TB (annual)</td>
        <td></td>
        <td>2021-02-08</td>
        <td>ag7ePsZlVv3</td>
      </tr>
      <tr>
        <td>TBc_1.3_New and relapse cases by age group (%) (annual)</td>
        <td></td>
        <td>2021-02-08</td>
        <td>aMrO2iGluMw</td>
      </tr>
      <tr>
        <td>TBc_6.1_TB/HIV (annual)</td>
        <td></td>
        <td>2021-02-08</td>
        <td>ATqz1kTBfxW</td>
      </tr>
      <tr>
        <td>TBc_5.3_TB cases with laboratory confirmed RR/MDR-TB (%) (annual)</td>
        <td></td>
        <td>2021-02-08</td>
        <td>aW6QKbEDCY7</td>
      </tr>
      <tr>
        <td>TBc_1.2a_New smear positive by age group and sex (annual)</td>
        <td></td>
        <td>2021-02-08</td>
        <td>b8BvZ2yyAGI</td>
      </tr>
      <tr>
        <td>TBc_6.2b_TB/HIV cascade of care (%)</td>
        <td></td>
        <td>2021-02-08</td>
        <td>BSKSZRKbSUU</td>
      </tr>
      <tr>
        <td>TBt_1.1_TB notifications</td>
        <td></td>
        <td>2021-02-08</td>
        <td>ByQmGVlO9GY</td>
      </tr>
      <tr>
        <td>TBc_3.1_Extrapulmonary among new TB cases (%) (annual)</td>
        <td></td>
        <td>2021-02-08</td>
        <td>cnmGWqRdu7f</td>
      </tr>
      <tr>
        <td>TBc_6.2c_TB/HIV cascade of care (all cases) (%)</td>
        <td></td>
        <td>2021-02-08</td>
        <td>cS2kUPAkWri</td>
      </tr>
      <tr>
        <td>TBc_4.3a_Treatment outcomes for DS-TB/HIV (%)</td>
        <td></td>
        <td>2021-02-08</td>
        <td>cT3HLHVOOwF</td>
      </tr>
      <tr>
        <td>TBc_1.1_TB notifications</td>
        <td></td>
        <td>2021-02-08</td>
        <td>dqXV24zjpab</td>
      </tr>
      <tr>
        <td>TB - DR-TB drugs stock status, last 6 months</td>
        <td></td>
        <td>2021-04-29</td>
        <td>dsQZNkGSTAc</td>
      </tr>
      <tr>
        <td>TBc_6.2b_TB/HIV cascade of care (%) (annual)</td>
        <td></td>
        <td>2021-02-08</td>
        <td>dXIKcGcRfC4</td>
      </tr>
      <tr>
        <td>TB - DR-TB drugs stock discrepancy</td>
        <td></td>
        <td>2021-04-29</td>
        <td>EMJHKidKuoc</td>
      </tr>
      <tr>
        <td>TBc_4.3_Treatment outcomes for DS-TB (%) (annual)</td>
        <td></td>
        <td>2021-02-08</td>
        <td>F5XKTZVRiTS</td>
      </tr>
      <tr>
        <td>TBc_2.1_TB notification rate (per 100 000 population) (annual)</td>
        <td></td>
        <td>2021-02-08</td>
        <td>flmCSE02H0L</td>
      </tr>
      <tr>
        <td>TBc_6.4_Treatment for TB/HIV (%) (annual)</td>
        <td></td>
        <td>2021-02-08</td>
        <td>fnMFUxmPG8Y</td>
      </tr>
      <tr>
        <td>TBc_5.5_Treatment outcomes for DR-TB (%) (annual)</td>
        <td></td>
        <td>2021-02-08</td>
        <td>Fw0CsA5Dpvf</td>
      </tr>
      <tr>
        <td>TBc_5.2_Drug susceptibility testing (DST) coverage for TB cases (%) (annual)</td>
        <td></td>
        <td>2021-02-08</td>
        <td>giHwCjbaeHp</td>
      </tr>
      <tr>
        <td>TBc_3.6_Bacteriologically confirmed among all pulmonary TB cases (%)</td>
        <td></td>
        <td>2021-02-08</td>
        <td>GL1rmJsVIax</td>
      </tr>
      <tr>
        <td>TBc_6.2a_TB/HIV cascade of care (all cases) (annual)</td>
        <td></td>
        <td>2021-02-08</td>
        <td>gOYlLJb51tn</td>
      </tr>
      <tr>
        <td>TBc_3.4_0-14 year olds among new and relapse TB cases (%)</td>
        <td></td>
        <td>2021-02-08</td>
        <td>H4ZogkYjAKR</td>
      </tr>
      <tr>
        <td>TBt_5.1_Drug resistance TB (annual)</td>
        <td></td>
        <td>2021-02-08</td>
        <td>hox3ExUTOAJ</td>
      </tr>
      <tr>
        <td>TBt_6.2_TB/HIV recorded at the time of case notification and treatment outcome (annual)</td>
        <td>Comparison of TB/HIV data recorded at the time of case notification and data recorded at the time of treatment outcome</td>
        <td>2021-02-08</td>
        <td>hQ1ksBSIpQr</td>
      </tr>
      <tr>
        <td>TBc_4.4_TB treatment success rate for DS and DR-TB (%) (annual)</td>
        <td></td>
        <td>2021-02-08</td>
        <td>irZRk20Tenx</td>
      </tr>
      <tr>
        <td>TBt_1.1_TB notifications (annual)</td>
        <td></td>
        <td>2021-02-08</td>
        <td>kVt5sqalZ0t</td>
      </tr>
      <tr>
        <td>TBc_1.1_TB notifications (annual)</td>
        <td></td>
        <td>2021-02-08</td>
        <td>LguXYuBEmNQ</td>
      </tr>
      <tr>
        <td>TBc_4.2_TB notifications vs treatment outcome cohort for DS-TB (annual)</td>
        <td></td>
        <td>2021-02-08</td>
        <td>lHQXAQohz06</td>
      </tr>
      <tr>
        <td>TBc_6.3_TB/HIV (%)</td>
        <td></td>
        <td>2021-02-08</td>
        <td>LrUYQgoxjjU</td>
      </tr>
      <tr>
        <td>TBc_3.4_0-14 year olds among new and relapse TB cases (%) (annual)</td>
        <td></td>
        <td>2021-02-08</td>
        <td>m4E9SYCJGk8</td>
      </tr>
      <tr>
        <td>TBt_6.1_TB/HIV</td>
        <td></td>
        <td>2021-02-08</td>
        <td>MovAqKdNJ8g</td>
      </tr>
      <tr>
        <td>TBc_4.1_TB treatment success rate for DS-TB (%) (annual)</td>
        <td></td>
        <td>2021-02-08</td>
        <td>MtQa13mO6rU</td>
      </tr>
      <tr>
        <td>TBc_3.1_Extrapulmonary among new TB cases (%)</td>
        <td></td>
        <td>2021-02-08</td>
        <td>mwZFo4vmMOW</td>
      </tr>
      <tr>
        <td>TBc_3.6_Bacteriologically confirmed among all pulmonary TB cases (%) (annual)</td>
        <td></td>
        <td>2021-02-08</td>
        <td>n5RtZTSpSMB</td>
      </tr>
      <tr>
        <td>TBt_6.2_TB/HIV recorded at the time of case notification and treatment outcome</td>
        <td>Comparison of TB/HIV data recorded at the time of case notification and data recorded at the time of treatment outcome</td>
        <td>2021-02-08</td>
        <td>n6ZXdAl1sfD</td>
      </tr>
      <tr>
        <td>TBc_3.3_Ratio of male:female in new and relapse TB cases (annual)</td>
        <td></td>
        <td>2021-02-08</td>
        <td>n88jd53fqYz</td>
      </tr>
      <tr>
        <td>TBc_3.3_Ratio of male:female in new and relapse TB cases</td>
        <td></td>
        <td>2021-02-08</td>
        <td>NAjbRucsu2k</td>
      </tr>
      <tr>
        <td>TBt_3.1_TB notifications (% and ratios) (red=outside of expected range)</td>
        <td></td>
        <td>2021-02-08</td>
        <td>NoiUFmU3mwj</td>
      </tr>
      <tr>
        <td>TBc_1.3a_New cases (all forms) by age group (%) (annual)</td>
        <td></td>
        <td>2021-02-08</td>
        <td>NpBI7jrzA0z</td>
      </tr>
      <tr>
        <td>TB - GenExpert Cartridges stock status</td>
        <td></td>
        <td>2021-04-29</td>
        <td>nSDMgCmJIuY</td>
      </tr>
      <tr>
        <td>TBc_6.3_TB/HIV (%) (annual)</td>
        <td></td>
        <td>2021-02-08</td>
        <td>NWjd84JZ9RD</td>
      </tr>
      <tr>
        <td>TBt_3.1_TB notifications (% and ratios) (red=outside of expected range) (annual)</td>
        <td></td>
        <td>2021-02-08</td>
        <td>o0FulK7B5Tm</td>
      </tr>
      <tr>
        <td>TBc_6.3a_TB/HIV – all TB cases (%)</td>
        <td></td>
        <td>2021-02-08</td>
        <td>obyjcDqxXls</td>
      </tr>
      <tr>
        <td>TBc_6.2_TB/HIV cascade of care</td>
        <td></td>
        <td>2021-02-08</td>
        <td>OhyeSu7q7iz</td>
      </tr>
      <tr>
        <td>TBc_4.3e_Treatment outcomes for smear positive DS-TB (%) (annual)</td>
        <td></td>
        <td>2021-02-08</td>
        <td>ORUu9PBi84b</td>
      </tr>
      <tr>
        <td>TBc_4.3a_Treatment outcomes for DS-TB/HIV (%) (annual)</td>
        <td></td>
        <td>2021-02-08</td>
        <td>q9Tag5rbuDJ</td>
      </tr>
      <tr>
        <td>TBc_4.3d_Treatment outcomes for bacteriologically confirmed DS-TB (%) (annual)</td>
        <td></td>
        <td>2021-02-08</td>
        <td>qjAxCdXK4it</td>
      </tr>
      <tr>
        <td>TB - DS-TB drugs stock</td>
        <td></td>
        <td>2021-04-29</td>
        <td>qjxIL321YEn</td>
      </tr>
      <tr>
        <td>TBc_6.2c_TB/HIV cascade of care (all cases) (%) (annual)</td>
        <td></td>
        <td>2021-02-08</td>
        <td>qmmhMtrCtby</td>
      </tr>
      <tr>
        <td>TBt_4.1_TB treatment success for new and relapse DS-TB (%)</td>
        <td></td>
        <td>2021-02-08</td>
        <td>QpBF8PgtqCo</td>
      </tr>
      <tr>
        <td>TBc_4.3_Treatment outcomes for DS-TB (%)</td>
        <td></td>
        <td>2021-02-08</td>
        <td>QviEQL6VIGG</td>
      </tr>
      <tr>
        <td>TBc_3.2_Previously treated among all TB cases (%)</td>
        <td></td>
        <td>2021-02-08</td>
        <td>QyQzm2GQCzQ</td>
      </tr>
      <tr>
        <td>TBc_5.4_Laboratory-confirmed RR/MDR-TB cases started MDR treatment (%) (annual)</td>
        <td></td>
        <td>2021-02-08</td>
        <td>rd4XoF2W92u</td>
      </tr>
      <tr>
        <td>TBc_2.2_Population</td>
        <td></td>
        <td>2021-02-08</td>
        <td>RebWOM2dwTr</td>
      </tr>
      <tr>
        <td>TB - Proportion of facilities with stockout days for DS-TB drugs</td>
        <td></td>
        <td>2021-04-29</td>
        <td>rPbD7zgFdZT</td>
      </tr>
      <tr>
        <td>TBc_3.5_Ratio of TB cases aged 0-4:5-14 year olds in new and relapse (annual)</td>
        <td></td>
        <td>2021-02-08</td>
        <td>sdrEn6gVLwu</td>
      </tr>
      <tr>
        <td>TBc_6.1_TB/HIV</td>
        <td></td>
        <td>2021-02-08</td>
        <td>SlEHkRsqvAC</td>
      </tr>
      <tr>
        <td>TBt_6.1_TB/HIV (annual)</td>
        <td></td>
        <td>2021-02-08</td>
        <td>T3gUqqzJLsH</td>
      </tr>
      <tr>
        <td>TBc_1.2_New and relapse cases by age group and sex</td>
        <td></td>
        <td>2021-02-08</td>
        <td>TfeoSE7Ha8F</td>
      </tr>
      <tr>
        <td>TBc_4.3b_Treatment outcomes for previously treated DS-TB (%) (annual)</td>
        <td></td>
        <td>2021-02-08</td>
        <td>UHn8QRtiKGH</td>
      </tr>
      <tr>
        <td>TBc_1.2_New and relapse cases by age group and sex (annual)</td>
        <td></td>
        <td>2021-02-08</td>
        <td>VBUUGBP8RFn</td>
      </tr>
      <tr>
        <td>TB - Proportion of facilities with stockout days for GeneXpert cartridges</td>
        <td></td>
        <td>2021-04-29</td>
        <td>VjMcZMgOVmC</td>
      </tr>
      <tr>
        <td>TB - DS-TB drugs stock discrepancy</td>
        <td></td>
        <td>2021-04-29</td>
        <td>VrMKZcU5a3W</td>
      </tr>
      <tr>
        <td>TBt_4.1_TB treatment success for new and relapse DS-TB (%) (annual)</td>
        <td></td>
        <td>2021-02-08</td>
        <td>WqjHS2fujHP</td>
      </tr>
      <tr>
        <td>TBc_6.2_TB/HIV cascade of care (annual)</td>
        <td></td>
        <td>2021-02-08</td>
        <td>X8UHouVdDjc</td>
      </tr>
      <tr>
        <td>TBc_4.1_TB treatment success rate for DS-TB (%)</td>
        <td></td>
        <td>2021-02-08</td>
        <td>xNUAsk6iKWN</td>
      </tr>
      <tr>
        <td>TBc_6.3a_TB/HIV – all TB cases (%) (annual)</td>
        <td></td>
        <td>2021-02-08</td>
        <td>xpiCsSSLVXp</td>
      </tr>
      <tr>
        <td>TBc_1.3_New and relapse cases by age group (%)</td>
        <td></td>
        <td>2021-02-08</td>
        <td>xZzgm1PhIUN</td>
      </tr>
      <tr>
        <td>TBc_3.2_Previously treated among all TB cases (%) (annual)</td>
        <td></td>
        <td>2021-02-08</td>
        <td>y1PsykoX8yk</td>
      </tr>
      <tr>
        <td>TBc_6.4_Treatment for TB/HIV (%)</td>
        <td></td>
        <td>2021-02-08</td>
        <td>YhP2FYWUnHK</td>
      </tr>
      <tr>
        <td>TBt_2.1_TB notification rate (per 100 000 population) (annual)</td>
        <td></td>
        <td>2021-02-08</td>
        <td>yme39V6fjq2</td>
      </tr>
      <tr>
        <td>TBc_4.2_TB notifications vs treatment outcome cohort for DS-TB</td>
        <td></td>
        <td>2021-02-08</td>
        <td>z4sqramOZ2O</td>
      </tr>
      <tr>
        <td>TB - Proportion of facilities with stockout days for DR-TB drugs</td>
        <td></td>
        <td>2021-04-29</td>
        <td>ZAeLdaLBgjB</td>
      </tr>
      <tr>
        <td>TBc_3.5_Ratio of TB cases aged 0-4:5-14 year olds in new and relapse</td>
        <td></td>
        <td>2021-02-08</td>
        <td>ZheCuN6QKui</td>
      </tr>
      <tr>
        <td>TBc_6.2a_TB/HIV cascade of care (all cases)</td>
        <td></td>
        <td>2021-02-08</td>
        <td>ztsp2Ew6kdN</td>
      </tr>
      <tr>
        <td>TBc_1.3b_New smear positive cases by age group (0-14 group) (%) (annual)</td>
        <td></td>
        <td>2021-02-08</td>
        <td>zvXhppFsdjd</td>
      </tr>
      <tr>
        <td>TB - GenExpert Cartridges stock discrepancy</td>
        <td></td>
        <td>2021-04-29</td>
        <td>zYQMT6pnu9V</td>
      </tr>
    </table>
    <h2 id="maps">Maps</h2>
    <table>
      <tr>
        <th>Name</th>
        <th>Description</th>
        <th>Last updated</th>
        <th>UID</th>
      </tr>
      <tr>
        <td>TBm_4.2_Died among DS-TB (%) (annual)</td>
        <td> </td>
        <td>2021-02-08</td>
        <td>AMHFI7PpJO5</td>
      </tr>
      <tr>
        <td>TB - Coverage time for DS-TB drugs by facility</td>
        <td> </td>
        <td>2021-05-03</td>
        <td>b1Q7LZBMulY</td>
      </tr>
      <tr>
        <td>TBm_3.5_Ratio of TB cases aged 0-4:5-14 year olds in new and relapse</td>
        <td> </td>
        <td>2021-02-08</td>
        <td>b6VznqkP4Hc</td>
      </tr>
      <tr>
        <td>TBm_3.2_Previously treated among all TB cases (%)</td>
        <td> </td>
        <td>2021-02-08</td>
        <td>B9OHkT2S5Xj</td>
      </tr>
      <tr>
        <td>TBm_3.3_Ratio of male:female in new and relapse TB cases (annual)</td>
        <td> </td>
        <td>2021-02-08</td>
        <td>DgdlRnHuE0A</td>
      </tr>
      <tr>
        <td>TBm_3.7_Bacteriologically confirmed among previously treated (incl. rel) pulmonary TB cases (%) (annual)</td>
        <td> </td>
        <td>2021-02-08</td>
        <td>Eq9lKUQOykM</td>
      </tr>
      <tr>
        <td>TB - Facilities with stockout days for GeneXpert cartridges</td>
        <td> </td>
        <td>2021-04-30</td>
        <td>eYZd1BLeELf</td>
      </tr>
      <tr>
        <td>TB - Facilities with stockout days for DR-TB drugs</td>
        <td> </td>
        <td>2021-04-29</td>
        <td>f51qX1C56dW</td>
      </tr>
      <tr>
        <td>TBm_3.7_Bacteriologically confirmed among previously treated (incl. rel) pulmonary TB cases (%)</td>
        <td> </td>
        <td>2021-02-08</td>
        <td>HFi8Oy2fFdJ</td>
      </tr>
      <tr>
        <td>TBm_4.4_Not evaluated among DS-TB (%) (annual)</td>
        <td> </td>
        <td>2021-02-08</td>
        <td>HtWmQvq3Big</td>
      </tr>
      <tr>
        <td>TBm_6.1a_All TB cases with known HIV status (%)</td>
        <td> </td>
        <td>2021-02-08</td>
        <td>ICV9ugEX8hT</td>
      </tr>
      <tr>
        <td>TBm_4.3_Lost to follow up among DS-TB (%)</td>
        <td> </td>
        <td>2021-02-08</td>
        <td>IvX8f4BVdep</td>
      </tr>
      <tr>
        <td>TBm_6.2_TB/HIV positive cases (%)</td>
        <td> </td>
        <td>2021-02-08</td>
        <td>j8zUgUmQFZf</td>
      </tr>
      <tr>
        <td>TBm_3.4_0-14 year olds among new and relapse TB cases (%)</td>
        <td> </td>
        <td>2021-02-08</td>
        <td>JCOu5xpYab7</td>
      </tr>
      <tr>
        <td>TBm_6.4_TB/HIV positive cases on ART (%)</td>
        <td> </td>
        <td>2021-02-08</td>
        <td>Jml9eHAea4a</td>
      </tr>
      <tr>
        <td>TBm_4.1_TB treatment success rate for DS-TB (%)</td>
        <td> </td>
        <td>2021-02-08</td>
        <td>JunQVZF5CRT</td>
      </tr>
      <tr>
        <td>TB - Facilities with stockout days for DS-TB drugs</td>
        <td> </td>
        <td>2021-04-29</td>
        <td>LDSu7bMS2Kl</td>
      </tr>
      <tr>
        <td>TBm_3.4_0-14 year olds among new and relapse TB cases (%) (annual)</td>
        <td> </td>
        <td>2021-02-08</td>
        <td>ldttHHBp997</td>
      </tr>
      <tr>
        <td>TBm_4.1_TB treatment success rate for DS-TB (%) (annual)</td>
        <td> </td>
        <td>2021-02-08</td>
        <td>LyVmrWtEG89</td>
      </tr>
      <tr>
        <td>TBm_2.1_TB notification rate (per 100 000 population) (annual)</td>
        <td> </td>
        <td>2021-02-08</td>
        <td>nwpHvLnBA9k</td>
      </tr>
      <tr>
        <td>TBm_3.5_Ratio of TB cases aged 0-4:5-14 year olds in new and relapse (annual)</td>
        <td> </td>
        <td>2021-02-08</td>
        <td>oA74TkHOKnX</td>
      </tr>
      <tr>
        <td>TBm_6.1_TB cases with known HIV status (%)</td>
        <td> </td>
        <td>2021-02-08</td>
        <td>owinxzHtr0A</td>
      </tr>
      <tr>
        <td>TBm_6.1_TB cases with known HIV status (%) (annual)</td>
        <td> </td>
        <td>2021-02-08</td>
        <td>P7av1zZyFUF</td>
      </tr>
      <tr>
        <td>TBm_6.1a_All TB cases with known HIV status (%) (annual)</td>
        <td> </td>
        <td>2021-02-08</td>
        <td>R2kLLio5dEv</td>
      </tr>
      <tr>
        <td>TBm_4.3_Lost to follow up among DS-TB (%) (annual)</td>
        <td> </td>
        <td>2021-02-08</td>
        <td>rJsFxDgQYVj</td>
      </tr>
      <tr>
        <td>TB - Coverage time for GeneXpert cartridges by facility</td>
        <td> </td>
        <td>2021-04-30</td>
        <td>RnpweIAT2Vp</td>
      </tr>
      <tr>
        <td>TBm_3.2_Previously treated among all TB cases (%) (annual)</td>
        <td> </td>
        <td>2021-02-08</td>
        <td>SscfJywlazw</td>
      </tr>
      <tr>
        <td>TBm_4.2_Died among DS-TB (%)</td>
        <td> </td>
        <td>2021-02-08</td>
        <td>tkxvwRtZerK</td>
      </tr>
      <tr>
        <td>TBm_6.3_TB/HIV positive cases</td>
        <td> </td>
        <td>2021-02-08</td>
        <td>TlTNSdMHKmh</td>
      </tr>
      <tr>
        <td>TBm_6.3_TB/HIV positive cases (annual)</td>
        <td> </td>
        <td>2021-02-08</td>
        <td>U6sHkqmq1Fb</td>
      </tr>
      <tr>
        <td>TBm_3.6_Bacteriologically confirmed among all pulmonary TB cases (%) (annual)</td>
        <td> </td>
        <td>2021-02-08</td>
        <td>ueZ62zNlFku</td>
      </tr>
      <tr>
        <td>TBm_6.2_TB/HIV positive cases (%) (annual)</td>
        <td> </td>
        <td>2021-02-08</td>
        <td>UI7LwLu8g36</td>
      </tr>
      <tr>
        <td>TBm_6.4_TB/HIV positive cases on ART (%) (annual)</td>
        <td> </td>
        <td>2021-02-08</td>
        <td>UOxCDyo3OAw</td>
      </tr>
      <tr>
        <td>TBm_1.1_Notified TB cases (new and relapse, all forms)</td>
        <td> </td>
        <td>2021-02-08</td>
        <td>VlwvfmQwK6w</td>
      </tr>
      <tr>
        <td>TBm_3.1_Extrapulmonary among new TB cases (%) (annual)</td>
        <td> </td>
        <td>2021-02-08</td>
        <td>vmbo6abJkSX</td>
      </tr>
      <tr>
        <td>TBm_3.6_Bacteriologically confirmed among all pulmonary TB cases (%)</td>
        <td> </td>
        <td>2021-02-08</td>
        <td>WBJLfr4wqn1</td>
      </tr>
      <tr>
        <td>TBm_1.1_Notified TB cases (new and relapse, all forms)(annual)</td>
        <td> </td>
        <td>2021-02-08</td>
        <td>WPvRBVgIYkG</td>
      </tr>
      <tr>
        <td>TBm_3.1_Extrapulmonary among new TB cases (%)</td>
        <td> </td>
        <td>2021-02-08</td>
        <td>ws2oWQsS755</td>
      </tr>
      <tr>
        <td>TBm_3.3_Ratio of male:female in new and relapse TB cases</td>
        <td> </td>
        <td>2021-02-08</td>
        <td>XMV8asb1Vw0</td>
      </tr>
      <tr>
        <td>TB - Coverage time for DR-TB drugs by facility</td>
        <td> </td>
        <td>2021-05-03</td>
        <td>Y2rQpAz7UMa</td>
      </tr>
      <tr>
        <td>TBm_2.2_Population</td>
        <td> </td>
        <td>2021-02-08</td>
        <td>yuVAwEOE8Ou</td>
      </tr>
      <tr>
        <td>TBm_4.4_Not evaluated among DS-TB (%)</td>
        <td> </td>
        <td>2021-02-08</td>
        <td>ZRCWpzVonSZ</td>
      </tr>
    </table>
    <h2 id="legendSets">Legend Sets</h2>
    <h3>Legend_TBm_3.6</h3>
    <table>
      <tr>
        <th>Property</th>
        <td>Value</td>
      </tr>
      <tr>
        <th>Name:</th>
        <td>Legend_TBm_3.6</td>
      </tr>
      <tr>
        <th>Last updated:</th>
        <td>2021-02-08</td>
      </tr>
      <tr>
        <th>UID</th>
        <td>AZLl9cQBN4T</td>
      </tr>
    </table>
    <h4>Legends</h4>
    <table>
      <tr>
        <th>Name</th>
        <th>Start</th>
        <th>End</th>
        <th>Last updated</th>
        <th>UID</th>
      </tr>
      <tr>
        <td>80 - 100</td>
        <td>80</td>
        <td>100</td>
        <td>2018-08-22</td>
        <td>RHfEO1vcqc6</td>
      </tr>
      <tr>
        <td>60 - 80</td>
        <td>60</td>
        <td>80</td>
        <td>2018-08-22</td>
        <td>JRYnl6RbBWQ</td>
      </tr>
      <tr>
        <td>40 - 60</td>
        <td>40</td>
        <td>60</td>
        <td>2018-08-22</td>
        <td>Sa4708TG8qf</td>
      </tr>
      <tr>
        <td>20 - 40</td>
        <td>20</td>
        <td>40</td>
        <td>2018-08-22</td>
        <td>WA71IIb4Hyu</td>
      </tr>
      <tr>
        <td>0 - 20</td>
        <td>0</td>
        <td>20</td>
        <td>2018-08-22</td>
        <td>vc91HEcRlln</td>
      </tr>
    </table>
    <h3>Legend_TBm_2.1_TB notification rate</h3>
    <table>
      <tr>
        <th>Property</th>
        <td>Value</td>
      </tr>
      <tr>
        <th>Name:</th>
        <td>Legend_TBm_2.1_TB notification rate</td>
      </tr>
      <tr>
        <th>Last updated:</th>
        <td>2021-02-08</td>
      </tr>
      <tr>
        <th>UID</th>
        <td>bvsTaKBeBJr</td>
      </tr>
    </table>
    <h4>Legends</h4>
    <table>
      <tr>
        <th>Name</th>
        <th>Start</th>
        <th>End</th>
        <th>Last updated</th>
        <th>UID</th>
      </tr>
      <tr>
        <td>300 +</td>
        <td>300</td>
        <td>2000</td>
        <td>2018-06-28</td>
        <td>Ov7aA8TPlFM</td>
      </tr>
      <tr>
        <td>200 - 300</td>
        <td>200</td>
        <td>300</td>
        <td>2018-06-28</td>
        <td>EdoKNBlMRjT</td>
      </tr>
      <tr>
        <td>100 - 200</td>
        <td>100</td>
        <td>200</td>
        <td>2018-06-28</td>
        <td>KDRQ5wgWeH8</td>
      </tr>
      <tr>
        <td>75 - 100</td>
        <td>75</td>
        <td>100</td>
        <td>2018-06-28</td>
        <td>NcptBWd0mER</td>
      </tr>
      <tr>
        <td>50 - 75</td>
        <td>50</td>
        <td>75</td>
        <td>2018-06-28</td>
        <td>cVbnXKvjmS3</td>
      </tr>
      <tr>
        <td>25 - 50</td>
        <td>25</td>
        <td>50</td>
        <td>2018-06-28</td>
        <td>XNnRpwmHDJH</td>
      </tr>
      <tr>
        <td>0 - 25</td>
        <td>0.01</td>
        <td>25</td>
        <td>2018-06-28</td>
        <td>VIbwsXYwf6o</td>
      </tr>
      <tr>
        <td>0</td>
        <td>0</td>
        <td>0.01</td>
        <td>2018-06-28</td>
        <td>kxGOEkgAkQh</td>
      </tr>
    </table>
    <h3>Legend_TBm_3.3_Ratio male:female</h3>
    <table>
      <tr>
        <th>Property</th>
        <td>Value</td>
      </tr>
      <tr>
        <th>Name:</th>
        <td>Legend_TBm_3.3_Ratio male:female</td>
      </tr>
      <tr>
        <th>Last updated:</th>
        <td>2021-02-08</td>
      </tr>
      <tr>
        <th>UID</th>
        <td>c2WmhDERIo9</td>
      </tr>
    </table>
    <h4>Legends</h4>
    <table>
      <tr>
        <th>Name</th>
        <th>Start</th>
        <th>End</th>
        <th>Last updated</th>
        <th>UID</th>
      </tr>
      <tr>
        <td>> 2</td>
        <td>2</td>
        <td>20</td>
        <td>2018-06-28</td>
        <td>HwDUqKYklZg</td>
      </tr>
      <tr>
        <td>1</td>
        <td>1</td>
        <td>1</td>
        <td>2018-06-28</td>
        <td>O7iJon3zqgA</td>
      </tr>
      <tr>
        <td>1-2</td>
        <td>1</td>
        <td>2</td>
        <td>2018-06-28</td>
        <td>YwboYL7y0lR</td>
      </tr>
      <tr>
        <td>0.5-1</td>
        <td>0.5</td>
        <td>1</td>
        <td>2018-06-28</td>
        <td>a0uC3QxlzJp</td>
      </tr>
      <tr>
        <td>
          < 0.5</td>
        <td>0</td>
        <td>0.5</td>
        <td>2018-06-28</td>
        <td>rrprM8Ddds3</td>
      </tr>
    </table>
    <h3>Legend_TBt_3.1_Children (%)</h3>
    <table>
      <tr>
        <th>Property</th>
        <td>Value</td>
      </tr>
      <tr>
        <th>Name:</th>
        <td>Legend_TBt_3.1_Children (%)</td>
      </tr>
      <tr>
        <th>Last updated:</th>
        <td>2021-02-08</td>
      </tr>
      <tr>
        <th>UID</th>
        <td>eKcBht0c5OQ</td>
      </tr>
    </table>
    <h4>Legends</h4>
    <table>
      <tr>
        <th>Name</th>
        <th>Start</th>
        <th>End</th>
        <th>Last updated</th>
        <th>UID</th>
      </tr>
      <tr>
        <td>15 - 100</td>
        <td>15</td>
        <td>100</td>
        <td>2018-06-28</td>
        <td>X03rO8hw7n2</td>
      </tr>
      <tr>
        <td>5-15</td>
        <td>5</td>
        <td>15</td>
        <td>2018-06-28</td>
        <td>nL5uBMartNu</td>
      </tr>
      <tr>
        <td>0 - 5</td>
        <td>0</td>
        <td>5</td>
        <td>2018-06-28</td>
        <td>CStbLXkDyI6</td>
      </tr>
    </table>
    <h3>Stock coverage time</h3>
    <table>
      <tr>
        <th>Property</th>
        <td>Value</td>
      </tr>
      <tr>
        <th>Name:</th>
        <td>Stock coverage time</td>
      </tr>
      <tr>
        <th>Last updated:</th>
        <td>2021-04-30</td>
      </tr>
      <tr>
        <th>UID</th>
        <td>f1hWZIYCTzc</td>
      </tr>
    </table>
    <h4>Legends</h4>
    <table>
      <tr>
        <th>Name</th>
        <th>Start</th>
        <th>End</th>
        <th>Last updated</th>
        <th>UID</th>
      </tr>
      <tr>
        <td>Invalid</td>
        <td>12</td>
        <td>200</td>
        <td>2021-04-30</td>
        <td>wfbGANgbnMR</td>
      </tr>
      <tr>
        <td>Overstock</td>
        <td>3</td>
        <td>12</td>
        <td>2021-04-30</td>
        <td>ee8QJxth4ul</td>
      </tr>
      <tr>
        <td>Adequate stock</td>
        <td>1</td>
        <td>3</td>
        <td>2021-04-30</td>
        <td>mmvDbIcm41d</td>
      </tr>
      <tr>
        <td>Understock</td>
        <td>0.0001</td>
        <td>1</td>
        <td>2021-04-30</td>
        <td>wAdm1fy3Fmk</td>
      </tr>
      <tr>
        <td>Stock out</td>
        <td>0</td>
        <td>0.0001</td>
        <td>2021-04-30</td>
        <td>fFBIEwglorN</td>
      </tr>
    </table>
    <h3>Legend_TBt_3.1_Ratio 0-4:5-14</h3>
    <table>
      <tr>
        <th>Property</th>
        <td>Value</td>
      </tr>
      <tr>
        <th>Name:</th>
        <td>Legend_TBt_3.1_Ratio 0-4:5-14</td>
      </tr>
      <tr>
        <th>Last updated:</th>
        <td>2021-02-08</td>
      </tr>
      <tr>
        <th>UID</th>
        <td>gLSVwEvgfnM</td>
      </tr>
    </table>
    <h4>Legends</h4>
    <table>
      <tr>
        <th>Name</th>
        <th>Start</th>
        <th>End</th>
        <th>Last updated</th>
        <th>UID</th>
      </tr>
      <tr>
        <td>3 - 100</td>
        <td>3</td>
        <td>100</td>
        <td>2018-06-28</td>
        <td>CeDN48v2HMJ</td>
      </tr>
      <tr>
        <td>1.5 - 3</td>
        <td>1.5</td>
        <td>3</td>
        <td>2018-06-28</td>
        <td>uwQfapDxDjH</td>
      </tr>
      <tr>
        <td>0 - 1.5</td>
        <td>0</td>
        <td>1.5</td>
        <td>2018-06-28</td>
        <td>V3aBpzhvkE9</td>
      </tr>
    </table>
    <h3>Legend_TBm_6.1_TB/HIV tested (%)</h3>
    <table>
      <tr>
        <th>Property</th>
        <td>Value</td>
      </tr>
      <tr>
        <th>Name:</th>
        <td>Legend_TBm_6.1_TB/HIV tested (%)</td>
      </tr>
      <tr>
        <th>Last updated:</th>
        <td>2021-02-08</td>
      </tr>
      <tr>
        <th>UID</th>
        <td>kgDM8HYbyOr</td>
      </tr>
    </table>
    <h4>Legends</h4>
    <table>
      <tr>
        <th>Name</th>
        <th>Start</th>
        <th>End</th>
        <th>Last updated</th>
        <th>UID</th>
      </tr>
      <tr>
        <td>> 80</td>
        <td>80</td>
        <td>100</td>
        <td>2018-05-29</td>
        <td>jJGbzlsli40</td>
      </tr>
      <tr>
        <td>60 - 80</td>
        <td>60</td>
        <td>80</td>
        <td>2018-05-29</td>
        <td>or4xT4wLIOh</td>
      </tr>
      <tr>
        <td>40 - 60</td>
        <td>40</td>
        <td>60</td>
        <td>2018-05-29</td>
        <td>dySuXqQdQhz</td>
      </tr>
      <tr>
        <td>20 - 40</td>
        <td>20</td>
        <td>40</td>
        <td>2018-05-29</td>
        <td>GZ3ihJU1VUQ</td>
      </tr>
      <tr>
        <td>0 - 20</td>
        <td>0</td>
        <td>20</td>
        <td>2018-05-29</td>
        <td>DzvgreGlT6r</td>
      </tr>
    </table>
    <h3>Legend_TBm_6.4_TB/HIV on ART (%)</h3>
    <table>
      <tr>
        <th>Property</th>
        <td>Value</td>
      </tr>
      <tr>
        <th>Name:</th>
        <td>Legend_TBm_6.4_TB/HIV on ART (%)</td>
      </tr>
      <tr>
        <th>Last updated:</th>
        <td>2021-02-08</td>
      </tr>
      <tr>
        <th>UID</th>
        <td>LHfQrsmoMOB</td>
      </tr>
    </table>
    <h4>Legends</h4>
    <table>
      <tr>
        <th>Name</th>
        <th>Start</th>
        <th>End</th>
        <th>Last updated</th>
        <th>UID</th>
      </tr>
      <tr>
        <td>75 - 100</td>
        <td>75</td>
        <td>100</td>
        <td>2018-06-28</td>
        <td>T7vRYnCgOdr</td>
      </tr>
      <tr>
        <td>50 - 75</td>
        <td>50</td>
        <td>75</td>
        <td>2018-06-28</td>
        <td>B4aPjoBS7gm</td>
      </tr>
      <tr>
        <td>25 - 50</td>
        <td>25</td>
        <td>50</td>
        <td>2018-06-28</td>
        <td>BjG951vEcqj</td>
      </tr>
      <tr>
        <td>0 - 25</td>
        <td>0</td>
        <td>25</td>
        <td>2018-06-28</td>
        <td>qpv2Wgfgvzq</td>
      </tr>
    </table>
    <h3>Legend_TBm_4.1_Tx success rate (all DS-TB) (%)</h3>
    <table>
      <tr>
        <th>Property</th>
        <td>Value</td>
      </tr>
      <tr>
        <th>Name:</th>
        <td>Legend_TBm_4.1_Tx success rate (all DS-TB) (%)</td>
      </tr>
      <tr>
        <th>Last updated:</th>
        <td>2021-02-08</td>
      </tr>
      <tr>
        <th>UID</th>
        <td>mkOwPv9yAsr</td>
      </tr>
    </table>
    <h4>Legends</h4>
    <table>
      <tr>
        <th>Name</th>
        <th>Start</th>
        <th>End</th>
        <th>Last updated</th>
        <th>UID</th>
      </tr>
      <tr>
        <td>90 - 100</td>
        <td>90</td>
        <td>100</td>
        <td>2018-05-29</td>
        <td>nWPtWz6STqn</td>
      </tr>
      <tr>
        <td>80 - 90</td>
        <td>80</td>
        <td>90</td>
        <td>2018-05-29</td>
        <td>EdNvsRg9Oxv</td>
      </tr>
      <tr>
        <td>50 - 80</td>
        <td>50</td>
        <td>80</td>
        <td>2018-05-29</td>
        <td>BUP3WbzqwSC</td>
      </tr>
      <tr>
        <td>20 - 50</td>
        <td>20</td>
        <td>50</td>
        <td>2018-05-29</td>
        <td>oNciUbh8Rhp</td>
      </tr>
      <tr>
        <td>0 - 20</td>
        <td>0</td>
        <td>20</td>
        <td>2018-05-29</td>
        <td>HgOxsev9XT0</td>
      </tr>
    </table>
    <h3>Legend_TBm_3.2_Previously treated (%)</h3>
    <table>
      <tr>
        <th>Property</th>
        <td>Value</td>
      </tr>
      <tr>
        <th>Name:</th>
        <td>Legend_TBm_3.2_Previously treated (%)</td>
      </tr>
      <tr>
        <th>Last updated:</th>
        <td>2021-02-08</td>
      </tr>
      <tr>
        <th>UID</th>
        <td>nyybajrEibI</td>
      </tr>
    </table>
    <h4>Legends</h4>
    <table>
      <tr>
        <th>Name</th>
        <th>Start</th>
        <th>End</th>
        <th>Last updated</th>
        <th>UID</th>
      </tr>
      <tr>
        <td>> 20</td>
        <td>20</td>
        <td>100</td>
        <td>2018-06-28</td>
        <td>m3I1Bm3Kx3i</td>
      </tr>
      <tr>
        <td>10 - 20</td>
        <td>10</td>
        <td>20</td>
        <td>2018-06-28</td>
        <td>JWxM9tlG8uC</td>
      </tr>
      <tr>
        <td>5 - 10</td>
        <td>5</td>
        <td>10</td>
        <td>2018-06-28</td>
        <td>grNxIkz6bQt</td>
      </tr>
      <tr>
        <td>0 - 5</td>
        <td>0</td>
        <td>5</td>
        <td>2018-06-28</td>
        <td>c1zdJAbzmPH</td>
      </tr>
    </table>
    <h3>Legend_TBm_3.1_New extrapulmonary (%)</h3>
    <table>
      <tr>
        <th>Property</th>
        <td>Value</td>
      </tr>
      <tr>
        <th>Name:</th>
        <td>Legend_TBm_3.1_New extrapulmonary (%)</td>
      </tr>
      <tr>
        <th>Last updated:</th>
        <td>2021-02-08</td>
      </tr>
      <tr>
        <th>UID</th>
        <td>PNIsr3txKyc</td>
      </tr>
    </table>
    <h4>Legends</h4>
    <table>
      <tr>
        <th>Name</th>
        <th>Start</th>
        <th>End</th>
        <th>Last updated</th>
        <th>UID</th>
      </tr>
      <tr>
        <td>≥ 30</td>
        <td>30</td>
        <td>100</td>
        <td>2018-06-28</td>
        <td>beKL24FwPTP</td>
      </tr>
      <tr>
        <td>20 - 30</td>
        <td>20</td>
        <td>30</td>
        <td>2018-06-28</td>
        <td>aZmoQaM7GNa</td>
      </tr>
      <tr>
        <td>15 - 20</td>
        <td>15</td>
        <td>20</td>
        <td>2018-06-28</td>
        <td>oUIZC6aGnCn</td>
      </tr>
      <tr>
        <td>10 - 15</td>
        <td>10</td>
        <td>15</td>
        <td>2018-06-28</td>
        <td>gHeuRjDITWT</td>
      </tr>
      <tr>
        <td>5 - 10</td>
        <td>5</td>
        <td>10</td>
        <td>2018-06-28</td>
        <td>FTmkA7TXDsj</td>
      </tr>
      <tr>
        <td>0 - 5</td>
        <td>0</td>
        <td>5</td>
        <td>2018-06-28</td>
        <td>ztDmjmHu5pP</td>
      </tr>
    </table>
    <h3>Stock discrepancy</h3>
    <table>
      <tr>
        <th>Property</th>
        <td>Value</td>
      </tr>
      <tr>
        <th>Name:</th>
        <td>Stock discrepancy</td>
      </tr>
      <tr>
        <th>Last updated:</th>
        <td>2021-05-11</td>
      </tr>
      <tr>
        <th>UID</th>
        <td>pxeFezcPnQl</td>
      </tr>
    </table>
    <h4>Legends</h4>
    <table>
      <tr>
        <th>Name</th>
        <th>Start</th>
        <th>End</th>
        <th>Last updated</th>
        <th>UID</th>
      </tr>
      <tr>
        <td>Positive</td>
        <td>9</td>
        <td>10000000</td>
        <td>2021-05-11</td>
        <td>IdLVcKSBYPP</td>
      </tr>
      <tr>
        <td>Correct stock</td>
        <td>1</td>
        <td>9</td>
        <td>2021-05-11</td>
        <td>bW5lmAtDMhX</td>
      </tr>
      <tr>
        <td>Negative</td>
        <td>-10000000</td>
        <td>1</td>
        <td>2021-05-11</td>
        <td>EcNjRnWM0Yw</td>
      </tr>
    </table>
    <h3>xxx Population (total)</h3>
    <table>
      <tr>
        <th>Property</th>
        <td>Value</td>
      </tr>
      <tr>
        <th>Name:</th>
        <td>xxx Population (total)</td>
      </tr>
      <tr>
        <th>Last updated:</th>
        <td>2021-02-08</td>
      </tr>
      <tr>
        <th>UID</th>
        <td>RcEA84L909S</td>
      </tr>
    </table>
    <h4>Legends</h4>
    <table>
      <tr>
        <th>Name</th>
        <th>Start</th>
        <th>End</th>
        <th>Last updated</th>
        <th>UID</th>
      </tr>
      <tr>
        <td>800000 - 1000000</td>
        <td>800000</td>
        <td>1000000</td>
        <td>2018-05-29</td>
        <td>EFVLtD05wMB</td>
      </tr>
      <tr>
        <td>600000 - 800000</td>
        <td>600000</td>
        <td>800000</td>
        <td>2018-05-29</td>
        <td>Qq7qzjYS0Yd</td>
      </tr>
      <tr>
        <td>400000 - 600000</td>
        <td>400000</td>
        <td>600000</td>
        <td>2018-05-29</td>
        <td>ShWS6PHHTuF</td>
      </tr>
      <tr>
        <td>200000 - 400000</td>
        <td>200000</td>
        <td>400000</td>
        <td>2018-05-29</td>
        <td>NYM6D7zGdNS</td>
      </tr>
      <tr>
        <td>0 - 200000</td>
        <td>0</td>
        <td>200000</td>
        <td>2018-05-29</td>
        <td>KUxkOBcYMGJ</td>
      </tr>
    </table>
    <h3>Legend_TBm_4.2-4_Treatment outcomes (died, lost, not evaluated) (%)</h3>
    <table>
      <tr>
        <th>Property</th>
        <td>Value</td>
      </tr>
      <tr>
        <th>Name:</th>
        <td>Legend_TBm_4.2-4_Treatment outcomes (died, lost, not evaluated) (%)</td>
      </tr>
      <tr>
        <th>Last updated:</th>
        <td>2021-02-08</td>
      </tr>
      <tr>
        <th>UID</th>
        <td>Tqmc5ihvo7W</td>
      </tr>
    </table>
    <h4>Legends</h4>
    <table>
      <tr>
        <th>Name</th>
        <th>Start</th>
        <th>End</th>
        <th>Last updated</th>
        <th>UID</th>
      </tr>
      <tr>
        <td>> 20</td>
        <td>20</td>
        <td>100</td>
        <td>2018-05-29</td>
        <td>V3fgUEXqUN6</td>
      </tr>
      <tr>
        <td>10 - 20</td>
        <td>10</td>
        <td>20</td>
        <td>2018-05-29</td>
        <td>zO30gF4ML5O</td>
      </tr>
      <tr>
        <td>5 - 10</td>
        <td>5</td>
        <td>10</td>
        <td>2018-05-29</td>
        <td>IZY14qHwFMq</td>
      </tr>
      <tr>
        <td>0 - 5</td>
        <td>0</td>
        <td>5</td>
        <td>2018-05-29</td>
        <td>Z2MWPGZa2TU</td>
      </tr>
    </table>
    <h3>Legend_TBm_3.4_0-14 year olds (%)</h3>
    <table>
      <tr>
        <th>Property</th>
        <td>Value</td>
      </tr>
      <tr>
        <th>Name:</th>
        <td>Legend_TBm_3.4_0-14 year olds (%)</td>
      </tr>
      <tr>
        <th>Last updated:</th>
        <td>2021-02-08</td>
      </tr>
      <tr>
        <th>UID</th>
        <td>uKiwPhS2VjW</td>
      </tr>
    </table>
    <h4>Legends</h4>
    <table>
      <tr>
        <th>Name</th>
        <th>Start</th>
        <th>End</th>
        <th>Last updated</th>
        <th>UID</th>
      </tr>
      <tr>
        <td>≥ 15</td>
        <td>15</td>
        <td>100</td>
        <td>2018-06-28</td>
        <td>up3VhU6QDqI</td>
      </tr>
      <tr>
        <td>5 - 15</td>
        <td>5</td>
        <td>15</td>
        <td>2018-06-28</td>
        <td>eOHaurFcaH8</td>
      </tr>
      <tr>
        <td>0 - 5</td>
        <td>0</td>
        <td>5</td>
        <td>2018-06-28</td>
        <td>qjN8wBO2fTz</td>
      </tr>
    </table>
    <h3>Legend_TBm_6.2_TB/HIV positive (%)</h3>
    <table>
      <tr>
        <th>Property</th>
        <td>Value</td>
      </tr>
      <tr>
        <th>Name:</th>
        <td>Legend_TBm_6.2_TB/HIV positive (%)</td>
      </tr>
      <tr>
        <th>Last updated:</th>
        <td>2021-02-08</td>
      </tr>
      <tr>
        <th>UID</th>
        <td>UnokSnIWjqw</td>
      </tr>
    </table>
    <h4>Legends</h4>
    <table>
      <tr>
        <th>Name</th>
        <th>Start</th>
        <th>End</th>
        <th>Last updated</th>
        <th>UID</th>
      </tr>
      <tr>
        <td>≥ 30</td>
        <td>30</td>
        <td>100</td>
        <td>2018-06-28</td>
        <td>rP9bZc8HbLP</td>
      </tr>
      <tr>
        <td>20 - 30</td>
        <td>20</td>
        <td>30</td>
        <td>2018-06-28</td>
        <td>BQ67g0uz5WB</td>
      </tr>
      <tr>
        <td>15 - 20</td>
        <td>15</td>
        <td>20</td>
        <td>2018-06-28</td>
        <td>Zge0Im44ZW7</td>
      </tr>
      <tr>
        <td>10 - 15</td>
        <td>10</td>
        <td>15</td>
        <td>2018-06-28</td>
        <td>WgCB94x0ZTH</td>
      </tr>
      <tr>
        <td>5 - 10</td>
        <td>5</td>
        <td>10</td>
        <td>2018-06-28</td>
        <td>LauTfAmIwKz</td>
      </tr>
      <tr>
        <td>0 - 5</td>
        <td>0</td>
        <td>5</td>
        <td>2018-06-28</td>
        <td>LOtEVAcUXT6</td>
      </tr>
    </table>
    <h3>Legend_TBm_3.5_Ratio 0-4:5-14</h3>
    <table>
      <tr>
        <th>Property</th>
        <td>Value</td>
      </tr>
      <tr>
        <th>Name:</th>
        <td>Legend_TBm_3.5_Ratio 0-4:5-14</td>
      </tr>
      <tr>
        <th>Last updated:</th>
        <td>2021-02-08</td>
      </tr>
      <tr>
        <th>UID</th>
        <td>xY9TN26ieF0</td>
      </tr>
    </table>
    <h4>Legends</h4>
    <table>
      <tr>
        <th>Name</th>
        <th>Start</th>
        <th>End</th>
        <th>Last updated</th>
        <th>UID</th>
      </tr>
      <tr>
        <td>> 3</td>
        <td>3</td>
        <td>100</td>
        <td>2018-05-29</td>
        <td>aaMYKK85CCR</td>
      </tr>
      <tr>
        <td>1.5 - 3.0</td>
        <td>1.45</td>
        <td>3</td>
        <td>2018-05-29</td>
        <td>cFV2cNkYyB7</td>
      </tr>
      <tr>
        <td>
          < 1.5</td>
        <td>0</td>
        <td>1.45</td>
        <td>2018-05-29</td>
        <td>oihOsZc6ZTA</td>
      </tr>
    </table>
    <h2 id="userGroups">User Groups</h2>
    <table>
      <tr>
        <th>Name</th>
        <th>Last updated</th>
        <th>UID</th>
      </tr>
      <tr>
        <td>TB access</td>
        <td>2021-05-20</td>
        <td>pyu2ZlNKbzQ</td>
      </tr>
      <tr>
        <td>TB admin</td>
        <td>2021-05-20</td>
        <td>Ubzlyfqm1gO</td>
      </tr>
    </table>
    <h2>Users</h2>
    <table>
      <tr>
        <th>Username</th>
        <th>Last updated</th>
        <th>UID</th>
      </tr>
      <tr>
        <td>who</td>
        <td>2018-07-13</td>
        <td>vUeLeQMSwhN</td>
      </tr>
    </table>
  </body>

</html>